2-Imino-1,3-thiazoline-based compounds and T-type calcium channel inhibitors containing the same

ABSTRACT

Novel 2-imino-1,3-thiazoline based compounds represented by Chemical Formula I, and T-type calcium channel inhibitors containing the compound are provided. The T-type calcium channel inhibitors according to the present invention are useful as a treating agent of diseases associated with over-expression of the T-type calcium channel.

CROSS REFERENCE TO RELATED APPLICATION

This application claims priority to and the benefit of Korean Patent Application No. 10-2007-0050185 filed on May 23, 2007, which is hereby incorporated by reference for all purposes as if fully set forth herein.

BACKGROUND OF THE INVENTION

(a) Field of the Invention

2-Imino-1,3-thiazoline-based compounds represented by the following Chemical Formula I, and T-type calcium channel inhibitors containing the compound are provided. The T-type calcium channel inhibitors according to the present invention are useful as a treating agent of diseases associated with over-expression of T-type calcium channel.

(b) Description of the Related Art

The T-type calcium channel is a kind of voltage-dependent calcium channel, and plays an important role in regulating the intracellular calcium level at depolarization. As coding genes for the voltage-dependent calcium channels, ten (10) genes have been found, which may be classified into two (2) families of a high voltage activated (HVA) family and a low voltage activated (LVA) family according to the intensity of the activating voltage. The voltage-dependent calcium channels may be classified into three (3) families of L-type channels (Cav1), P/Q-type and N-type (nervous unit) channels (Cav2), and T-type channels, wherein the L-type channels and the P/Q-type and N-type channels belong to the high voltage activated family, and the T-type channels belong to the low voltage activated family (Ertel et al., 2000).

The T-type calcium channel is characterized by a low-voltage activated calcium current, rapid activation, and slow inactivation. Thus far, as coding genes for the T-type calcium channel, three (3) genes have been identified, and they are called α1G (Cav3.1), α1H (Cav3.2), and α1I (Cav3.3), respectively (Cribbs et al., 1998; Perez-Reyes et al., 1998; Klugbauer et al., 1999; Lee et al., 1999; Monteil et al., 2000). The T-type calcium channels may be expressed in the whole body, such as in nervous tissue, the heart, the kidney, smooth muscles, and endocrine organs. The T-type calcium channels have been found to have functions of regulating burst-firing of nervous cells (Huguenard, J. R. et al., Annu. Rev. Physiol. 1996, 58, 329-348), heart pacemaker activity (Zhou, Z. et al., J. Mol. Cell. Cardiol. 1994, 26, 1211-1219), secretion of the hormone aldosterone (Rossier, M. E et al., Endocrinology 1996, 137, 4817-4826), and fertilization (Amoult, C. et al., Proc. Natl. Acad. Sci. 1996, 93, 13004-13009). Recently, it has been revealed that the T-type calcium channels are also associated with pain signaling (Ikeda, H. et al., Science, 2003, 299, 1237-1240).

A relationship between the expression of the T-type calcium channel and various diseases has been found. The expression of the T-type calcium channel in the brain has been found to be associated with nociception and repetitive low threshold firing. Particularly, a recent study has reported a direct relationship between the expression of the T-type calcium channel and pain using a knock-out mouse wherein the T-type calcium channel was deleted (Bourinet E. et al., EMBO, 2005, 24, 315-324; Shin, H. S. et al., Science, 2003, 302, 117-119). In addition, the T-type calcium channel is associated with epilepsy. Absence seizure, which is a type of epilepsy, is caused by over-activation of the T-type calcium channel in the brain (Tsakiridou E. et al., J. Neurosci. 1995, 15, 3110-3117). Ethosuccimide is an inhibitor against the T-type calcium channel, and has been used in treatment of absence seizure. The T-type calcium channel is commonly expressed in the heart and smooth muscles, and thus the inhibitors thereof can also be useful in treatment of hypertension, angina pectoris, and arrhythmia. Recently, it has been found that the T-type calcium channel is associated with the invasion and metastasis of cancer cells, and thus inhibitors thereof may be useful as anticancer drugs (Petty, H. R. et al., US 20060003020A1; McCalmont, W. F. et al, Bioorg. Med. Chem. Lett. 2004, 14, 3691-3695).

The exemplary inhibitor against the T-type calcium channel is miberfradil (Posicor®), developed by Roche. Mibefradil, which is a non-dihydropyridine calcium channel inhibitor, obtained FDA approval as a treatment drug against hypertension and angina pectoris in 1997. However, Mibefradil has been voluntarily removed since 1999 because of its side effect caused by drug-drug interaction by CYP 3A4 enzyme inhibition.

Therefore, efficient T-type calcium channel inhibitors have not yet been developed. In view of the effects of the T-type calcium channel on nerves, pain, epilepsy, hypertension, angina pectoris, heart muscle diseases, blood vessels, cancer metastasis, and the like, it has been required to develop efficient T-type calcium channel inhibitors that are capable of preventing and treating various T-type calcium channel associated diseases by inhibiting the over-expression and over-activation of the T-type calcium channel.

SUMMARY OF THE INVENTION

To satisfy the above request, an embodiment of the present invention provides novel 2-imino-1,3-thiazoline-based compounds having T-type calcium channel inhibiting activity, and T-type calcium channel inhibitors containing the compound.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

A more complete appreciation of the invention, and many of the attendant advantages thereof, will be readily apparent as the same becomes better understood by reference to the following detailed description.

2-imino-1,3-thiazoline-based compounds represented by the following Chemical Formula I, and T-type calcium channel inhibitors containing the compound are provided. The T-type calcium channel inhibitors according to the present invention are useful as a treating agent of diseases associated with over-expression of the T-type calcium channel.

An embodiment of the present invention provides 2-imino-1,3-thiazoline-based compounds represented by the following Chemical Formula I:

wherein

R₁ may be a hydrogen atom, or a C1-C5 linear or branched alkyl group,

R₂, R₃, and R₄ may be the same or different from one another, and independently selected from the group consisting of a hydrogen atom, a halogen atom, a C1-C5 linear or branched alkyl group, a C1-C5 alkyloxy group, a trifluoromethyl group, a trifluoromethoxy group, a phenyloxy group, an amino group, a methanesulfoneamino group, a paratoluenesulfoneamino group, a nitro group, a C1-C5 cyanoalkyl group, a cyano group, a C1-C6 alkoxycarbonyl group, and a C3-C12 cycloalkyl group,

R₅ may be selected from the group consisting of a C1-C5 linear or branched alkyl group, a C3-C6 cycloalkyl group, and a benzyl group,

R₆ may be selected from the group consisting of a C3-C12 cycloalkyl group, a C4-C17 alkylcycloalkyl group, an adamantly group, a benzyl group, and a C8-C13 benzylalkyl group,

n and m may be independently 0 or 1,

HX may be present or absent, and

when HX is present, X may be a halogen atom.

Another embodiment of the present invention provides a method of preparing the 2-imino-1,3-thiazoline based compound.

In a preferable embodiment, the method may include the steps of:

heating/reflowing the compounds represented by Chemical Formulas II and III in a solution of a C1 to C5 alcohol, preferably ethanol, for 5 to 20 hours, preferably 8 to 12 hours, at 20 to 130° C., preferably 50 to 90° C., to prepare the a compound represented by Chemical Formula IV; adding a basic aqueous solution, preferably a caustic soda solution, heating/reflowing for 30 minutes to 5 hours, preferably 1 to 3 hours, at 20 to 120° C., preferably 80 to 100° C., and then adjusting the pH to 1 to 4, preferably 2 to 3, by adding a hydrogen halide, to prepare the compound represented by Chemical Formula V; and adding the compound represented by Chemical Formula VI and an amide condensation binder to the obtained compound represented by Chemical Formula V, and allowing them to react, to prepare the compound represented by Chemical Formula I.

The amide condensation binder may be any agent that is capable of allowing condensation binding of an amino group and a carboxylic acid group, for example one or more selected from the group consisting of diisopropylcarbodiimide, dicyclohexylcarbodiimide, diethylcarbodiimide, and the like.

In Chemical Formula II, R₇ may be an alkoxy having 1 to 6 carbon atoms, preferably methoxy or ethoxy.

The preparation method may be illustrated by Reaction Scheme 1.

The HX and HY may be independently selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, and hydroiodic acid, X and Y may be the same or different from each other, and may be a halogen atom independently selected from the group consisting of fluorine, chlorine, bromine, and iodine, R₁ to R₆ are the same as defined above, and R₇ may be an alkoxy having 1 to 6 carbon atoms, preferably methoxy or ethoxy.

For example, the preparation method of the compound of Chemical Formula I where R₁ is hydrogen, any one of R₂, R₃, and R₄ is phenyloxy, R₅ is methyl, R₆ is cycloheptyl, and the other substituents are hydrogen, may be illustrated by Reaction Scheme 1-1.

In another embodiment, the method of preparing the compound represented by Chemical Formula I may include the step of heating/reflowing the compounds represented by Chemical Formulas VII and VIII in a solution of a C1 to C5 alcohol, preferably ethanol, for 5 to 25 hours, preferably 10 to 20 hours, at 20 to 130° C., preferably 50 to 80° C., and allowing them to directly react, to prepare the compound represented by Chemical Formula I.

The preparation method may be illustrated by Reaction Scheme 2.

wherein R₁ to R₆ and X are the same as defined above.

For example, the preparation method of the compound represented by Chemical Formula I where R₁ is hydrogen, any one of R₂, R₃, and R₄ is phenyloxy, R₅ is methyl, R₆ is cycloheptyl, and the other substituents are hydrogen, may be illustrated by Reaction Scheme 2-1.

The compound represented by Chemical Formula I may be prepared by any one of Reaction Schemes 1 and 2, and any other conventional method known to the relevant field. Among the methods of Reaction Schemes 1 and 2, the method of Reaction Scheme 2 is simpler and excellent in terms of yield, but in other aspects, the method requires a high degree of technology to directly prepare the starting material, the compound of Chemical Formula VII. The method of Reaction Scheme 1 is convenient in obtaining the starting material, but the processes thereof are complicated. Any one of the two methods may be appropriately selected according to the availability of the starting material.

The 2-imino-1,3-thiazoline-based compounds of the present invention have excellent T-type calcium channel inhibiting activities, as shown in the experimental examples below. As described above, since the over-expression or over-activation of the T-type calcium channel may cause nerve diseases, pain, epilepsy, hypertension, angina pectoris, heart muscle disease, vascular disorder, cancer metastasis, and the like, the 2-imino-1,3-thiazoline-based compounds of the present invention can be used in preventing or treating such diseases.

Therefore, another embodiment of the present invention provides a composition for inhibiting T-type calcium channel, and a composition for preventing or treating a disease selected from the group consisting of nerve disease, pain, epilepsy, hypertension, angina pectoris, heart muscle disease, vascular disorder, and cancer, which contains the 2-imino-1,3-thiazoline based compound represented by Chemical Formula I, or pharmaceutically acceptable salt thereof, as an active ingredient.

The amount of the 2-imino-1,3-thiazoline-based compound contained in the composition according to the present invention may be approximately 0.1 to 99 wt %, but is more preferably appropriately controlled according to its usage. Further, the administration dosage may be determined considering age, sex, and condition of the patient, absorption and inactivation rates in the body of the active ingredient, and co-administered drugs. For example, the dosage of the composition may be 1 mg/kg (body weight)/day to 500 mg/kg/day, preferably 1 mg/kg/day to 100 mg/kg/day, based on the active ingredient.

The composition according to the present invention may contain the 2-imino-1,3-thiazoline-based compound with or without other pharmaceutically acceptable drugs, carriers, or excipients. The carriers and excipients used in the present invention may be appropriately selected depending on the intended formulation type of the composition, for example, one or more selected from the group consisting of conventional diluents, fillers, expanders, wetting agents, disintegrants, and/or surfactants. Representative diluents or excipients may include water, dextrin, calcium carbonate, lactose, propylene glycol, liquid paraffin, talc, isomerized sugar, sodium metabisulfite, methylparaben, propylparaben, magnesium stearate, milk sugar, normal saline, flavorings, and colorants.

The composition may be administered by oral or parenteral pathway. The formulation type of the composition may vary depending on its usage. For example, the composition may be formulated in the form of plasters, granules, lotions, powders, syrups, liquids, solutions, aerosols, ointments, fluidextracts, emulsions, suspensions, infusions, tablets, injections, capsules, pills, and the like.

Another embodiment of the present invention provides foods, health supplement foods, or food additives containing the compounds of the present invention. The foods, health supplement foods, or food additives have no special limitations, and for example include foods for special diets (e.g., formula milks, foods for infants or toddlers, and the like), processed meat products, processed fish products, bean curd, acorn curd, noodles (e.g., instant noodles, noodles, and the like), breads, functional foods, seasoning foods (e.g., soy sauces, soybean pastes, Korean hot pepper pastes, mixed sauces, and the like), sauces, confectionery (e.g., snacks), processed milk products (e.g., fermented milk, cheeses, and the like), other processed foods, kimchi, pickled foods (e.g., various kimchies, Korean pickles, and the like), beverages (e.g., fruit or vegetables drinks, soybean milk, fermented drinks, and the like), and seasonings (e.g., instant noodle seasoning and the like), and may be prepared by any conventional method.

The present invention is further explained in more detail with reference to the following examples. These examples, however, should not be interpreted as limiting the scope of the present invention in any manner.

EXAMPLE 1 EXAMPLE 1 Preparation According to Reaction Scheme 1 EXAMPLE 1-1 Synthesis of KHG24123 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

4-bromo-3-oxopentanoic acid methyl ester (14.6 g 75 mmol) and cycloheptylmethylthiourea (13.04 g, 70 mmol) were added to ethanol (150 mL), and subjected to heat/reflow for 10 hours. The reaction mixture was cooled to room temperature, and left for 3 hours at room temperature and for a further 12 hours at −20° C. The produced precipitate was filtrated to obtain a light yellow solid (17.6 g). The obtained solid was dissolved in methanol (35 mL), 6N caustic soda solution (22 mL) was added thereto, and the reaction mixture was subjected to heat/reflow for 2.5 hours.

The reaction mixture was cooled to room temperature and washed once with methylenechloride. To the reaction mixture, 6N hydrochloric acid solution was slowly added until the pH reached 2-3. The produced precipitate was filtrated and dried in the atmosphere to obtain a white solid (9.6 g). (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-acetic acid hydrochloride (305 mg, 1 mmol) and 4-phenoxyaniline (185 mg, 1 mmol) were dissolved in methylenechloride (10 mL), and cooled to 0° C. by ice bath. To the reaction mixture, diisopropylcarbodiimide (126 mg) was slowly added over 10 minutes.

The obtained reaction mixture was stirred at the same temperature for 3 hours, washed three times with water, once with dilute hydrochloric acid, once with a solution of bicarbonate of soda, and once with water, in turn, and then dried with anhydrous magnesium sulfate. The solvent was removed by reduced pressure evaporation. The remained reaction mixture was crystallized in ethylacetate and n-hexane to obtain (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl] (212 mg).

yield: 45%; melting point: 229-230° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.60 (s, 1H, HCl), 9.68 (s, 1H, NH), 7.51 (d, 2H, J=7.8 H_(z), Ar—H), 7.17 (d, 2H, J=7.9 H_(z), Ar—H), 7.04 (s, 1H, vinyl-H), 3.96 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.23 (s, 1H, cyclohexyl-C₁H), 2.81 (m, 1H, J=6.6 H_(z), Ar—CH(CH₃)₂), 1.99-1.16 (m, 10H, cyclohexyl-H), 1.16 (d, 6H, J=6.8 H_(z), Ar—CH(CH₃)₂).

EXAMPLE 1-2 Synthesis of KHG24816 (2-adamantylimino-3-propyl-1,3-thiazolidine-4-yl)-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=n-Pr, R₆=1-adamantyl, n=1, m=0, X=Cl]

Ethyl 4-chloro acetoacetate (13.1 g 80 mmol) and 1-adamantyl-n-propylthiourea (20.1 g, 80 mmol) were added to ethanol (150 ml), and subjected to heat/reflow for 10 hours. The reaction mixture was cooled to room temperature, and left for 3 hours at room temperature and for a further 12 hours at −20° C. The produced precipitate was filtrated to obtain a white solid (23.2 g). The obtained solid was dissolved in methanol (50 mL), 6N caustic soda solution (25 mL) was added thereto, and the reaction mixture was subject to heat/reflow for 2.5 hours.

The reaction mixture was cooled to room temperature, and washed once with methylenechloride. To the reaction mixture, 6N hydrochloric acid solution was slowly added until the pH reached 2-3. The produced precipitate was filtrated and dried in the atmosphere to obtain a white solid (14.1 g).

(2-adamantylimino-3-propyl-1.3-thiazolidine-4-yl)-acetic acid hydrochloride (370 mg, 1 mmol) and 4-chloro-2-fluoroaniline (145 mg, 1 mmol) were dissolved in methylenechloride (5 ml), and cooled to 0° C. by ice bath. To the reaction mixture, diisopropylcarbodiimide (126 mg) was slowly added over 10 minutes.

The obtained reaction mixture was stirred at the same temperature for 3 hours, washed three times with water, once with dilute hydrochloric acid, once with a solution of bicarbonate of soda, and once with water, in turn, and then dried with anhydrous magnesium sulfate. The solvent was removed by reduced pressure evaporation. The remaining reaction mixture was crystallized in ethylacetate and n-hexane to obtain (2-adamantylimino-3-propyl-1.3-thiazolidine-4-yl)-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride (331 mg).

yield: 66.4%; melting point: 131° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.52 (s, 1H, HCl), 8.64 (s, 1H, NH), 7.90-7.27 (m, 3H, ArH), 7.13 (s, 1H, vinyl-H), 4.24 (m, 2H, CH₂CH₂), 4.06 (s, 2H, CH₂), 2.16-1.61 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.86 (t, J=7.3 Hz, 3H, CH₃)

EXAMPLE 2 Preparation According to Reaction Scheme 2 EXAMPLE 2-1 Synthesis of KHG24123 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

4-chloro-3-oxo-N-(4-phenoxyphenyl) butaneamide (152 mg, 0.5 mmol) and cycloheptylmethylurea (93 mg, 0.5 mmol) were added to ethanol (5 mL), and subjected to heat/reflow for 18 hours. The obtained reaction mixture was cooled to room temperature, diethylether (15 mL) was added thereto, and the reaction mixture was left overnight at −20°. The produced white solid was filtrated (166 mg).

yield: 70.6%; melting point: 229-230° C.

¹H NMR (300 MHz, DMSO-d6) δ 10.60 (s, 1H, HCl), 9.68 (s, 1H, NH), 7.51 (d, 2H, J=7.8 Hz, Ar—H), 7.17 (d, 2H, J=7.9 Hz, Ar—H), 7.04 (s, 1H, vinyl-H), 3.96 (s, 2H, 4-CH2), 3.58 (s, 3H, N—CH3), 3.23 (s, 1H, cyclohexyl-C1H), 2.81 (m, 1H, J=6.6 Hz, Ar—CH(CH3)2), 1.99-1.16 (m, 10H, cyclohexyl-H), 1.16 (d, 6H, J=6.8 Hz, Ar—CH(CH3)2).

EXAMPLE 2-2 Synthesis of KHG24237 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

4-chloro-3-oxo-N-(4-fluorophenyl) butaneamide (115 mg, 0.5 mmol) and 1-adamantylmethylurea (112 mg, 0.5 mmol) were added to ethanol (5 mL), and subjected to heat/reflow for 15 hours. The obtained reaction mixture was cooled to room temperature, diethylether (15 mL) was added thereto, and the reaction mixture was left overnight at −20° C. The produced white solid was filtrated (211 mg).

yield: 96.8%; melting point: 201.9° C.

¹H NMR (300 MHz, CD₃OD) δ 7.58 (dd, 2H, J=9.06, 4.84 Hz, ArH-3′ and ArH-5′), 7.08 (dd, 2H, J=8.78, 8.77 Hz, ArH-2′ and ArH-6′), 6.99 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 2.20-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl).

EXAMPLE 2-3 Synthesis of KHG24847 [2-(1-adamantylimino)-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=C₂H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

4-chloro-3-oxo-N-(4-ethylphenyl) butaneamide (120 mg, 0.5 mmol) and 1-adamantylethylurea (119 mg, 0.5 mmol) was added to ethanol (5 mL), and subjected to heat/reflow for 15 hours. The obtained reaction mixture was cooled to room temperature, diethylether (15 mL) was added thereto, and the reaction mixture was left overnight at −20° C. The produced white solid was filtrated (43.5 mg).

yield: 18.9%; melting point: 144-145° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.63 (s, 1H, HCl), 8.40 (s, 1H, NH), 7.50 (d, 2H, J=8.4 Hz, ArH), 7.14 (d, 2H, J=8.4 Hz, ArH), 7.11 (s, 1H, vinyl H), 4.32-4.25 (m, 2H, 3-CH₂CH₃), 3.96 (s, 2H, CH₂), 2.55 (m, 2H, CH₂CH₃) 2.49-1.67 (m, 15H, adamantyl), 1.21-1.12 (m, 6H, 2

CH₃)

The compounds shown in Table 1 were prepared as illustrated in Example 1-1 to 2-3. As described above, the compounds of Table 1 may prepared by any method according to Reaction Scheme 1 or 2, and one skilled in the art may easily select an appropriate method of the two methods to prepare the compounds.

TABLE 1 Compound salt(O, HBr, code R₁ n m R₂, R₃, R₄ R₅ R₆ HCl) KHG23210 H 1 0 4-F CH3 cy-6 HCl KHG23354 H 1 0 4-Br CH3 cy-6 HCl KHG23355 H 1 0 4-OPh CH3 cy-6 HCl KHG23356 H 1 0 3-Cl, 5-Cl CH3 cy-6 HCl KHG23360 H 1 0 2-F, 5-NO2 CH3 cy-6 HCl KHG23361 H 1 0 2-F, 4-Cl CH3 cy-6 HCl KHG23362 H 1 0 4-Cl CH3 cy-6 HCl KHG23364 H 1 0 4-isoPr CH3 cy-6 HCl KHG23365 H 1 0 4-n-Bu CH3 cy-6 HCl KHG24070 H 1 0 3-Cl, 4-OCH3 CH3 cy-6 HCl KHG24071 H 1 0 2-Cl, 4-CH3, 5-Cl CH3 cy-6 HCl KHG24072 H 1 0 3-Cl, 4-CH3 CH3 cy-6 HCl KHG24073 H 1 0 4-tBu CH3 cy-6 HCl KHG24074 H 1 0 4-CF3 CH3 cy-6 HCl KHG24075 H 1 0 3-CF3, 5-CF3 CH3 cy-6 HCl KHG24076 H 1 0 3-OCH3 CH3 cy-6 HCl KHG24077 H 1 0 4-CH3 CH3 cy-6 HCl KHG24080 H 1 0 2-F, 5-F CH3 cy-6 HCl KHG24081 H 1 0 2-F, 4-F CH3 cy-6 HCl KHG24082 H 1 1 2-CH3 CH3 cy-6 HCl KHG24083 H 1 1 2-CF3 CH3 cy-6 HCl KHG24084 H 1 1 3-CF3 CH3 cy-6 HCl KHG24085 H 1 0 3-CO2Et CH3 cy-6 HCl KHG24086 H 1 1 3,4-OCH2O CH3 cy-6 HCl KHG24087 H 1 0 2-F, 5-F CH3 cy-6 HCl KHG24088 H 1 0 3-Cl, 4-Cl CH3 cy-6 HCl KHG24089 H 1 1 H CH3 cy-6 HCl KHG24090 H 1 0 3-OCH3, 4-OCH3 CH3 cy-6 HCl KHG24091 H 1 0 3-F, 4-CH3 CH3 cy-6 HCl KHG24092 H 1 0 4-C2H5 CH3 cy-5 HCl KHG24093 H 1 0 4-F CH3 cy-5 HCl KHG24094 H 1 0 4-OCH3 CH3 cy-5 HCl KHG24095 H 1 0 2-Cl, 4-F CH3 cy-5 HCl KHG24096 H 1 0 4-CH2CN CH3 cy-5 HCl KHG24097 H 1 0 2-Cl, 4-CH3 CH3 cy-5 HCl KHG24098 H 1 0 4-Br CH3 cy-5 HCl KHG24099 H 1 0 4-OPh CH3 cy-5 HCl KHG24100 H 1 0 3-Cl, 5-Cl CH3 cy-5 HCl KHG24101 H 1 0 2-F, 4-CH3 CH3 cy-5 HCl KHG24102 H 1 0 2-F, 4-F CH3 cy-5 HCl KHG24103 H 1 0 2-F, 5-Cl CH3 cy-5 HCl KHG24104 H 1 0 2-F, 5-N02 CH3 cy-5 HCl KHG24105 H 1 0 2-F, 4-Cl CH3 cy-5 HCl KHG24106 H 1 0 4-Cl CH3 cy-5 HCl KHG24107 H 1 0 H CH3 cy-5 HCl KHG24108 H 1 0 3-N02 CH3 cy-6 HCl KHG24109 H 1 0 3-F CH3 cy-6 HCl KHG24110 H 1 0 4-isoPr CH3 cy-6 HCl KHG24111 H 1 0 3-CH3, 4-Br CH3 cy-6 HCl KHG24112 H 1 1 4-F CH3 cy-6 HCl KHG24113 H 1 1 4-Cl CH3 cy-6 HCl KHG24114 H 1 1 4-0CH3 CH3 cy-6 HCl KHG24115 H 1 0 4-isoPr CH3 cy-5 HCl KHG24116 H 1 0 4-n-Bu CH3 cy-5 HCl KHG24117 H 1 0 4-C2H5 CH3 cy-7 HCl KHG24118 H 1 0 4-F CH3 cy-7 HCl KHG24119 H 1 0 4-0CH3 CH3 cy-7 HCl KHG24120 H 1 0 2-Cl, 4-F CH3 cy-7 HCl KHG24121 H 1 0 4-CH2CN CH3 cy-7 HCl KHG24122 H 1 0 4-Br CH3 cy-7 HCl KHG24123 H 1 0 4-0Ph CH3 cy-7 HCl KHG24124 H 1 0 2-Cl, 4-CH3 CH3 cy-7 HCl KHG24125 H 1 0 3-Cl, 5-Cl CH3 cy-7 HCl KHG24126 H 1 0 2-F, 4-CH3 CH3 cy-7 HCl KHG24127 H 1 0 2-F, 4-F CH3 cy-7 HCl KHG24128 H 1 0 2-F, 5-Cl CH3 cy-7 HCl KHG24129 H 1 0 2-F, 5-N02 CH3 cy-7 HCl KHG24130 H 1 0 2-F, 4-Cl CH3 cy-7 HCl KHG24131 H 1 0 4-Cl CH3 cy-7 HCl KHG24132 H 1 0 H CH3 cy-7 HCl KHG24133 H 1 0 4-isoPr CH3 cy-7 HCl KHG24134 H 1 0 4-n-Bu CH3 cy-7 HCl KHG24135 H 1 0 4-Et CH3 cy-3 HCl KHG24136 H 1 0 4-F CH3 cy-3 HCl KHG24137 H 1 0 4-0CH3 CH3 cy-3 HCl KHG24138 H 1 0 2-Cl, 4-F CH3 cy-3 HCl KHG24139 H 1 0 4-CH2CN CH3 cy-3 HCl KHG24140 H 1 0 4-Br CH3 cy-3 HCl KHG24141 H 1 0 4-0Ph CH3 cy-3 HCl KHG24142 H 1 0 2-Cl, 4-Me CH3 cy-3 HCl KHG24144 H 1 0 2-F, 4-CH3 CH3 cy-3 HCl KHG24145 H 1 0 2-F, 4-F CH3 cy-3 HCl KHG24146 H 1 0 2-F, 5-Cl CH3 cy-3 HCl KHG24147 H 1 0 2-F, 5-N02 CH3 cy-3 HCl KHG24148 H 1 0 2-F, 4-Cl CH3 cy-3 HCl KHG24149 H 1 0 4-Cl CH3 cy-3 HCl KHG24150 H 1 0 H CH3 cy-3 HCl KHG24151 H 1 0 4-isoPr CH3 cy-3 HCl KHG24152 H 1 0 4-n-Bu CH3 cy-3 HCl KHG24153 H 1 1 4-F CH3 cy-3 HCl KHG24154 H 1 1 4-Cl CH3 cy-3 HCl KHG24155 H 1 1 4-0CH3 CH3 cy-3 HCl KHG24156 H 1 1 4-F CH3 cy-5 HCl KHG24157 H 1 1 4-Cl CH3 cy-5 HCl KHG24158 H 1 1 4-0CH3 CH3 cy-5 HCl KHG24159 H 1 1 4-F CH3 cy-7 HCl KHG24160 H 1 1 4-Cl CH3 cy-7 HCl KHG24161 H 1 1 4-0CH3 CH3 cy-7 HCl KHG24216 H 1 0 3-CF3, 5-CF3 CH3 CH2CH2Ph HCl KHG24218 H 1 0 3-CF3, 5-CF3 CH3 CH2-cy-6 HCl KHG24220 H 1 0 4-isoPr CH3 CH2CH2Ph HCl KHG24222 H 1 0 4-isoPr CH3 CH2-cy-6 HCl KHG24224 H 1 0 4-0Ph CH3 CH2CH2Ph HCl KHG24226 H 1 0 4-0Ph CH3 CH2-cy-6 HCl KHG24228 H 1 0 4-Cl CH3 CH2CH2Ph HCl KHG24230 H 1 0 4-Cl CH3 CH2-cy-6 HCl KHG24232 H 1 0 2-F, 5-N02 CH3 CH2CH2Ph HCl KHG24234 H 1 0 2-F, 5-N02 CH3 CH2-cy-6 HCl KHG24235 H 1 0 4-CH3 CH3 1-Ad HCl KHG24236 H 1 0 4-CH2CH3 CH3 1-Ad HCl KHG24237 H 1 0 4-F CH3 1-Ad HCl KHG24238 H 1 0 4-Cl CH3 1-Ad HCl KHG24239 H 1 0 4-Br CH3 1-Ad HCl KHG24240 H 1 0 4-CF3 CH3 1-Ad HCl KHG24241 H 1 0 3-CF3, 5-CF3 CH3 1-Ad HCl KHG24242 H 1 0 2-F, 5-Cl CH3 1-Ad HCl KHG24243 H 1 0 4-isoPr CH3 1-Ad HCl KHG24244 H 1 0 4-0C6H5 CH3 1-Ad HCl KHG24261 H 1 0 3-CF3, 5-CF3 CH2CH3 cy-6 HCl KHG24262 H 1 0 4-Cl n-Bu cy-6 HCl KHG24263 H 1 0 4-Br n-Bu cy-6 HCl KHG24264 H 1 0 3-CF3, 5-CF3 n-Bu cy-6 HCl KHG24265 H 1 0 4-Br cy-6 cy-6 HCl KHG24266 H 1 0 4-Cl cy-6 cy-6 HCl KHG24267 H 1 0 3-CF3, 5-CF3 cy-3 cy-6 HCl KHG24268 H 1 0 4-CF3 cy-3 cy-6 HCl KHG24270 H 1 0 4-n-Bu cy-3 cy-6 HCl KHG24271 H 1 0 2-F, 5-Cl cy-3 cy-6 HCl KHG24272 H 1 0 4-CH2CH3 cy-3 cy-6 HCl KHG24273 H 1 0 4-Br cy-3 cy-6 HCl KHG24274 H 1 0 4-CH3 cy-3 cy-6 HCl KHG24275 H 1 0 4-Cl CH2CH3 cy-6 HCl KHG24276 H 1 0 4-0Ph CH2CH3 cy-6 HCl KHG24277 H 1 0 4-n-Bu CH2CH3 cy-6 HCl KHG24278 H 1 0 2-F, 5-N02 CH2CH3 cy-6 HCl KHG24279 H 1 0 4-CH3 CH2CH3 cy-6 HCl KHG24280 H 1 0 4-CF3 CH2CH3 cy-6 HCl KHG24281 H 1 0 4-0Ph n-Bu cy-6 HCl KHG24282 H 1 0 4-n-Bu n-Bu cy-6 HCl KHG24283 H 1 0 4-isoPr n-Bu cy-6 HCl KHG24284 H 1 0 4-F n-Bu cy-6 HCl KHG24285 H 1 0 4-CH3 n-Bu cy-6 HCl KHG24286 H 1 0 4-CH2CH3 n-Bu cy-6 HCl KHG24287 H 1 0 4-Cl n-Pr cy-6 HCl KHG24288 H 1 0 4-Br n-Pr cy-6 HCl KHG24289 H 1 0 3-CF3, 5-CF3 n-Pr cy-6 HCl KHG24290 H 1 0 4-0Ph n-Pr cy-6 HCl KHG24291 H 1 0 4-n-Bu n-Pr cy-6 HCl KHG24292 H 1 1 4-CH3 CH2CH3 cy-6 HCl KHG24293 H 1 1 4-CH3 n-Bu cy-6 HCl KHG24294 H 1 0 4-isoPr n-Pr cy-6 HCl KHG24295 H 1 0 2-F, 5-N02 n-Pr cy-6 HCl KHG24296 H 1 0 4-F n-Pr cy-6 HCl KHG24297 H 1 0 4-CH3 n-Pr cy-6 HCl KHG24298 H 1 0 4-CH2CH3 n-Pr cy-6 HCl KHG24299 H 1 0 4-Cl benzyl cy-6 HCl KHG24300 H 1 0 4-Br benzyl cy-6 HCl KHG24301 H 1 0 3-CF3, 5-CF3 benzyl cy-6 HCl KHG24302 H 1 0 4-0Ph benzyl cy-6 HCl KHG24303 H 1 0 4-isoPr benzyl cy-6 HCl KHG24304 H 1 0 2-F, 5-N02 benzyl cy-6 HCl KHG24305 H 1 0 4-F benzyl cy-6 HCl KHG24306 H 1 0 4-CH2CH3 benzyl cy-6 HCl KHG24307 H 1 0 3-CF3, 5-CF3 cy-6 cy-6 HCl KHG24308 H 1 0 4-isoPr cy-6 cy-6 HCl KHG24309 H 1 0 4-0Ph cy-6 cy-6 HCl KHG24310 H 1 0 4-CF3 cy-6 cy-6 HCl KHG24311 H 1 0 4-n-Bu cy-6 cy-6 HCl KHG24312 H 1 0 4-F cy-6 cy-6 HCl KHG24313 H 1 0 4-CH3 cy-6 cy-6 HCl KHG24314 H 1 0 4-CH2CH3 cy-6 cy-6 HCl KHG24315 H 1 0 4-0Ph cy-3 cy-6 HCl KHG24336 H 0 1 3-Cl CH3 cy-7 HCl KHG24337 H 0 1 4-Cl CH3 cy-7 HCl KHG24338 H 0 1 3-Cl, 4-Cl CH3 cy-7 HCl KHG24339 H 0 1 4-0CH3 CH3 cy-7 HCl KHG24403 H 1 0 4-F CH2CH3 cy-6 HCl KHG24404 H 1 0 4-CF3 n-Pr cy-6 HCl KHG24405 H 1 0 3-Cl, 4-CH3 n-Pr cy-6 HCl KHG24406 H 1 0 4-n-Bu benzyl cy-6 HCl KHG24407 H 1 0 4-CF3 benzyl cy-6 HCl KHG24408 H 1 0 2-F, 5-Cl benzyl cy-6 HCl KHG24409 H 1 0 4-n-Bu CH3 1-Ad HCl KHG24410 H 1 0 3-Cl, 5-Cl CH3 1-Ad HCl KHG24411 H 1 0 2-F, 4-Cl CH3 1-Ad HCl KHG24412 H 1 0 H CH3 1-Ad HCl KHG24413 H 1 0 2-Cl, 4-CH3 CH3 1-Ad HCl KHG24414 H 1 0 3-Cl, 5-Cl CH2CH3 cy-6 HCl KHG24415 H 1 0 3-Cl, 5-Cl n-Pr cy-6 HCl KHG24416 H 1 0 3-Cl, 5-Cl n-Bu cy-6 HCl KHG24417 H 1 0 3-Cl, 5-Cl CH3 1-Ad HCl KHG24418 H 1 0 2-Cl, 4-CH3 CH3 1-Ad HCl KHG24419 H 1 0 4-0CH3 CH3 1-Ad HCl KHG24420 H 1 0 2-Cl, 4-CH3 CH2CH3 cy-6 HCl KHG24421 H 1 0 2-Cl, 4-CH3 n-Bu cy-6 HCl KHG24422 H 1 0 3-Cl, 5-Cl benzyl cy-6 HCl KHG24445 H 1 0 4-N02 CH3 cy-7 HCl KHG24446 H 1 0 4-NH2 CH3 cy-7 HCl KHG24447 H 1 0 4-NHMs CH3 cy-7 HCl KHG24448 H 1 0 4-NHTs CH3 cy-7 HCl KHG24449 H 1 1 4-NHTs CH3 cy-7 HCl KHG24450 H 1 1 4-NHMs CH3 cy-7 HCl KHG24478 H 1 0 3-Cl, 5-Cl H H HCl KHG24479 H 1 0 4-Cl H H HCl KHG24480 CH3 1 0 4-Cl CH3 cy-6 0 KHG24481 CH3 1 0 4-0CH3 CH3 cy-6 0 KHG24482 CH3 1 0 4-Br CH3 cy-6 0 KHG24483 CH3 1 0 3-Cl, 5-Cl CH3 cy-6 0 KHG24484 CH3 1 0 2-F, 5-N02 CH3 cy-6 0 KHG24485 CH3 1 0 4-0CH3 CH3 cy-7 0 KHG24486 CH3 1 0 4-Br CH3 cy-7 0 KHG24516 CH3 1 0 4-n-Bu CH3 cy-7 HCl KHG24517 CH3 1 0 4-CH2CH3 CH3 cy-7 HCl KHG24518 CH3 1 0 4-F CH3 cy-7 HCl KHG24519 CH3 1 0 4-isoPr CH3 cy-7 HCl KHG24520 CH3 1 0 4-CF3 CH3 cy-7 HCl KHG24521 CH3 1 0 4-t-Bu CH3 cy-7 HCl KHG24522 CH3 1 0 3-CF3, 5-CF3 CH3 cy-6 HCl KHG24523 CH3 1 0 4-CH2CH3 CH3 cy-6 HCl KHG24524 CH3 1 0 4-0CF3 CH3 cy-6 HCl KHG24525 CH3 1 0 4-F CH3 cy-6 HCl KHG24526 CH3 1 0 4-isoPr CH3 cy-6 HCl KHG24527 CH3 1 0 4-CF3 CH3 cy-6 HCl KHG24528 H 1 0 3-isoPr CH3 cy-6 HCl KHG24529 H 1 0 3-CF3, 5-CF3 CH3 cy-6 HCl KHG24530 H 1 0 2-Cl, 3-Cl CH3 cy-6 HCl KHG24531 H 1 0 3-Cl, 4-Cl CH3 cy-6 HCl KHG24532 H 1 0 2-Cl, 5-Cl CH3 cy-6 HCl KHG24533 H 1 0 2-Cl, 4-Cl, 5-Cl CH3 cy-6 HCl KHG24534 H 1 0 3-F, 5-F CH3 cy-6 HCl KHG24535 H 1 0 4-CH3 cy-6 cy-6 HCl KHG24536 H 1 0 4-F cy-6 cy-6 HCl KHG24537 H 1 0 3-Cl, 4-CH3 cy-6 cy-6 HCl KHG24538 H 1 0 4-CH2CH3 cy-6 cy-6 HCl KHG24539 H 1 0 4-Cl cy-6 cy-6 HCl KHG24540 H 1 0 2-F, 5-Cl cy-6 cy-6 HCl KHG24541 H 1 0 4-n-Pr cy-6 cy-6 HCl KHG24542 H 1 0 4-Br cy-6 cy-6 HCl KHG24543 H 1 0 4-CF3 cy-6 cy-6 HCl KHG24544 H 1 1 4-Cl cy-6 cy-6 HCl KHG24545 H 1 0 4-t-Bu cy-6 cy-6 HCl KHG24546 H 1 0 3-CF3, 5-CF3 cy-6 cy-6 HCl KHG24547 H 1 1 2-CF3 cy-6 cy-6 HCl KHG24548 H 1 0 4-0Ph cy-6 cy-6 HCl KHG24549 H 1 0 3-Cl, 5-Cl cy-6 cy-6 HCl KHG24550 H 1 0 cy-7 CH3 Ph(2-Cl) HCl KHG24622 H 0 1 H CH3 cy-7 0 KHG24623 H 0 1 H CH3 cy-7 HCl KHG24624 H 0 1 2-Cl CH3 cy-7 0 KHG24625 H 0 1 2-F, 5-F CH3 cy-7 0 KHG24626 H 0 1 2-F, 5-F CH3 cy-7 HCl KHG24627 H 0 1 3-F, 4-F CH3 cy-7 0 KHG24628 H 0 1 4-CH3 CH3 cy-7 0 KHG24629 H 0 1 4-CH3 CH3 cy-7 HCl KHG24630 H 0 1 3-CF3, 5-CF3 CH3 cy-7 0 KHG24631 H 0 0 4-F CH3 cy-7 0 KHG24632 H 0 1 3-CF3, 5-CF3 CH3 cy-7 HCl KHG24633 H 0 1 2-Br CH3 cy-7 0 KHG24634 H 0 1 2-Br CH3 cy-7 HCl KHG24635 CH3 1 0 H CH3 cy-6 HCl KHG24636 CH3 1 0 3-F CH3 cy-6 HCl KHG24637 CH3 1 0 4-t-Bu CH3 cy-6 HCl KHG24638 CH3 1 0 H CH3 cy-7 HCl KHG24639 CH3 1 0 4-CH3 CH3 cy-7 HCl KHG24640 CH3 1 0 2-F CH3 cy-7 HCl KHG24641 CH3 1 0 3-F CH3 cy-7 HCl KHG24642 CH3 1 0 4-N02 CH3 cy-7 HCl KHG24643 CH3 1 0 4-Cl CH3 cy-7 HCl KHG24644 CH3 1 0 3-Cl, 5-Cl CH3 cy-7 HCl KHG24645 CH3 1 0 2-F, 5-N02 CH3 cy-7 HCl KHG24646 CH3 1 0 3-CF3, 5-CF3 CH3 cy-7 HCl KHG24647 CH3 1 0 4-0CF3 CH3 cy-7 HCl KHG24653 CH3 1 0 H CH3 cy-5 HCl KHG24654 CH3 1 0 4-CH3 CH3 cy-5 HCl KHG24655 CH3 1 0 3-F CH3 cy-5 HCl KHG24656 CH3 1 0 4-t-Bu CH3 cy-5 HCl KHG24657 CH3 1 0 4-Cl CH3 cy-5 HCl KHG24658 CH3 1 0 4-N02 CH3 cy-6 HCl KHG24659 CH3 1 0 2-F CH3 cy-5 HCl KHG24660 H 0 0 2-F, 5-N02 CH3 cy-7 HBr KHG24661 H 0 0 2-F, 5-N02 CH3 cy-7 0 KHG24662 H 0 0 4-F CH3 cy-7 HCl KHG24663 H 0 0 4-CH2CH3 CH3 cy-7 HBr KHG24664 H 0 0 4-CH2CH3 CH3 cy-7 0 KHG24666 H 0 1 3-F CH3 cy-7 HCl KHG24667 H 0 1 3-F CH3 cy-7 0 KHG24668 H 0 1 3-Br CH3 cy-7 HBr KHG24669 H 0 1 3-Br CH3 cy-7 0 KHG24670 H 0 1 2-CF3 CH3 cy-7 HBr KHG24671 H 0 1 2-CF3 CH3 cy-7 0 KHG24672 H 0 0 4-CH3 CH3 cy-7 HBr KHG24673 H 0 0 4-CH3 CH3 cy-7 0 KHG24674 H 0 0 3-Cl, 5-Cl CH3 cy-7 0 KHG24675 H 0 0 3-Cl, 5-Cl CH3 cy-7 HBr KHG24676 H 0 0 4-Cl CH3 cy-7 HBr KHG24677 H 0 0 4-Cl CH3 cy-7 0 KHG24678 H 0 0 4-n-Bu CH3 cy-7 HBr KHG24679 H 0 0 4-isoPr CH3 cy-7 HBr KHG24680 H 0 0 4-isoPr CH3 cy-7 0 KHG24681 H 0 0 4-0Ph CH3 cy-7 HBr KHG24682 H 0 0 4-0Ph CH3 cy-7 0 KHG24683 H 0 0 4-t-Bu CH3 cy-7 HBr KHG24684 H 0 0 4-t-Bu CH3 cy-7 0 KHG24685 H 0 0 2-F, 5-Cl CH3 cy-7 HBr KHG24686 H 0 0 2-F, 5-Cl CH3 cy-7 0 KHG24687 H 0 0 3-CF3, 5-CF3 CH3 cy-7 HBr KHG24688 H 0 0 3-CF3, 5-CF3 CH3 cy-7 0 KHG24689 H 0 0 4-n-Bu CH3 cy-7 0 KHG24775 H 1 0 4-Cl n-Bu 1-Ad HCl KHG24776 H 1 0 4-n-Bu n-Bu 1-Ad HCl KHG24777 H 1 0 4-CF3 n-Bu 1-Ad HCl KHG24778 H 1 0 3-Cl, 5-Cl n-Bu 1-Ad HCl KHG24779 H 1 0 3-CF3, 5-CF3 n-Bu 1-Ad HCl KHG24780 H 1 0 4-F n-Bu 1-Ad HCl KHG24781 H 1 0 4-CH3 n-Bu 1-Ad HCl KHG24782 H 1 0 4-CH2CH3 n-Bu 1-Ad HCl KHG24783 H 1 0 2-F, 4-Cl n-Bu 1-Ad HCl KHG24784 H 1 0 4-Br n-Bu 1-Ad HCl KHG24785 H 1 0 2-F, 5-Cl n-Bu 1-Ad HCl KHG24788 H 1 0 4-isoPr cy-3 1-Ad HCl KHG24789 H 1 0 4-n-Bu cy-3 1-Ad HCl KHG24790 H 1 0 4-CF3 cy-3 1-Ad HCl KHG24792 H 1 0 3-CF3, 5-CF3 cy-3 1-Ad HCl KHG24795 H 1 0 4-isoPr n-Bu 1-Ad HCl KHG24796 H 1 0 4-0Ph n-Bu 1-Ad HCl KHG24799 H 1 0 4-CH2CH3 cy-3 1-Ad HCl KHG24800 H 1 0 4-0Ph cy-3 1-Ad HCl KHG24801 H 1 0 2-F, 4-Cl cy-3 1-Ad HCl KHG24802 H 1 0 2-F, 5-Cl cy-3 1-Ad HCl KHG24803 H 1 0 3-0CH20-4 n-Bu 1-Ad HCl KHG24804 H 1 0 3-0CH20-4 cy-3 1-Ad HCl KHG24805 H 1 0 3-Cl, 5-Cl n-Pr 1-Ad HCl KHG24807 H 1 0 4-isoPr n-Pr 1-Ad HCl KHG24808 H 1 0 4-n-Bu n-Pr 1-Ad HCl KHG24809 H 1 0 4-CF3 n-Pr 1-Ad HCl KHG24811 H 1 0 4-F n-Pr 1-Ad HCl KHG24812 H 1 0 4-Br n-Pr 1-Ad HCl KHG24813 H 1 0 4-CH3 n-Pr 1-Ad HCl KHG24814 H 1 0 4-CH2CH3 n-Pr 1-Ad HCl KHG24815 H 1 0 4-0Ph n-Pr 1-Ad HCl KHG24816 H 1 0 2-F, 4-Cl n-Pr 1-Ad HCl KHG24817 H 1 0 2-F, 5-Cl n-Pr 1-Ad HCl KHG24818 H 1 0 2-Cl, 4-CH3 n-Pr 1-Ad HCl KHG24819 H 1 0 4-isoPr CH2CH3 1-Ad HCl KHG24820 H 1 0 4-n-Bu CH2CH3 1-Ad HCl KHG24821 H 1 0 4-CF3 CH2CH3 1-Ad HCl KHG24823 H 1 0 4-Cl isoPr 1-Ad HCl KHG24825 H 1 0 4-n-Bu isoPr 1-Ad HCl KHG24826 H 1 0 4-CF3 isoPr 1-Ad HCl KHG24828 H 1 0 3-CF3, 5-CF3 isoPr 1-Ad HCl KHG24829 H 1 0 4-F isoPr 1-Ad HCl KHG24831 H 1 0 4-CH3 isoPr 1-Ad HCl KHG24832 H 1 0 4-CH2CH3 isoPr 1-Ad HCl KHG24833 H 1 0 4-0Ph isoPr 1-Ad HCl KHG24834 H 1 0 2-F, 4-Cl isoPr 1-Ad HCl KHG24835 H 1 0 2-F, 5-Cl isoPr 1-Ad HCl KHG24836 H 1 0 2-Cl, 4-CH3 isoPr 1-Ad HCl KHG24837 H 1 0 3-0CH20-4 n-Pr 1-Ad HCl KHG24838 H 1 0 3-0CH20-4 isoPr 1-Ad HCl KHG24839 H 1 0 2-F, 5-N02 n-Pr 1-Ad HCl KHG24840 H 1 0 2-F, 5-N02 isoPr 1-Ad HCl KHG24841 H 1 0 4-n-Bu CH3 2-Ad HCl KHG24842 H 1 0 4-F CH3 2-Ad HCl KHG24844 H 1 0 4-isoPr CH3 2-Ad HCl KHG24847 H 1 0 4-CH2CH3 CH2CH3 1-Ad HCl

wherein

NHMs indicates

NHTs indicates

cy-3 indicates cyclopropyl, cy-5 indicates cyclopentyl, cy-6 indicates cyclohexyl, cy-7 indicates cycloheptyl, Pr indicates propyl, Bu indicates butyl, Ph indicates phenyl, 1-Ad indicates 1-adamantyl, and 2-Ad indicates 2-adamantyl.

R₂, R₃, and R₄ represent substituents at the phenyl group, and when the substituent is hydrogen, it is not indicated.

COMPARATIVE EXAMPLE Preparation of Compounds where R₆ is a Phenyl Group

The compounds where R₆ is a phenyl group were prepared by the same method of Example 1 or Example 2. The prepared compounds are shown in Table 3 below.

EXPERIMENTAL EXAMPLE Test for T-type Calcium Channel Inhibiting Activity

In the present invention, in order to examine an efficient inhibitor against the T-type calcium channel, a primary assay for T-type calcium channel inhibiting activity was conducted by a high-efficient assay using FDSS6000, wherein mammal HEK293 cell lines (originated from human kidney carcinoma cells) that specifically express α1G of the T-type calcium channel was used for primary assay. Through the primary assay, compounds that show meaningful inhibition effects were selected. The selected compounds were used in a second assay for T-type calcium channel inhibiting activity using an electrophysiological whole cell patch clamp method, wherein mammal HEK293 cell lines (originated from human kidney carcinoma cells) that specifically express α_(1G) of the T-type calcium channel was used for the second assay. Mibefradil, which had been developed as a T-type calcium channel inhibitor, was used as a reference.

EXPERIMENTAL EXAMPLE 1 Method of Assay for % Inhibiting Activity Against T-Type Calcium Channel Using FDSS6000

At 12-24 hours before being used for this assay, cells of HEK293 cell line (α_(1G) cell line: KCTC 10519BP, Korean Collection for Type Cultures), which stably express α_(1G) T-type calcium channel and Kir2.1, were sub-cultured in a poly-L-lysine treated 96-well plate with the density of 4×10⁴ per well using a 96-well cell dispenser (Titertek). On the day of assay, the 96-well plate to which the cells were attached was washed three times with HEPES buffer solution (150 mM of NaCl, 5 mM of KCl, 1 mM of MgCl₂, 2 mM of CaCl₂, 10 mM of HEPES, 10 mM of glucose; pH 7.4) using a 96-well plate automatic washing device (Bio Tek), then reacted with HEPES buffer solution containing 5 μM fluo-3/AM and 0.001% Pluronic F-127 at room temperature for 1 hour, to label with fluorescent dye, and then further washed two times with HEPES buffer solution.

Thereafter, at 10 minutes before the measurement using device FDSS6000, washing with HEPES buffer solution containing 10 mM CaCl₂ was conducted once more, and the final volume was adjusted to 81 μl. Besides the above 96-well plate containing the cells, two additional drug 96-well plates were provided, wherein the 96-well plates contained an inhibiting drug and KCl (final concentration: 75 mM) for activating the T-type calcium channel, respectively. Since most of cell-based HTS devices are equipped with a liquid application system for injection of drug, but have no liquid sucking system, the inhibiting drug to be tested and KCl were respectively provided at a five-times higher concentration in 10 mM CaCl₂ HEPES buffer solution at the amount of 27 μl, diluted by five-times at the final cell plate volume of 135 μl, and then used in this test. The concrete method of measurement using FDSS6000 was as follows. After recording the reference value of 20 seconds, the change of intracellular Ca²⁺ concentration that was induced by treatment of the inhibiting drug to be tested for 75 seconds followed by administration of KCl was measured, wherein the percentage (%) inhibition effect of the test drug, through estimating the area of ratio value of 340/380 in the control without treatment of the test drug, was 100%. As a reference drug, 10 μM mibefradil was used.

For accurate calcium imaging, the light source of 4 xenon lamps in FDSS6000 were radiated to selectively expose the cells to the excitation wavelength (340 nm and 380 nm) by a computer-controlled filter wheel. Data was obtained at intervals of 1.23 seconds. The emitter fluorescence light inflowed through a long-pass filter was obtained as an average 340/380 ratio value for each well in the 96-wells by using a CCD camera and a digital fluorescence analyzer in FDSS6000. All image data and analyses were obtained by using a FDSS6000-exclusive program from Hamamatsu Photonics.

The obtained results are shown in Table 2 (the results from the compounds according to the examples of the present invention) and Table 3 (the results from the compounds according to the comparative example where R₆ is a phenyl group) [FDSS (% inhibition) 10 μM].

TABLE 2 FDSS values of the compounds according to the examples of the present invention (concentration: 10 μM) Compound Code FDSS (% inhibition)/10uM KHG23210 46.69 KHG23354 54.26 KHG23355 58.95 KHG23356 60.46 KHG23360 66.64 KHG23361 62.4 KHG23362 66.17 KHG23364 53 KHG23365 60.16 KHG24070 52.96 KHG24071 52.13 KHG24072 63.5 KHG24073 57.30 KHG24074 65.2 KHG24075 73.72 KHG24076 39.94 KHG24077 46.41 KHG24081 38.27 KHG24082 37.39 KHG24083 47.92 KHG24084 58.61 KHG24085 52.60 KHG24086 30.49 KHG24087 35.35 KHG24088 43.19 KHG24090 32.09 KHG24091 30.27 KHG24092 43.13 KHG24093 34.77 KHG24095 30.53 KHG24098 50.54 KHG24099 58.17 KHG24100 60.81 KHG24103 45.01 KHG24104 34.30 KHG24105 40.42 KHG24106 49.44 KHG24108 44.42 KHG24109 48.39 KHG24110 53.56 KHG24111 67.74 KHG24112 30.27 KHG24113 54.13 KHG24115 49.91 KHG24116 65.43 KHG24117 67.09 KHG24118 66 KHG24119 52.85 KHG24120 60.08 KHG24121 41.02 KHG24122 71.12 KHG24123 76.6 KHG24124 59.49 KHG24125 71.79 KHG24126 53.79 KHG24127 49.69 KHG24128 62.56 KHG24129 61.39 KHG24130 70.4 KHG24131 72.86 KHG24132 50.94 KHG24133 69.18 KHG24134 75.92 KHG24141 35.67 KHG24152 33.88 KHG24157 36.68 KHG24159 48.52 KHG24160 61.93 KHG24161 31.29 KHG24216 35.96 KHG24218 52.8 KHG24220 40.77 KHG24222 34.75 KHG24224 31.98 KHG24228 48.58 KHG24230 32.97 KHG24232 33.68 KHG24234 45.44 KHG24235 61.65 KHG24236 69.55 KHG24237 74.81 KHG24238 73.31 KHG24239 69.55 KHG24240 70.68 KHG24241 70.68 KHG24242 53.38 KHG24243 60.9 KHG24244 53.67 KHG24261 65.03 KHG24262 52.95 KHG24263 52.11 KHG24266 33.58 KHG24267 70.98 KHG24268 58.73 KHG24270 62.65 KHG24271 37.76 KHG24272 37.64 KHG24273 48.47 KHG24276 42.79 KHG24277 61.14 KHG24278 53.77 KHG24279 44.11 KHG24280 54.04 KHG24281 31.39 KHG24282 43.59 KHG24283 51.17 KHG24284 44.56 KHG24285 46.01 KHG24286 55.16 KHG24287 58.52 KHG24288 54.96 KHG24290 62.21 KHG24291 63.16 KHG24292 43.85 KHG24293 55.83 KHG24294 65.74 KHG24295 36.18 KHG24296 53.09 KHG24297 51.03 KHG24298 60.39 KHG24299 45.63 KHG24300 36.73 KHG24303 31.1 KHG24305 58.88 KHG24306 53.2 KHG24307 43.88 KHG24313 31.04 KHG24315 60.8 KHG24336 60.11 KHG24337 56.62 KHG24338 70.79 KHG24339 44.19 KHG24403 49.12 KHG24404 64.67 KHG24405 68.39 KHG24406 34.44 KHG24407 48.66 KHG24408 32.62 KHG24409 57.43 KHG24410 64.09 KHG24411 62.67 KHG24412 56.4 KHG24413 62.08 KHG24414 60.98 KHG24415 64.16 KHG24416 59.78 KHG24417 59.08 KHG24418 56.94 KHG24419 46.7 KHG24420 58.51 KHG24421 65.75 KHG24422 46.27 KHG24445 50.8 KHG24448 47.4 KHG24449 40.5 KHG24480 51.65 KHG24482 52.39 KHG24483 52.53 KHG24484 32.82 KHG24486 55.82 KHG24516 54.57 KHG24517 49.61 KHG24518 50.74 KHG24519 55.73 KHG24520 64.82 KHG24521 54.29 KHG24522 47.91 KHG24523 46.3 KHG24524 41.33 KHG24525 31.51 KHG24526 42.32 KHG24527 46.97 KHG24528 54.17 KHG24529 58.22 KHG24530 38.5 KHG24531 48.42 KHG24532 52.54 KHG24533 48.89 KHG24534 45.69 KHG24535 40.31 KHG24547 51.06 KHG24626 42.6 KHG24627 48.51 KHG24628 42.63 KHG24629 47.03 KHG24630 56.77 KHG24632 57.06 KHG24633 40.39 KHG24634 46.88 KHG24636 35.24 KHG24638 40.77 KHG24639 48.46 KHG24640 39.61 KHG24641 63.52 KHG24642 66.74 KHG24643 65.38 KHG24644 53.37 KHG24645 48.38 KHG24646 58.12 KHG24647 62.36 KHG24656 46.14 KHG24657 47.95 KHG24666 46.2 KHG24667 45.99 KHG24668 50.71 KHG24669 36.57 KHG24670 46.74 KHG24671 47.2 KHG24775 62.91 KHG24776 33.76 KHG24777 49.23 KHG24780 55.28 KHG24781 47.18 KHG24782 30.6 KHG24783 54.43 KHG24784 36.63 KHG24785 47.09 KHG24788 72.88 KHG24789 78.21 KHG24790 73.05 KHG24792 67.05 KHG24795 33.71 KHG24799 63.41 KHG24800 83.5 KHG24801 63.76 KHG24802 62.39 KHG24803 66.47 KHG24804 44.67 KHG24805 32.24 KHG24807 59.69 KHG24808 37.57 KHG24809 57.27 KHG24811 71.82 KHG24812 53.84 KHG24813 61.56 KHG24814 76.32 KHG24815 32.7 KHG24816 80.83 KHG24817 60.49 KHG24818 68.24 KHG24819 69.25 KHG24820 58.02 KHG24821 73.69 KHG24823 54.1 KHG24826 46.49 KHG24828 35.38 KHG24829 68.99 KHG24831 57 KHG24832 46.52 KHG24833 37.05 KHG24834 65.73 KHG24835 55.17 KHG24836 48.91 KHG24837 68.43 KHG24838 53.33 KHG24839 59.7 KHG24840 49.43 KHG24842 59.82 KHG24847 72.23

TABLE 3 FDSS values of the compounds where R₆ is a phenyl group (concentration: 10 μM) Compond HX(O, HCl, Code R₁ n m R₂, R₃, R₄ R₅ R₆ HBr) FDSS KHG21648 H 1 0 4-Cl CH₃ Ph(4-OCH₃) HCl 26.19 KHG21649 H 1 0 4-Cl CH₃ Ph(3-OCH₃) HCl 27.79 KHG21650 H 1 0 4-Cl CH₃ Ph(4-OPh) HCl 2.59 KHG21651 H 1 0 4-Cl CH₃ Ph(4-OCF₃) HCl −0.56 KHG21652 H 1 0 4-Cl CH₃ Ph(4-Cl) HCl −7.70 KHG21653 H 1 0 4-Cl CH₃ Ph(3-OCH(CH₃)₂) HCl −2.17 KHG21654 H 1 0 4-Cl CH₃ Ph(4-n-Bu) HCl −1.13 KHG21655 H 1 0 4-Cl CH₃ Ph(3-NO₃) HCl 4.68 KHG21943 H 1 0 4-CH(CH₃)₂ CH₃ Ph(4-CF₃) HCl −2.56 KHG21944 H 1 0 4-CH(CH₃)₂ CH₃ Ph(2-F, 4-Cl, 5-OCH(CH₃)₂) HCl 5.89 KHG21945 H 1 0 4-CH(CH₃)₂ CH₃ Ph(4-CN) HCl 7.71 KHG21947 H 1 0 4-CH(CH₃)₂ CH₃ Ph(3-Cl, 4-F) HCl 23.90 KHG21949 H 1 0 4-(CH₃)₂ CH₃ Ph(3-Br) HCl 5.41 KHG23064 H 1 0 2-F, 4-Cl CH₃ Ph(4-Cl) HCl 7.37 KHG23065 H 1 0 2-F, 4-Cl CH₃ Ph(4-Br) HCl 3.57 KHG23066 H 1 0 2-F, 4-Cl CH₃ Ph(4-n-Bu) HCl 1.30 KHG23067 H 1 0 2-F, 4-Cl CH₃ Ph(4-CN) HCl −2.73 KHG23068 H 1 0 2-F, 4-Cl CH₃ Ph(4-CF₃) HCl 5.76 KHG23069 H 1 0 2-F, 4-Cl CH₃ Ph(4-CH₃) HCl 4.33 KHG23070 H 1 0 2-F, 4-Cl CH₃ Ph(4-OCF₃) HCl 7.44 KHG23071 H 1 0 2-F, 4-Cl CH₃ Ph(4-CH(CH₃)₂) HCl 15.51 KHG23072 H 1 0 2-F, 4-Cl CH₃ Ph(2-CH₂CH₃) HCl 29.45 KHG23073 H 1 0 2-F, 4-Cl CH₃ Ph(4-Ph) HCl 28.31 KHG32076 H 1 0 2-F, 4-Cl CH₃ Ph(3-F) HCl 20.50

As shown in Tables 2 and 3, the compounds according to the examples of the present invention have excellent FDSS values compared to the compounds where R₆ is a phenyl group.

The compounds where R6 of Chemical Formula I is a phenyl have already been published (Korean Patent No. 247729, Korean Patent No. 387583, WO 02/13611, U.S. Pat. No. 6,921,770, EP 1311160, Korean Patent No. 0559367). However, as shown in Tables 1 and 2, the compounds where R6 is a phenyl has a lower effect of inhibiting T-type calcium channel activity than the compounds according to the present invention. Therefore, the substituents used at R₆ in the present invention exhibit different activities from those of the phenyl that has been known, and thus the compounds according to the present invention are distinguished from the known compounds in effects as well as structure.

EXPERIMENTAL EXAMPLE 2 Measurement of IC50 for T-type Calcium Channel Activity in HEK293 Cells Using an Electrophysiological Method

10% Fetal bovine serum (FBS) and 1% penicillin/streptomycin (v/v) were added to Dulbecco's modified Eagle's medium (DMEM), to be used as a media solution. The cells were cultured in an incubator under a wet condition of 95% air/5% CO₂ and a temperature of 36.5° C. The media solution was refreshed every 3 or 4 days, and the cells were sub-cultured every week. Only the cells that expressed α_(1G) T-type calcium channel were cultured using a G-418 (0.5 mg/ml) solution. The recording of the cells used in the T-type calcium channel activity analysis was conducted at 2-7 days after the cells were culturing on a cover slip coated with poly-L-lysine (0.5 mg/ml) when conducting every sub-culture. For analysis at a single cell level, the T-type calcium channel current was measured by an electrophysiological whole cell patch clamp method using EPC-9 amplifier (HEKA, German).

As solutions for analyzing T-type calcium channel activity, a solution including NaCl 140 mM, CaCl₂ 2 mM, and HEPES10 mM (pH 7.4, Sigma; 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid) was used as an extracellular solution, and a solution including KCl 130 mM, HEPES 10 mM (Sigma), EGTA 11 mM (ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, Sigma), and MgATP 5 mM (pH 7.4, Sigma) was used as an intracellular solution. The protocol for T-type calcium channel activity that is activated at low voltage is as follows. A micro-glass electrode with resistance of 3-4 MΩ wherein the above-prepared intracellular solution was filled was pricked into a single cell, to make a whole-cell recording mode. Thereafter, the cell membrane potential was fixed to −100 mV, and then the inward current due to the T-type calcium channel activity when hypopolarizing to −30 mV (50 ms duration) was measured every 10 seconds.

Each compound to be tested was dissolved in 100% dimethylsulfoxide (DMSO) to make a 10 mM stock solution. The effect of the compound on the T-type calcium channel current compound was initially examined in the stock solution with the 1000-times diluted concentration of 10 μM (containing 0.1% DMSO) and then examined in the solution with the concentration for IC50 measurement (mostly 0.1 to 100 μM), to obtain an IC₅₀ value. More specifically, the cells were treated in each compound together with the extracellular solution for 30 to 60 seconds, and the inhibition level of peak current induced by the compound was calculated as a percentage, to obtain the % inhibition value as shown in Table 4.

TABLE 4 HEK293cell Compound Code (% Inhibition) 10 μM IC50 (a1G) KHG22344 53.9 ± 2.8 0.07 ± 0.02 KHG22671 66.4 ± 3.6 1.11 ± 0.24 KHG23185 88.2 ± 1.4 1.31 ± 0.22 KHG23210 59.6 ± 1.5 6.50 ± 0.50 KHG23354 83.0 ± 1.4 2.47 ± 0.18 KHG23355 88.1 ± 2.0 1.51 ± 0.17 KHG23356 97.0 ± 0.7 0.23 ± 0.01 KHG23360 87.8 ± 2.2 0.78 ± 0.08 KHG23361 71.4 ± 3.4 4.09 ± 0.70 KHG23362 89.3 ± 0.9 0.53 ± 0.03 KHG23364 97.0 ± 0.7 0.87 ± 0.18 KHG23365 97.6 ± 0.5 0.60 ± 0.06 KHG23394 95.9 ± 1.1 1.28 ± 0.20 KHG24072 91.2 ± 1.6 0.99 ± 0.03 KHG24074 94.7 ± 0.5 0.66 ± 0.06 KHG24075 94.1 ± 1.5 0.32 ± 0.02 KHG24077 57.0 ± 1.5 7.22 ± 0.36 KHG24083 76.5 ± 2.3 3.63 ± 0.54 KHG24084 82.2 ± 1.4 2.79 ± 0.11 KHG24113 64.8 ± 1.4 5.40 ± 0.41 KHG24117 93.0 ± 2.5 0.57 ± 0.07 KHG24118 80.3 ± 1.1 1.88 ± 0.22 KHG24119 72.9 ± 1.0 4.44 ± 0.28 KHG24120 82.7 ± 0.9 2.75 ± 0.25 KHG24121 58.1 ± 4.9 8.53 ± 1.72 KHG24122 94.6 ± 0.5 0.39 ± 0.03 KHG24123 94.2 ± 2.0 1.09 ± 0.20 KHG24124 87.1 ± 1.2 1.77 ± 0.10 KHG24125 95.6 ± 1.2 0.08 ± 0.01 KHG24126 87.7 ± 0.6 1.20 ± 0.08 KHG24127 80.8 ± 0.6 2.66 ± 0.33 KHG24128 88.1 ± 1.9 0.55 ± 0.01 KHG24129 90.0 ± 0.4 1.57 ± 0.11 KHG24130 90.0 ± 0.9 0.81 ± 0.08 KHG24131 86.8 ± 0.3 0.52 ± 0.02 KHG24132 76.8 ± 1.0 5.00 ± 1.97 KHG24133 96.0 ± 1.9 0.42 ± 0.01 KHG24134 95.1 ± 2.0 0.34 ± 0.03 KHG24159 76.8 ± 1.4 3.57 ± 0.29 KHG24160 92.9 ± 0.7 1.33 ± 0.03 KHG24161 81.2 ± 1.3 1.67 ± 0.51 KHG24235 93.2 ± 1.9 1.17 ± 0.08 KHG24236 94.4 ± 0.6 0.23 ± 0.02 KHG24237 91.2 ± 3.1 0.77 ± 0.03 KHG24238 95.9 ± 1.8 0.53 ± 0.02 KHG24239 96.5 ± 1.3 0.61 ± 0.07 KHG24240 96.2 ± 1.1 0.23 ± 0.02 KHG24241 92.2 ± 0.5 0.17 ± 0.02 KHG24242 85.2 ± 1.3 0.97 ± 0.14 KHG24243 97.0 ± 1.1 0.05 ± 0.01 KHG24244 90.6 ± 3.6 0.92 ± 0.08 KHG24788 95.3 ± 0.4 0.31 ± 0.02 KHG24789 95.1 ± 0.7 0.19 ± 0.02 KHG24790 94.8 ± 0.9 0.24 ± 0.01 KHG24800 95.4 ± 0.5 0.43 ± 0.07 KHG24811 94.8 ± 0.7 0.60 ± 0.04 KHG24814 96.9 ± 1.8 0.30 ± 0.01 KHG24816 95.6 ± 0.8 0.51 ± 0.01 KHG24821 92.3 ± 1.8 0.36 ± 0.02 KHG24847 95.5 ± 2.7 0.35 ± 0.01

As shown in Table 4, the 2-imino-1,3-thiazoline based compounds according to the present invention have excellent T-type calcium channel inhibiting activities.

Identification Data

The identification data of the compounds shown in Tables 1 and 2 are as follows.

KHG21648 [2-(4-methoxyphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (4-OCH₃), n=1, m=0, X=Cl]

yield: 46%; melting point: 250-253° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.75 (s, 3H, 3-CH₃), 3.80 (s, 3H, OCH₃), 4.05 (s, 2H, 4-CH₂), 7.01 (s, 1H, 5-vinyl H), 7.08-7.70 (m, 8H, ArH), 11.01 (s, 1H, NH).

KHG21649 [2-(3-methoxyphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (3-OCH₃), n=1, m=0, X=Cl]

yield: 74%; melting point: 228-231° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.77 (s, 3H, 3-CH₃), 3.78 (s, 3H, OCH₃), 4.07 (s, 2H, 4-CH₂), 6.96 (s, 1H, 5-vinyl H), 7.07-7.70 (m, 8H, ArH), 11.04 (s, 1H, NH).

KHG21650 [2-(4-phenoxyphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (4-OC₆H₅), n=1, m=0, X=Cl]

yield: 38%; melting point: 238-242° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.76 (s, 3H, 3-CH₃), 4.05 (s, 2H, 4-CH₂), 7.03 (s, 1H, 5-vinyl H), 7.10-7.70 (m, 8H, ArH), 10.96 (s, 1H, NH).

KHG21652 [2-(4-chlorophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (4-Cl), n=1, m=0, X=Cl]

yield: 90%; melting point: 239-242° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.76 (s, 3H, 3-CH₃), 4.07 (s, 2H, 4-CH₂), 7.05 (s, 1H, 5-vinyl H), 7.36-7.70 (m, 8H, ArH), 10.30 (s, 1H, NH).

KHG21653 [2-(3-isopropoxyphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (4-OCH(CH₃)₂), n=1, m=0, X=Cl]

yield: 65%; melting point: 201-203° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.28 (d, 6H, J=6.0 Hz, isopropoxy (CH₃)₂), 3.78 (s, 3H, 3-CH₃), 4.06 (s, 2H, 4-CH₂), 4.61 (m, 1H, J=6.0 Hz, isopropoxy CH), 6.93 (s, 1H, 5-vinyl H), 7.01-7.70 (m, 8H, ArH), 10.30 (s, 1H, NH).

KHG21654 [2-(4-n-butylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (4-n-C₄H₉), n=1, m=0, X=Cl]

yield: 59%; melting point: 239-241° C.

¹H NMR (300 MHz, DMSO-d₆) δ 0.90 (t, 3H, J=7.2 Hz, n-butyl CH₃), 1.32 (m, 2H, CH₂), 1.57 (m, 2H, CH₂), 2.62 (t, 2H, J=7.2 Hz, CH₂), 3.78 (s, 3H, 3-CH₃), 4.06 (s, 2H, 4-CH₂), 7.03 (s, 1H, 5-vinyl H), 7.33-7.70 (m, 8H, ArH), 10.99 (s, 1H, NH).

KHG21655 [2-(3-nitrophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃H, R₅=CH₃, R₆=Ph (3-NO₂), n=1, m=0, X=Cl]

yield: 26%; melting point: 228° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.79 (s, 3H, 3-CH₃), 4.04 (s, 2H, 4-CH₂), 6.96 (s, 1H, 5-vinyl H), 7.36-8.28 (m, 8H, ArH), 10.83 (s, 1H, NH).

KHG21943 [2-(4-trifluoromethylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃H, R₄=H, R₅=CH₃, R₆=Ph (4-CF₃), n=1, m=0, X=Cl]

yield: 56%; melting point: 238-242.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.16-1.18 (d, 6H, J=6.9 Hz, CH(CH₃)₂), 2.80-2.88 (m, 1H, J=6.9 Hz, CH(CH₃)₂), 3.79 (s, 3H, 3-CH₃), 4.03 (s, 2H, 4-CH₂), 7.04 (s, 1H, 5-vinyl H), 7.17-7.88 (m, 8H, ArH), 10.65 (s, 1H, NH).

KHG21944 [2-(4-chloro-5-isopropoxy-2-fluorophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=Ph (2-F, 4-Cl, 5-OCH(CH₃)₂, n=1, m=0, X=Cl]

yield: 46%; melting point: 190-194° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.16-1.18 (d, 6H, J=6.9 Hz, CH(CH₃)₂), 1.28-1.30 (d, 6H, J=6.0 Hz, OCH(CH₃)₂), 2.80-2.88 (m, 1H, J=6.9 Hz, CH(CH₃)₂), 3.68 (s, 3H, 3-CH₃), 3.97 (s, 2H, 4-CH₂), 4.53-4.62 (m, 1H, J=6.0 Hz, OCH(CH₃)₂), 6.86 (s, 1H, 5-vinyl H), 7.17-7.67 (m, 6H, ArH), 10.61 (s, 1H, NH).

KHG21945 [2-(4-cyanophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=H, R₅=CH₃, R₆=Ph (4-CN), n=1, m=0, X=Cl]

yield: 39%; melting point: 234-235° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.16-1.18 (d, 6H, J=6.8 Hz, CH(CH₃)₂), 2.80-2.88 (m, 1H, J=6.8 Hz, CH(CH₃)₂), 3.72 (s, 3H, 3-CH₃), 3.99 (s, 2H, 4-CH₂), 6.95 (s, 1H, 5-vinyl H), 7.17-7.93 (m, 8H, ArH), 10.56 (s, 1H, NH).

KHG21947 [2-(3-chloro-4-fluorophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=Ph (3-Cl, 4-F), n=1, m=0, X=Cl]

yield: 77%; melting point: 239-241° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.16-1.19 (d, 6H, J=6.8 Hz, CH(CH₃)₂), 2.80-2.88 (m, 1H, J=6.8 Hz, CH(CH₃)₂), 3.78 (s, 3H, 3-CH₃), 4.03 (s, 2H, 4-CH₂), 7.02 (s, 1H, 5-vinyl H), 7.17-7.81 (m, 8H, ArH), 10.67 (s, 1H, NH).

KHG21949 [2-(3-bromophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=Ph (3-Br), n=1, m=0, X=Cl]

yield: 74%; melting point: 198-201° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.16-1.19 (d, 6H, J=7.3 Hz, CH(CH₃)₂), 2.80-2.88 (m, 1H, J=7.3 Hz, CH(CH₃)₂), 3.78 (s, 3H, 3-CH₃), 4.02 (s, 2H, 4-CH₂), 7.02 (s, 1H, 5-vinyl H), 7.17-7.75 (m, 8H, ArH), 10.65 (s, 1H, NH).

KHG23064 [2-(4-chlorophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-Cl), n=1, m=0, X=Cl]

yield: 64%; melting point: 239-240° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.81 (s, 3H, N—CH₃), 4.14 (s, 2H, 4-CH₂), 7.07 (s, 1H, vinyl H), 7.29-7.93 (m, 7H, Ar—H), 10.51 (s, 1H, NH).

KHG23065 [2-(4-bromophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-Br), n=1, m=0, X=Cl]

yield: 84%; melting point: 239-240° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.79 (s, 3H, N—CH₃), 4.12 (s, 2H, 4-CH2), 7.04 (s, 1H, vinyl H), 7.29-7.94 (m, 7H, Ar—H), 10.47 (s, 1H, NH).

KHG23066 [2-(4-n-butylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-n-C₄H₉), n=1, m=0, X=Cl]

yield: 70%; melting point: 223-224° C.

¹H NMR (300 MHz, DMSO-d₆) δ 0.91-0.96 (t, 3H, CH₂CH₂CH₂CH₃), 1.30-1.38 (m, 2H, CH₂CH₂CH₂CH₃), 1.55-1.63 (m, 2H, CH₂CH₂CH₂CH₃), 2.63-2.68 (t, 2H, CH₂CH₂CH₂CH₃), 3.76 (s, 3H, N—CH₃), 4.11 (s, 2H, 4-CH₂), 7.02 (s, 1H, vinyl H), 7.30-7.95 (m, 7H, Ar—H), 10.43 (s, 1H, NH).

KHG23067 [2-(4-cyanophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-CN), n=1, m=0, X=Cl]

yield: 74%; melting point: 136-137° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.67 (s, 3H, N—CH₃), 4.06 (s, 2H, 4-CH₂), 6.86 (s, 1H, vinyl H), 7.29-7.95 (m, 7H, Ar—H), 10.39 (s, 1H, NH).

KHG23068 [2-(4-trifluoromethylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-CF₃), n=1, m=0, X=Cl]

yield: 67%; melting point: 222-223° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.67 (s, 3H, N—CH₃), 4.06 (s, 2H, 4-CH₂), 6.86 (s, 1H, vinyl H), 7.29-7.95 (m, 7H, Ar—H), 10.39 (s, 1H, NH).

KHG23069 [2-(4-methylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-CH₃), n=1, m=0, X=Cl]

yield: 74%; melting point: 243-245° C.

¹H NMR (300 MHz, DMSO-d₆) δ 2.37 (s, 3H, Ar—CH₃), 3.81 (s, 3H, N—CH₃), 4.13 (s, 2H, 4-CH₂), 7.05 (s, 1H, vinyl H), 7.29-7.93 (m, 7H, Ar—H), 10.51 (s, 1H, NH).

KHG23070 [2-(4-trifluoromethoxyphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-OCF₃), n=1, m=0, X=Cl]

yield: 66%; melting point: 236-237° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.74 (s, 3H, N—CH₃), 4.09 (s, 2H, 4-CH₂), 6.97 (s, 1H, vinyl H), 7.26-7.97 (m, 7H, Ar—H), 10.39 (s, 1H, NH).

KHG23071 [2-(4-isopropylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-CH(CH₃)₂, n=1, m=0, X=Cl]

yield: 72%; melting point: 237-238° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.24-1.26 (d, 6H, CH(CH₃)₂), 2.93-3.02 (m, 1H, CH(CH₃)₂), 3.77 (s, 3H, N—CH₃), 4.11 (s, 2H, 4-CH₂), 7.02 (s, 1H, vinyl H), 7.30-7.95 (m, 7H, Ar—H), 10.42 (s, 1H, NH).

KHG23072 [2-(4-ethylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-C₂H₅), n=1, m=0, X=Cl]

yield: 87%; melting point: 242° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.20-1.25 (t, 3H, CH₂CH₃), 2.64-2.72 (q, 2H, CH₂CH₃), 3.79 (s, 3H, N—CH₃), 4.12 (s, 2H, 4-CH₂), 7.04 (s, 1H, vinyl H), 7.29-7.94 (m, 7H, Ar—H), 10.47 (s, 1H, NH).

KHG23073 [2-(4-phenylphenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (4-C₆H₅), n=1, m=0, X=Cl]

yield: 65%; melting point: 222-223° C.

¹H NMR (300 MHz, _(DMSO)-d₆) δ 3.77 (s, 3H, N—CH₃), 4.11 (s, 2H, 4-CH₂), 7.02 (s, 1H, vinyl H), 7.10-7.95 (m, 12H, Ar—H), 10.43 (s, 1H, NH).

KHG23076 [2-(3-fluorophenylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=Ph (3-CF₃), n=1, m=0, X=Cl]

yield: 74%; melting point: 229-231° C.

¹H NMR (300 MHz, DMSO-d₆) δ 3.77 (s, 3H, N—CH₃), 4.11 (s, 2H, 4-CH₂), 7.02 (s, 1H, vinyl H), 7.19-7.94 (m, 7H, Ar—H), 10.43 (s, 1H, NH).

KHG23210 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 75%; melting point: 265-266° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.80 (s, 1H, HCl), 9.64 (br. s, 1H, NH), 7.66-7.14 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.98 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.34 (br. s, 1H, cyclohexyl-C₁H), 1.99-1.10 (m, 10H, cyclohexyl-H).

KHG23354 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 94%; melting point: 261-263° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.03 (s, 1H, HCl), 9.75 (d, 1H, J=4.6 H_(z), NH), 7.62-7.47 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.00 (s, 2H, 4-CH₂), 3.59 (s, 3H, N—CH₃), 3.22 (br. s, 1H, cyclohexyl-C₁H), 1.97-1.11 (m, 10H, cyclohexyl-H).

KHG23355 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OPh, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 98%; melting point: 255-257° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.80 (s, 1H, HCl), 9.71 (d, 1H, J=3.7 H_(z), NH), 7.65-6.94 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.98 (s, 2H, 4-CH₂), 3.60 (s, 3H, N—CH₃), 3.23 (br. s, 1H, cyclohexyl-C₁H), 1.98-1.08 (m, 10H, cyclohexyl-H).

KHG23356 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-Cl), R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 62%; melting point: 255-257° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.37 (s, 1H, HCl), 9.61 (d, 1H, J=5.5 H_(z), NH), 7.73 (s, 2H, o-ArH), 7.29 (s, 1H, p-ArH), 7.07 (s, 1H, vinyl-H), 4.02 (s, 2H, 4-CH₂), 3.56 (s, 3H, N—CH₃), 3.22 (br. s, 1H, cyclohexyl-C₁H), 1.98-1.08 (m, 10H, cyclohexyl-H).

KHG23360 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 96%; melting point: 219-221° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.77 (s, 1H, HCl), 9.71 (br. s, 1H, NH), 8.92-7.57 (m, 3H, ArH), 7.06 (s, 1H, vinyl-H), 4.10 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.24 (br. s, 1H, cyclohexyl-C₁H), 1.98-1.09 (m, 10H, cyclohexyl-H).

KHG23361 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₃=CH₃, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 90%; melting point: 255-257° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.38 (s, 1H, HCl), 9.67 (br. s, 1H, NH), 7.88-7.25 (m, 3H, ArH), 7.03 (s, 1H, vinyl-H), 4.02 (s, 2H, 4-CH₂), 3.56 (s, 3H, N—CH₃), 3.23 (br. s, 1H, cyclohexyl-C₁H), 1.98-1.08 (m, 10H, cyclohexyl-H).

KHG23362 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 72%; melting point: 266.8-267.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.1 (s, 1H, HCl), 9.82 (br. s, 1H, NH), 7.69-7.34 (m, 4H, ArH), 7.07 (s, 1H, vinyl-H), 4.01 (s, 2H, 4-CH₂), 3.65 (s, 3H, N—CH₃), 3.21 (br. s, 1H, cyclohexyl-C₁H), 1.97-1.10 (m, 10H, cyclohexyl-H).

KHG23364 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 94%; melting point: 244° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.48 (s, 1H, HCl), 9.55 (br. s, 1H, NH), 7.50-7.16 (m, 4H, ArH), 7.02 (s, 1H, vinyl-H), 3.93 (s, 2H, 4-CH₂), 3.55 (s, 3H, N—CH₃), 3.24 (br. s, 1H, cyclohexyl-C₁H), 2.85-2.97 (m, 1H, isopropyl-CH), 1.98-1.22 (m, 10H, cyclohexyl-H), 1.16 (d, 6H, J=5.1 Hz, isopropyl-(CH₃)₂).

KHG23365 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 79%; melting point: 242-244° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.42 (s, 1H, HCl), 9.47 (d, J=4.1 Hz, 1H, NH), 7.48-7.10 (m, 4H, ArH), 7.02 (s, 1H, vinyl-H), 3.92 (s, 2H, 4-CH₂), 3.53 (s, 3H, N—CH₃), 3.23 (br. s, 1H, cyclohexyl-C₁H), 2.50 (t, 2H, J=5.5 Hz, CH₂CH₂CH₂CH₃), 1.98-1.12 (m, 14H, cyclohexyl-H and CH₂CH₂CH₂CH₃), 0.87 (t, 3H, J=5.5 Hz, CH₂CH₂CH₂CH₃).

KHG24070 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-chloro-4-methoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-OCH₃, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 75.6%; melting point: 233.5-235° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.90 (s, 1H, HCl), 9.71 (d, 1H, J=6.3 H_(z), NH), 7.81 (d, 1H, J=2.4 Hz, Ar—H), 7.49 (dd, 1H, J=8.7 H_(z), J=2.4 H_(z), Ar—H), 7.11 (d, 1H, J=8.9 Hz, Ar—H), 7.06 (s, 1H, vinyl-H), 3.97 (s, 2H, 4-CH₂), 3.81 (s, 3H, Ar—OCH₃), 3.60 (s, 3H, N—CH₃), 3.24 (s, 1H, cyclohexyl-C₁H), 1.93-1.11 (m, 10H, cyclohexyl-H).

KHG24071 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,5-dichloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=5-Cl, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 66.9%; melting point: 146° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.86 (s, 1H, HCl), 9.79 (d, 1H, NH), 8.05 (s, 2H, Ar—H), 7.10 (s, 1H, vinyl-H), 4.08 (s, 2H, 4-CH₂), 3.61 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.98-1.11 (m, 10H, cyclohexyl-H).

KHG24072 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₃=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 72.1%; melting point: 224-224.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.06 (s, 1H, HCl), 9.77 (d, 1H, J=5.5 H_(z), NH), 7.83 (d, 1H, J=1.8 H_(z), Ar—H), 7.41 (q, 1H, J=8.3 H_(z), J=1.8 H_(z), Ar—H), 7.27 (d, 1H, J=8.3 H_(z), Ar—H), 7.07 (s, 1H, vinyl-H), 4.01 (s, 2H, 4-CH₂), 3.61 (s, 3H, N—CH₃), 3.23 (s, 1H, cyclohexyl-C₁H), 2.26 (s, 3H, Ar—CH₃), 1.93-1.11 (m, 10H, cyclohexyl-H).

KHG24073 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 59.2%; melting point: 234-235.5° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.56 (s, 1H, HCl), 9.64 (d, 1H, J=5.4 H_(z), NH), 7.51 (d, 2H, J=8.6 H_(z), Ar—H), 7.32 (d, 2H, J=8.6 H_(z), Ar—H), 7.04 (s, 1H, vinyl-H), 3.95 (s, 2H, 4-CH₂), 3.57 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.99-1.16 (m, 10H, cyclohexyl-H), 1.25 (s, 9H, Ar—C(CH₃)₃).

KHG24074 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 61.6%; melting point: 241-242° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.23 (s, 1H, HCl), 9.69 (d, 1H, J=6.7 H_(z), NH), 7.86 (d, 1H, J=8.5 H_(z), Ar—H), 7.69 (d, 1H, J=8.6 H_(z), Ar—H), 7.08 (s, 1H, vinyl-H), 4.06 (s, 2H, 4-CH₂), 3.59 (s, 3H, N—CH₃), 3.26 (s, 1H, cyclohexyl-C₁H), 1.99-1.12 (m, 10H, cyclohexyl-H).

KHG24075 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 80.1%; melting point: 208-209° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.76 (s, 1H, HCl), 9.62 (d, 1H, J=7.3 H_(z), NH), 8.35 (s, 2H, Ar—H), 7.78 (s, 1H, Ar—H), 7.10 (s, 1H, vinyl-H), 4.08 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.99-1.16 (m, 10H, cyclohexyl-H).

KHG24076 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-methoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=3-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 78.2%; melting point: 156-158° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.73 (s, 1H, HCl), 9.70 (d, 1H, J=6.4 H_(z), NH), 7.34 (s, 1H, Ar—H), 7.24-7.10 (m, 2H, Ar—H), 7.05 (s, 1H, vinyl-H), 6.66-6.63 (m, 1H, J=7.8 Hz, Ar—H), 3.98 (s, 2H, 4-CH₂), 3.71 (s, 3H, Ar—OCH₃), 3.58 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.99-1.15 (m, 10H, cyclohexyl-H).

KHG24077 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 57.2%; melting point: 238-240° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.59 (s, 1H, HCl), 9.67 (d, 1H, J=5.7 H_(z), NH), 7.49 (d, 2H, J=8.3 H_(z), Ar—H), 7.11 (d, 2H, J=8.3 H_(z), Ar—H), 7.04 (s, 1H, vinyl-H), 3.96 (s, 2H, 4-CH₂), 3.59 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 2.25 (s, 3H, Ar—CH₃), 1.93-1.11 (m, 10H, cyclohexyl-H).

KHG24080 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,5-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-F, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 47.1%; melting point: 216-218° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.67 (d, 1H, J=5.0 H_(z), HCl), 8.98 (t, 1H, J=5.6 H_(z), NH), 7.28-7.12 (m, 3H, Ar—H), 6.97 (s, 1H, vinyl-H), 4.31 (d, 2H, J=5.6 H_(z), N—CH2), 3.80 (s, 2H, 4-CH₂), 3.52 (s, 3H, N—CH₃), 3.23 (s, 1H, cyclohexyl-C₁H), 1.97-1.11 (m, 10H, cyclohexyl-H).

KHG24081 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,4-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 19.7%; melting point: 206-208° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.60 (d, 1H, J=5.7 H_(z), HCl), 8.95 (t, 1H, J=5.8 H_(z), NH), 7.44-7.30 (m, 2H, Ar—H), 7.13 (s, 1H, Ar—H), 6.97 (s, 1H, vinyl-H), 4.27 (d, 2H, J=5.8 H_(z), N—CH₂), 3.78 (s, 2H, 4-CH₂), 3.50 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.98-1.11 (m, 10H, cyclohexyl-H).

KHG24082 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-methylbenzyl)-acetamide hydrochloride [R₁=H, R₂=2-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 64.2%; melting point: 220-221° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.70 (d, 1H, J=4.6 H_(z), HCl), 8.75 (t, 1H, J=5.2 H_(z), NH), 7.23-7.17 (m, 4H, Ar—H), 6.96 (s, 1H, vinyl-H), 4.26 (d, 2H, J=5.5 H_(z), N—CH₂), 3.77 (s, 2H, 4-CH₂), 0.54 (s, 3H, N—CH₃), 3.23 (s, 1H, cyclohexyl-C₁H), 2.27 (s, 3H, Ar—CH₃), 1.97-1.15 (m, 10H, cyclohexyl-H).

KHG24083 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 54.2%; melting point: 189-190° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.82 (s, 1H, HCl), 9.07 (t, 1H, J=5.6 H_(z), NH), 7.73-7.46 (m, 4H, Ar—H), 7.00 (s, 1H, vinyl-H), 4.47 (d, 2H, J=5.4 H_(z), N—CH₂), 3.85 (s, 2H, 4-CH₂), 3.57 (s, 3H, N—CH₃), 3.22 (s, 1H, cyclohexyl-C₁H), 1.97-1.11 (m, 10H, cyclohexyl-H).

KHG24084 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 19.7%; melting point: 189-191° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.75 (s, 1H, HCl), 9.08 (t, 1H, J=57 H_(z), NH), 7.61-7.56 (m, 4H, Ar—H), 6.97 (s, 1H, vinyl-H), 4.38 (d, 2H, J=5.8 Hz, N—CH₂), 3.81 (s, 2H, 4-CH₂), 3.52 (s, 3H, N—CH₃), 3.21 (s, 1H, cyclohexyl-C₁H), 1.96-1.15 (m, 10H, cyclohexyl-H).

KHG24085 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-ethoxycarbonylethoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=3-COOC₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 70.8%; melting point: 241-242° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 11.20 (s, 1H, HCl), 9.72 (d, 1H, J=6.9 H_(z), NH), 7.92 (d, 2H, J=8.7 H_(z), Ar—H), 7.78 (d, 2H, J=8.7 H_(z), Ar—H), 7.07 (s, 1H, vinyl-H), 4.27 (q, 2H, J=7.0 H_(z), Ar—CO₂CH₂CH₃), 4.05 (s, 2H, 4-CH₂), 3.60 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.99-1.11 (m, 10H, cyclohexyl-H), 1.30 (t, 3H, J=7.0 Hz, Ar—CO₂CH₂CH₃).

KHG24086 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,4-methylenedioxyphenyl)-acetamide hydrochloride [R₁=H, R₂, R₃=3,4-OCH₂O—, R₄=H, R₅=CH₃, R₆=C₆H, n=1, m=1, X=Cl]

yield: 35.2%; melting point: 146-147° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.68 (d, 1H, J=5.2 Hz, HCl), 8.82 (t, 1H, J=5.8 H_(z), NH), 6.96 (s, 1H, Ar—H), 6.86-6.73 (m, 2H, Ar—H), 6.84 (s, 1H, vinyl-H), 5.98 (s, 2H, OCH₂), 4.18 (d, 2H, J=5.8 H_(z), N—CH₂), 3.75 (s, 2H, 4-CH₂), 3.52 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.97-1.30 (m, 10H, cyclohexyl-H).

KHG24087 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,5-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-F, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 68.3%; melting point: 196.5-198° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.49 (s, 1H, HCl), 9.77 (d, 1H, J=6.3 H_(z), NH), 7.85-7.00 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.06 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.98-1.15 (m, 10H, cyclohexyl-H).

KHG24088 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,4-dichlorobenzyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-Cl, R₄=H, R₅═CH₃, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 51.3%; melting point: 215-216° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.79 (d, 1H, J=4.7 Hz, HCl), 8.97 (t, 1H, J=5.6 H_(z), NH), 7.46-7.30 (m, 3H, Ar—H), 6.98 (s, 1H, vinyl-H), 4.36 (d, 2H, J=5.6 H_(z), N—CH₂), 3.82 (s, 2H, 4-CH₂), 3.56 (s, 3H, N—CH₃), 3.22 (s, 1H, cyclohexyl-C₁H), 1.97-1.30 (m, 10H, cyclohexyl-H).

KHG24089 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-benzyl-acetamide hydrochloride [R₁=H, R₂=R₃R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 44.6%; melting point: 206-206.5° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.77 (d, 1H, J=5.5 Hz, HCl), 8.93 (t, 1H, J=5.7 H_(z), NH), 7.35-7.22 (m, 5H, Ar—H), 6.97 (s, 1H, vinyl-H), 4.28 (d, 2H, J=5.7 H_(z), N—CH₂), 3.77 (s, 2H, 4-CH₂), 3.54 (s, 3H, N—CH₃), 3.23 (s, 1H, cyclohexyl-C₁H), 1.97-1.11 (m, 10H, cyclohexyl-H).

KHG24090 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,4-dimethoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=3-OCH₃, R₃=4-OCH₃, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 86.9%; melting point: 233-234° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.90 (s, 1H, HCl), 9.71 (d, 1H, J=6.3 H_(z), NH), 7.81 (d, 1H, J=2.4 H_(z), Ar—H), 7.49 (dd, 1H, J=8.7 H_(z), J=2.4 H_(z), Ar—H), 7.11 (d, 1H, J=8.9 H_(z), Ar—H), 7.06 (s, 1H, vinyl-H), 3.97 (s, 2H, 4-CH₂), 3.81 (s, 3H, Ar—OCH₃), 3.60 (s, 3H, N—CH₃), 3.24 (s, 1H, cyclohexyl-C₁H), 1.93-1.11 (m, 10H, cyclohexyl-H).

KHG24091 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-fluoro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-F, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 51.1%; melting point: 210-212° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.26 (s, 1H, HCl), 9.85 (d, 1H, J=6.0 H_(z), N—(H), 7.63-6.95 (m, 3H, Ar—H), 6.97 (s, 1H, vinyl-H), 4.02 (s, 2H, 4-CH₂), 3.60 (s, 3H, N—CH₃), 3.24 (s, 1H, cyclohexyl-C₁H), 2.25 (s, 3H, Ar—CH₃), 1.98-1.09 (m, 10H, cyclohexyl-H).

KHG24092 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 87.5%; melting point: 213-214.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 1.14-1.18 (t, J=7.5 Hz, 3H, CH₂CH₃), 9.67 (s, 1H, NH—Ar), 7.12-7.52 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 2.53-2.60 (q, J=7.5 Hz, 2H, CH₂CH₃), 1.58-3.80 (m, 9H, NH-cyclopentyl-H), 1.14-1.18 (t, J=7.5 Hz, 3H, CH₂CH₃).

KHG24093 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-C₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 78.9%; melting point: 242-242.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.72 (d, 1H, J=4.5 Hz NH—Ar), 7.12-7.67 (m, 4H, ArH), 7.05 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 1.45-3.85 (m, 9H, NH-cyclopentyl-H).

KHG24094 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 46.2%; melting point: 210-211° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68 (s, 1H, NH—Ar), 6.86-7.67 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.93 (s, 2H, COCH₂), 3.70 (s, 3H, OCH₃), 3.60 (s, 3H, N—CH₃), 1.58-3.8 (m, 9H, NH-cyclopentyl-H).

KHG24095 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-chloro-4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-F), R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 93.4%; melting point: 209-210.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.77 (s, 1H, NH—Ar), 7.20-7.64 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.61 (s, 3H, N—CH₃), 1.58-3.80 (m, 9H, NH-cyclopentyl-H).

KHG24096 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-cyanomethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₂CN, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]R₃=R₄=H,

yield: 18.5%; melting point: 199.5-200° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.46 (s, 1H, NH—Ar), 7.28-7.62 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 3.97 (s, 2H, COCH₂), 3.55 (d, J=4.0 Hz, 2H, CN—CH₂), 3.32 (s, 3H, N—CH₃), 1.59-3.80 (m, 9H, NH-cyclopentyl-H).

KHG24097 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 82.7%; melting point: 185-186.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.84 (d, 1H, J=4.0 Hz NH—Ar), 7.12-7.49 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.00 (s, 2H, COCH₂), 3.63 (s, 3H, N—CH₃), 2.28 (s, 3H, Ar—CH₃), 1.56-3.80 (m, 9H, NH-cyclopentyl-H).

KHG24098 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 30.0%; melting point: 228-228.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68 (d, 1H, J=4.7 Hz NH—Ar), 7.47-7.62 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.58-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24099 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OPh, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 74.1%; melting point: 230-230.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68 (d, 1H, J=4.7 Hz NH—Ar), 7.07-7.64 (m, 5H, O—Ar—H), 7.05 (s, 1H, vinyl-H), 6.94-7.01 (m, 4H, N—Ar—H), 3.97 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 1.58-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24100 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 87.6%; melting point: 231-232.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.64 (d, 1H, J=4.7 Hz NH—Ar), 7.28-7.74 (m, 3H, Ar—H), 7.07 (s, 1H, vinyl-H), 4.03 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 1.58-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24101 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 43.9%; melting point: 189-190° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.84 (d, 1H, J=4.0 Hz NH—Ar), 6.95-7.65 (m, 3H, Ar—H), 7.07 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 2.28 (s, 3H, Ar—CH₃), 1.58-3.80 (m, 9H, NH-cyclopentyl-H).

KHG24102 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,4-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 13.6%; melting point: 240-242.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.78 (d, 1H, J=4.7 Hz NH—Ar), 7.04-7.79 (m, 3H, Ar—H), 7.07 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 1.58-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24103 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, =H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 54.3%; melting point: 214-216° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.86 (s, 1H, NH—Ar), 7.20-8.01 (m, 3H, Ar—H), 7.06 (s, 1H, vinyl-H), 4.06 (s, 2H, COCH₂), 3.62 (s, 3H, N—CH₃), 1.56-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24104 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 55.4%; melting point: 234.5-236° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.83 (d, 1H, J=4.7 Hz NH—Ar), 7.56-8.93 (m, 3H, Ar—H), 7.08 (s, 1H, vinyl-H), 4.12 (s, 2H, COCH2), 3.62 (s, 3H, N—CH₃), 1.56-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24105 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, =H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 54.2%; melting point: 228-230.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.76 (s, 1H, NH—Ar), 7.25-7.89 (m, 3H, Ar—H), 7.04 (s, 1H, vinyl-H), 4.03 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.58-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24106 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆═C₅H₉, n=1, m=0, X=Cl]

yield: 81.5%; melting point: 215-216° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.65 (d, 1H, NH—Ar), 7.36-7.66 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 1.58-3.80 (m, 9H, NH-cyclopentyl-H).

KHG24107 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-phenyl-acetamide hydrochloride [R₁=H, R₂=R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 65.6%; melting point: 231.5-233° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.77 (s, 1H, NH—Ar), 7.06-7.63 (m, 5H, Ar—H), 7.03 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.62 (s, 3H, N—CH₃), 1.56-3.79 (m, 9H, NH-cyclopentyl-H).

KHG24108 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=3-NO₂, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 34%; melting point: 207° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.41 (s, 1H, HCl), 9.54 (br. s, 1H, NH), 7.83-6.98 (m, 4H, ArH), 7.01 (s, 1H, vinyl-H), 4.03 (s, 2H, 4-CH₂), 3.54 (s, 3H, N—CH₃), 3.23 (br. s, 1H, cyclohexyl-C₁H), 1.98-1.12 (m, 10H, cyclohexyl-H).

KHG24109 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-F, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 78.3%; melting point: 238-239.5° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 11.06 (s, 1H, HCl), 9.68 (d, 1H, J=4.8 H_(z), NH), 7.63-6.87 (m, 4H, Ar—H), 6.93 (s, 1H, vinyl-H), 4.01 (s, 2H, 4-CH₂), 3.59 (s, 3H, N—CH₃), 3.29 (s, 1H, cyclohexyl-C₁H), 1.99-1.11 (m, 10H, cyclohexyl-H).

KHG24110 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=C₆H₄(4-CH(CH₃)₂, R₃=CH₃, R₄=C₆H₁₁, n=1, m=0, X=Cl]

yield: 70.6%; melting point: 229-230° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.60 (s, 1H, HCl), 9.68 (s, 1H, NH), 7.51 (d, 2H, J=7.8 H_(z), Ar—H), 7.17 (d, 2H, J=7.9 H_(z), Ar—H), 7.04 (s, 1H, vinyl-H), 3.96 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.23 (s, 1H, cyclohexyl-C₁H), 2.81 (m, 1H, J=6.6 H_(z), Ar—CH(CH₃)₂), 1.99-1.16 (m, 10H, cyclohexyl-H), 1.16 (d, 6H, J=6.8 Hz, Ar—CH(CH₃)₂).

KHG24111 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-bromo-3-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CH₃, R₃=4-Br, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 79.6%; melting point: 237-238° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.86 (s, 1H, HCl), 9.67 (d, 1H, J=6.3 H_(z), NH), 7.65-7.38 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.99 (s, 2H, 4-CH₂), 3.58 (s, 3H, N—CH₃), 3.25 (s, 1H, cyclohexyl-C₁H), 1.98-1.11 (m, 10H, cyclohexyl-H).

KHG24112 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 63.4%; melting point: 200-201° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.68 (s, 1H, HCl), 8.93 (t, 1H, J=5.7 H_(z), NH), 7.34-7.12 (m, 4H, Ar—H), 6.96 (s, 1H, vinyl-H), 4.26 (d, 2H, J=5.6 H_(z), N—CH₂), 3.76 (d, 2H, 4-CH₂), 3.53 (s, 3H, N—CH₃), 3.22 (s, 1H, cyclohexyl-C₁H), 1.98-1.15 (m, 10H, cyclohexyl-H).

KHG24113 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 77.0%; melting point: 204° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.79 (d, 1H, J=5.0 H_(z), HCl), 9.01 (t, 1H, J=5.7 H_(z), NH), 7.38 (d, 2H, J=8.4 H_(z), Ar—H), 7.29 (d, 2H, J=8.4 H_(z), Ar—H), 6.97 (s, 1H, vinyl-H), 4.27 (d, 2H, J=5.8 H_(z), N—CH₃), 3.78 (s, 2H, 4-CH₂), 3.54 (s, 3H, N—CH₃), 3.21 (s, 1H, cyclohexyl-C₁H), 1.97-1.11 (m, 10H, cyclohexyl-H).

KHG24114 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxybenzyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅═CH₃, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 64.8%; melting point: 193-195° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.67 (s, 1H, J=6.2 Hz, HCl), 8.80 (t, 1H, J=5.6 H_(z), NH), 7.19 (d, 2H, J=8.5 H_(z), Ar—H), 6.95 (s, 1H, vinyl-H), 3.97 (s, 2H, 4-CH₂), 6.98 (d, 2H, J=8.5 Hz, Ar—H), 4.21 (d, 2H, J=5.7 Hz, N—CH₂), 3.73 (s, 2H, 4-CH₂), 3.72 (s, 3H, Ar—OCH₃), 3.52 (s, 3H, N—CH₃), 3.21 (s, 1H, cyclohexyl-C₁H), 1.97-1.11 (m, 10H, cyclohexyl-H).

KHG24115 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 75.9%; melting point: 213-215.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.77 (s, 1H, NH—Ar), 7.15-7.53 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.96 (s, 2H, COCH₂), 3.61 (s, 3H, N—CH₃), 2.78-2.85 (q, 1H, J=6.8 Hz Ar—CH(CH₃)₂), 1.56-3.79 (m, 9H, NH-cycloheptyl-H), 1.15-1.17 (d, 6H, J=6.9 Hz Ar—CH(CH₃)₂.

KHG24116 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 36.9%; melting point: 216-217.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.70 (s, 1H, NH—Ar), 7.10-7.51 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 1.23-3.79 (m, 15H, NH-cycloheptyl-H, Ar—(CH₂)₃(CH₃)), 0.85-0.89 (t, 3H, J=7.2 Hz Ar—(CH₂)₃(CH₃)).

KHG24117 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 93.8%; melting point: 217-218° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.61-9.63 (d, J=6.0 Hz 1H, NH—Ar), 7.12-7.52 (m, 4H, Ar—H), 7.03 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 2.53-2.58 (q, J=7.5 Hz, 2H, CH₂CH₃), 1.46-3.42 (m, 13H, NH-cycloheptyl-H), 1.11 (t, J=7.5 Hz, 3H, CH₂CH₃).

KHG24118 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 70.7%; melting point: 219-220.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.59-9.61 (d, J=5.9 Hz 1H, NH—Ar), 7.13-7.65 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 3.96 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 1.47-3.41 (m, 13H, NH-cycloheptyl-H).

KHG24119 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 63.6%; melting point: 230-232° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68-9.70 (d, 1H, J=6.5 Hz, NH—Ar), 6.86-7.54 (m, 4H, Ar—H), 7.03 (s, 1H, vinyl-H), 3.94 (s, 2H, COCH₂), 3.71 (s, 3H, OCH₃), 3.59 (s, 3H, N—CH₃), 1.45-3.43 (m, 13H, NH-cycloheptyl-H).

KHG24120 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-chloro-4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 84.6%; melting point: 172-173.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68-9.71 (d, 1H, J=6.9 Hz, NH—Ar), 7.23-7.64 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.46-3.42 (m, 13H, NH-cycloheptyl-H).

KHG24121 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-cyanomethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₂CN, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 91.4%; melting point: 216-218.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.61-9.63 (d, 1H, J=6.8 Hz, NH—Ar), 7.27-7.64 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 3.97-3.98 (d, J=2.50 Hz, 4H, CNCH₂, COCH₂), 3.57 (s, 3H, N—CH₃), 1.46-3.57 (m, 13H, NH-cycloheptyl-H).

KHG24122 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 49.5%; melting point: 224-224.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.60-9.62 (d, 1H, J=6.7 Hz, NH—Ar), 7.48-7.61 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.56 (s, 3H, N—CH₃), 1.46-3.41 (m, 13H, NH-cycloheptyl-H).

KHG24123 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 85.8%; melting point: 229.5-232° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.72-9.74 (d, 1H, J=6.4 Hz, NH—Ar), 6.93-7.66 (m, 10H, O—Ar—H, Ar—H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 1.45-3.41 (m, 13H, NH-cycloheptyl-H).

KHG24124 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methyl-2-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 68.4%; melting point: 153-155° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.64 (s, 1H, NH—Ar), 7.12-7.50 (m, 3H, Ar—H), 7.03 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 2.28 (s, 3H, Ar—CH₃), 1.46-3.41 (m, 13H, NH-cycloheptyl-H).

KHG24125 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-

chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 72.9%; melting point: 215-217.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.58-9.60 (d, 1H, J=7.0 Hz, NH—Ar), 7.28-7.73 (m, 3H, Ar—H), 7.06 (s, 1H, vinyl-H), 4.02 (s, 2H, COCH₂), 3.56 (s, 3H, N—CH₃), 1.46-3.42 (m, 13H, NH-cycloheptyl-H).

KHG24126 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 54.5%; melting point: 183-185° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68-9.70 (d, 1H, J=7.1 Hz, NH—Ar), 6.95-7.65 (m, 3H, Ar—H), 7.02 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 2.28 (s, 3H, Ar—CH₃), 1.46-3.43 (m, 13H, NH-cycloheptyl-H).

KHG24127 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,4-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 57.1%; melting point: 196.5-198.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.78-9.81 (d, 1H, J=7.1 Hz NH—Ar), 7.07-7.76 (m, 3H, Ar—H), 7.04 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.45-3.42 (m, 13H, NH-cycloheptyl-H).

KHG24128 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 54.7%; melting point: 163-165° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.67-9.70 (d, 1H, J=7.2 Hz NH—Ar), 7.22-8.04 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.05 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 1.43-3.46 (m, 13H, NH-cycloheptyl-H).

KHG24129 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 46.6%; melting point: 223-223.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.71-9.73 (d, 1H, J=7.2 Hz NH—Ar), 7.58-8.95 (m, 3H, Ar—H), 7.08 (s, 1H, vinyl-H), 4.11 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.44-3.42 (m, 13H, NH-cycloheptyl-H).

KHG24130 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl), R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 67.8%; melting point: 204.5-205° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.71-9.73 (d, 1H, J=7.3 Hz NH—Ar), 7.26-7.90 (m, 3H, Ar—H), 7.04 (s, 1H, vinyl-H), 4.02 (s, 2H, COCH₂), 3.55 (s, 3H, N—CH₃), 1.43-3.42 (m, 13H, NH-cycloheptyl-H).

KHG24131 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃==R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 77.6%; melting point: 215-217° C.

¹H NMR (400 MHz, DMSO-d₆) δ 9.69-9.71 (d, 1H, J=7.0 Hz NH—Ar), 7.36-7.68 (m, 4H, Ar—H), 7.06 (s, 1H, vinyl-H), 4.00 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.52-3.42 (m, 13H, NH-cycloheptyl-H).

KHG24132 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-phenyl-acetamide hydrochloride [R₁=H, R₂=R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 64.3%; melting point: 174-176° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.67-9.69 (d, 1H, J=6.7 Hz NH—Ar), 7.06-7.63 (m, 5H, Ar—H), 7.05 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 1.46-3.43 (m, 13H, NH-cycloheptyl-H).

KHG24133 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 87.2%; melting point: 242-242.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 19.57-9.59 (d, 1H, J=7.2 Hz NH—Ar), 7.16-7.52 (m, 4H, Ar—H), 7.03 (s, 1H, vinyl-H), 3.94 (s, 2H, COCH₂), 3.56 (s, 3H, N—CH₃), 2.79-2.85 (q, 1H, J=6.8 Hz Ar—CH(CH₃)₂, 1.56-3.42 (m, 13H, NH-cycloheptyl-H), 1.15-1.18 (d, 6H, J=6.8 Hz Ar—CH(CH₃)₂).

KHG24134 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 49.0%; melting point: 209.5-210° C.

¹H NMR (400 MHz, DMSO-d₆) δ 9.66-9.67 (d, 1H, J=7.0 Hz NH—Ar), 7.11-7.52 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 3.96 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 1.27-3.42 (m, 19H, NH-cycloheptyl-H, Ar—(CH₂)₃CH₃), 0.86-0.90 (t, 3H, J=7.3 Hz Ar—(CH₂)₃CH₃).

KHG24135 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-ethoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₂H₅, R₃H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 90.3%; melting point: 219-220° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.26 (s, 1H, NH—Ar), 7.13-7.52 (m, 4H, Ar—H), 7.08 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 2.51-2.57 (q, J=7.5 Hz, 2H, CH₂CH₃), 1.12-1.16 (t, J=7.5 Hz, 3H, CH₂CH₃), 0.80-2.80 (m, 5H, NH-cyclopropyl-H).

KHG24136 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 75.5%; melting point: 252-253.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ10.31 (s, 1H, NH—Ar), 7.08-7.67 (m, 4H, Ar—H), 7.04 (s, 1H, vinyl-H), 4.00 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 0.89-2.77 (m, 5H, NH-cyclopropyl-H).

KHG24137 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 94.1%; melting point: 119-200° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.26 (s, 1H, NH—Ar), 6.86-7.54 (m, 4H, Ar—H), 7.07 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.71 (s, 3H, OCH₃), 3.57 (s, 3H, N—CH₃), 0.79-2.80 (m, 5H, NH-cyclopropyl-H).

KHG24138 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-chloro-4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 89.3%; melting point: 237-239° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.22 (s, 1H, NH—Ar), 7.22-7.63 (m, 3H, Ar—H), 7.09 (s, 1H, vinyl-H), 4.04 (s, 2H, COCH₂), 3.59 (s, 3H, N—CH₃), 0.81-2.80 (m, 5H, NH-cyclopropyl-H).

KHG24139 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-cyanomethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₂CN, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 91.1%; melting point: 245-245.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.25 (s, 1H, NH—Ar), 7.28-7.65 (m, 4H, Ar—H), 7.09 (s, 1H, vinyl-H), 3.97 (s, 2H, COCH₂), 3.97-4.01 (d, J=9.6 Hz, 4H, CN—CH₂, COCH₂), 3.57 (s, 3H, N—CH₃), 0.81-2.79 (m, 5H, NH-cyclopropyl-H).

KHG24140 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 82.9%; melting point: 227-228.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.32 (s, 1H, NH—Ar), 7.48-7.64 (m, 4H, Ar—H), 7.10 (s, 1H, vinyl-H), 4.03 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 0.81-2.79 (m, 5H, NH-cyclopropyl-H).

KHG24141 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 84.3%; melting point: 219.5-220° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.28 (s, 1H, NH—Ar), 6.93-7.65 (m, 10H, O—Ar—H, Ar—H, vinyl-H), 4.00 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 0.81-2.78 (m, 5H, NH-cyclopropyl-H).

KHG24142 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 80.2%; melting point: 212-212.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.06 (s, 1H, NH—Ar), 7.12-7.49 (m, 3H, Ar—H), 7.08 (s, 1H, vinyl-H), 4.03 (s, 2H, COCH₂), 3.60 (s, 3H, N—CH₃), 2.28 (s, 3H, Ar—CH₃), 0.82-2.79 (m, 5H, NH-cyclopropyl-H).

KHG24143

(2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 88.3%; melting point: 260.5-261° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.15 (s, 1H, NH—Ar), 7.30-7.72 (m, 3H, Ar—H), 7.10 (s, 1H, vinyl-H), 4.04 (s, 2H, COCH₂), 3.54 (s, 3H, N—CH₃), 0.80-2.81 (m, 5H, NH-cyclopropyl-H).

KHG24144 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 91.2%; melting point: 199.5-200.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.16 (s, 1H, NH—Ar), 6.95-7.66 (m, 4H, Ar—H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.62 (s, 3H, N—CH₃), 2.28 (s, 3H, Ar—CH₃), 0.81-2.78 (m, 5H, NH-cyclopropyl-H).

KHG24145 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,4-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 75.2%; melting point: 245-246° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.36 (s, 1H, NH—Ar), 7.07-7.78 (m, 3H, Ar—H), 7.04 (s, 1H, vinyl-H), 4.03 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 0.81-2.78 (m, 5H, NH-cyclopropyl-H).

KHG24146 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 78.9%; melting point: 233.5-234.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 010.40 (s, 1H, NH—Ar), 7.21-8.01 (m, 3H, Ar—H), 7.08 (s, 1H, vinyl-H), 4.07 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 0.81-2.78 (m, 5H, NH-cyclopropyl-H).

KHG24147 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 88.0%; melting point: 237.5-238° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.31 (s, 1H, NH—Ar), 7.57-8.93 (m, 3H, Ar—H), 7.10 (s, 1H, vinyl-H), 4.12 (s, 2H, COCH₂), 3.57 (s, 3H, N—CH₃), 0.81-2.80 (m, 5H, NH-cyclopropyl-H).

KHG24148 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, =H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 82.8%; melting point: 237-237.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.38 (d, 1H, NH—Ar), 7.25-7.87 (m, 3H, Ar—H), 7.07 (s, 1H, vinyl-H), 4.05 (s, 2H, COCH₂), 3.56 (s, 3H, N—CH₃), 0.78-2.78 (m, 5H, NH-cyclopropyl-H).

KHG24149 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 90.7%; melting point: 241.5-242.5° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.26 (s, 1H, NH—Ar), 7.34-7.67 (m, 4H, Ar—H), 7.08 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.56 (s, 3H, N—CH₃), 0.80-2.78 (m, 5H, NH-cyclopropyl-H).

KHG24150 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-phenyl-acetamide hydrochloride [R₁=H, R₂═R₃H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 79.3%; melting point: 240.5-241° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.34 (a, 1H, NH—Ar), 7.02-7.63 (m, 6H, Ar—H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 0.81-2.78 (m, 13H, NH-cyclopropyl-H).

KHG24151 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 86.6%; melting point: 238-238.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.35 (s, 1H, NH—Ar), 7.14-7.60 (m, 4H, Ar—H), 7.07 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.58 (s, 3H, N—CH₃), 0.81-2.86 (m, 12H, NH-cyclopropyl-H, Ar—CH(CH₃)₂).

KHG24152 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=0, X=Cl]

yield: 84.4%; melting point: 227.5-228.5° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.26 (s, 1H, NH—Ar), 7.10-7.51 (m, 4H, Ar—H), 7.07 (s, 1H, vinyl-H), 3.97 (s, 2H, COCH₂), 3.56 (s, 3H, N—CH₃), 0.86-2.76 (m, 14H, NH-cyclopropyl-H, Ar—(CH₂)₃CH₃).

KHG24153 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=1, X=Cl]

yield: 72.3%; melting point: 200.5-202.5° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.26 (s, 1H, HCl), 8.90 (t, 1H, J=5.3 H_(z), NH), 7.12-7.34 (m, 4H, Ar—H), 6.99 (s, 1H, vinyl-H), 4.28 (d, 2H, J=5.7 H_(z), N—CH₂), 3.78 (s, 2H, COCH₂), 3.50 (s, 3H, N—CH₃), 0.80-2.78 (m, 5H, cyclopropyl-H).

KHG24154 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₃H₅, n=1, m=1, X=Cl]

yield: 78.7%; melting point: 225.5-227° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.34 (s, 1H, HCl), 8.98 (t, 1H, J=5.7 H_(z), NH), 7.28-7.39 (m, 4H, Ar—H), 6.99 (s, 1H, vinyl-H), 4.27 (d, 2H, J=5.7 H_(z), N—CH₂), 3.79 (s, 2H, COCH₂), 3.51 (s, 3H, N—CH₃), 0.80-2.76 (m, 5H, cyclopropyl-H).

KHG24155 (2-cyclopropylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxybenzyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃H, R₅=CH₃, R₆=C₃H₅, n=1, m=1, X=Cl]

yield: 78.2%; melting point: 220.5-222° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 10.31 (s, 1H, J=6.2 Hz, HCl), 8.84 (t, 1H, J=5.6 H_(z), NH), 6.85-7.20 (m, 4H, Ar—H), 6.98 (s, 1H, vinyl-H), 4.21 (d, 2H, J=5.7 H_(z), N—CH₂), 3.76 (s, 2H, COCH₂), 3.72 (s, 3H, Ar—OCH₃), 3.52 (s, 3H, N—CH₃), 0.77-2.76 (m, 5H, cyclopropyl-H).

KHG24156 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=1, X=Cl]

yield: 36.8%; melting point: 160.5-162° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.76 (s, 1H, HCl), 8.92 (t, 1H, J=5.3 H_(z), NH), 7.03-7.34 (m, 4H, Ar—H), 6.97 (s, 1H, vinyl-H), 4.28 (d, 2H, J=5.7 H_(z), N—CH₂), 3.77 (s, 3H, COCH₂, Ar—C¹H), 3.54 (s, 3H, N—CH₃), 1.58-2.03 (m, 8H, cyclopentyl-H).

KHG24157 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=1, X=Cl]

yield: 71.3%; melting point: 180-182° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.76 (s, 1H, HCl), 8.98 (t, 1H, J=5.4 H_(z), NH), 7.28-7.39 (m, 4H, Ar—H), 6.99 (s, 1H, vinyl-H), 4.27 (d, 2H, J=5.7 H_(z), N—CH₂), 3.78 (s, 3H, COCH₂, Ar—C¹H), 3.54 (s, 3H, N—CH₃), 1.58-2.03 (m, 8H, cyclopentyl-H).

KHG24158 (2-cyclopentylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxybenzyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=1, X=Cl]

yield: 56.4%; melting point: 172-173.5° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.83 (s, 1H, J=6.2 Hz, HCl), 8.84 (t, 1H, J=5.6 H_(z), NH), 6.86-7.26 (m, 4H, Ar—H), 6.97 (s, 1H, vinyl-H), 3.75 (d, 6H, J=7.3 H_(z), COCH₂, Ar—C¹H, OCH₃), (d, 2H, J=5.6 H_(z), N—CH₂), 3.56 (s, 3H, N—CH₃), 1.58-2.03 (m, 8H, cyclopentyl-H).

KHG24159 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=1, X=Cl]

yield: 65.0%; melting point: 210.5-211.5° C.

¹H NMR (300 MH_(z), DMSO-d₆) δ 9.65 (d, 1H, J=6.7H_(z), HCl), 8.90 (t, 1H, J=5.4 H_(z), NH), 7.11-7.33 (m, 4H, Ar—H), 6.95 (s, 1H, vinyl-H), 4.27 (d, 2H, J=5.7 H_(z), N—CH₂), 3.75 (s, 2H, COCH₂), 3.50 (s, 3H, N—CH₃), 1.45-3.41 (m, 13H, cycloheptyl1H).

KHG24160 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=1, X=Cl]

yield: 81.2%; melting point: 216-216.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.65 (d, 1H, J=6.6H_(z), HCl), 8.94 (t, 1H, J=5.4 H_(z), NH), 7.28-7.39 (m, 4H, Ar—H), 6.95 (s, 1H, vinyl-H), 4.27 (d, 2H, J=5.7 H_(z), N—CH₂), 3.76 (s, 2H, COCH₂), 3.51 (s, 3H, N—CH₃), 1.45-3.40 (m, 13H, cycloheptyl-H).

KHG24161 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxybenzyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅═CH₃, R₆=C₇H₁₃, n=1, m=1, X=Cl]

yield: 70.8%; melting point: 188-190° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.68 (s, 1H, J=6.9 Hz, HCl), 8.79 (t, 1H, J=5.7 H_(z), NH), 6.86-7.20 (m, 4H, Ar—H), 6.95 (s, 1H, vinyl-H), 4.21 (d, 2H, J=5.7 H_(z), N—CH₂), 3.77 (d, 3H, J=9.1 H_(z), Ar—OCH₃, COCH₂), 3.51 (s, 3H, N—CH₃), 1.45-3.41 (m, 13H, cycloheptyl-H).

KHG24216 (2-phenethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=CH₂CH₂C₆H₅, n=1, m=0, X=Cl]

yield: 43.5%; melting point: 221.3° C.

¹H NMR (400 MHz, CD₃OD) δ 8.22 (s, 2H, ArH-2′ and ArH-6′), 7.69 (s, 1H, ArH-4′), 7.22-7.34 (m, 5H, benzyl), 6.90 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.67 (t, 2H, J=7.15 Hz, NCH₂CH₂), 3.58 (s. 3H, NCH₃), 3.06 (t, 2H, J=7.15 Hz, NCH₂CH₂).

KHG24218 (2-cyclohexylmethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₅=CH₃, R₆=CH₂C₆H₁₁, n=1, m=0, X=Cl]

yield: 91.6%; melting point: 119.6° C.

¹H NMR (400 MHz, CD₃OD) δ 8.21 (s, 2H, ArH-2′ and ArH-6′), 7.69 (s, 1H, ArH-4′), 6.89 (s, 1H, vinyl-H), 4.01 (s, 2H, COCH₂), 3.58 (s, 3H, NCH₃), 3.25 (d, 2H, J=6.77 Hz, NCH₂CH), 1.71-1.87 (m, 6H, cyclohexyl), 1.19-1.34 (m, 3H, cyclohexyl), 1.04-1.10 (m, 2H, cyclohexyl).

KHG24220 (2-phenethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃H, R₅=CH₃, R₆=CH₂CH₂C₆H₅, n=1, m=0, X=Cl]

yield: 90%; melting point: 225° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.51 (s, 1H, HCl), 10.06 (br. s, 1H, NH), 7.50-7.15 (m, 9H, ArH), 7.00 (s, 1H, vinyl-H), 3.93 (s, 2H, 4-CH₂), 3.55 (s, 3H, N—CH₃), 3.02-2.98 (m, 4H, (CH₂)₂C₆H₅), 2.85-2.79 (m, 1H, isopropyl CH), 1.16 (d, J=5.2 Hz, 6H, isopropyl(CH₃)₂).

KHG24222 (2-cyclohexylmethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃H, R₅=CH₃, R₆=CH₂C₆H₁₁, n=1, m=0, X=Cl]

yield: 94.4%; melting point: 250.7° C.

¹H NMR (400 MHz, CD₃OD) δ 7.47 (d, 2H, J=8.43 Hz, ArH-2′ and ArH-6′), 7.20 (d, J=8.44 Hz, ArH-3′ and ArH-5′), 6.92 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.60 (s, 3H, NCH₃), 3.27 (d, 2H, J=6.76 Hz, NCH₂CH), 2.88 (septet, 1H, J=6.91 Hz, CH(CH₃)₂), 1.71-1.86 (m, 6H, cyclohexyl), 1.24-1.37 (m, 3H, cyclohexyl), 1.04-1.10 (m, 2H, cyclohexyl).

KHG24224 (2-phenethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=CH₂CH₂C₆H₅, n=1, m=0, X=Cl]

yield: 72.8%; melting point: 225.5° C.

¹H NMR (400 MHz, CD₃OD) δ 7.55 (d, 2H, J=8.94 Hz, ArH-2′ and ArH-6′), 7.22-7.36 (m, 7H, ArH-3″, ArH-5″ and benzyl), 7.09 (t, 1H, J=7.38 Hz, ArH-4″), 6.97 (d, J=8.99 Hz, ArH-3′ and ArH-5′), 6.96 (dd, J=8.22, 1.05 Hz, ArH-2″ and ArH-4″), 6.88 (s, 1H, vinyl-H), 3.93 (s, 2H, COCH₂), 3.67 (t, 2H, J=7.22 Hz, NCH₂CH₂), 3.57 (s, 3H, NCH₃), 3.06 (t, 2H, J=7.20 Hz, NCH₂CH₂).

KHG24226 (2-cyclohexylmethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃H, R₅=CH₃, R₆=CH₂C₆H₁₁, n=1, m=0, X=Cl]

yield: 80.6%; melting point: 250.8° C.

¹H NMR (400 MHz, CD₃OD) δ 7.55 (d, 2H, J=8.68 Hz, ArH-2′ and ArH-6′), 7.34 (t, 2H, J=7.66 Hz, ArH-3″ and ArH-5″), 7.09 (t, 1H, J=6.74 Hz, ArH-4″), 6.95-6.97 (m, 4H, ArH-3′, ArH-5′, ArH-2″ and ArH-4″), 6.92 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.60 (s, 3H, NCH₃), 3.13-3.26 (br s, 2H, NCH₂CH and CD₃OD), 1.70-1.86 (m, 6H, cyclohexyl), 1.28-1.34 (m, 3H, cyclohexyl), 1.04-1.07 (m, 2H, cyclohexyl).

KHG24228 (2-phenethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃==R₄=H, R₅=CH₃, R₆=CH₂CH₂C₆H₅, n=1, m=0, X=Cl]

yield: 39.4%; melting point: 226.7° C.

¹H NMR (400 MHz, CD₃OD) δ 7.57 (d, 2H, J=8.67 Hz, ArH-2′ and ArH-6′), 7.24-7.33 (m, 7H, ArH-3″, ArH-5″ and benzyl), 6.91 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.68 (t, 2H, J=7.11 Hz, NCH₂CH₂), 3.48 (s, 3H, NCH₃), 3.06 (t, 2H, J=6.98 Hz, NCH₂CH₂).

KHG24230 (2-cyclohexylmethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=CH₂C₆H₁₁, n=1, m=0, X=Cl]

yield: 94.7%; melting point: 177.1° C.

¹H NMR (400 MHz, DMSO) δ 9.63 (s, 1H, CONH), 7.62 (d, 2H, J=9.00 Hz, ArH-2′ and ArH-6′), 7.39 (d, 2H, J=8.88 Hz, ArH-3′ and ArH-5′), 7.02 (s, 1H, vinyl-H), 3.95 (s, 2H, COCH₂), 3.52 (s, 3H, NCH₃), 3.18 (s, 2H, NCH₂CH), 1.66-1.74 (m, 6H, cyclohexyl), 0.86-1.23 (m, 5H, cyclohexyl).

KHG24232 (2-phenethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=CH₂CH₂C₆H₅, n=1, m=0, X=Cl]

yield: 99%; melting point: 196.4° C.:

¹H NMR (400 MHz, CD₃OD) δ 9.07 (t, 1H, J=3.29 Hz, ArH-6′), 8.09 (t, 1H, J=4.53 Hz, ArH-4′), 7.45 (t, 1H, J=9.51 Hz, ArH-5′), 7.22-7.35 (m, 5H, benzyl), 6.88 (s, 1H, vinyl-H), 4.05 (s, 2H, COCH₂), 3.66 (d, 2H, J=7.20 Hz, NCH₂CH), 3.57 (s, 3H, NCH₃), 3.06 (t, 2H, J=7.18 Hz, NCH₂CH₂).

KHG24234 (2-cyclohexylmethylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂), R₄=H, R₅=CH₃, R₆=CH₂C₆H₁₁, n=1, m=0, X=Cl]

yield: 63.5%; melting point: 225.0° C.

¹H NMR (300 MHz, CD₃OD) δ 9.07 (dd, 1H, J=6.66, 7.81 Hz, ArH-6′), 8.11 (ddt, 1H, J=6.78, 4.30, 2.97 Hz, ArH-4′), 7.45 (t, 1H, J=9.76 Hz, ArH-3′), 6.96 (s, 1H, vinyl-H), 4.09 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 3.29 (d, 2H, J=6.85 Hz, NCH₂CH), 1.72-1.89 (m, 6H, cyclohexyl), 1.19-1.36 (m, 3H, cyclohexyl), 1.02-1.13 (m, 2H, cyclohexyl).

KHG24235 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 36.0%; melting point: 119.6° C.

¹H NMR (300 MHz, CD₃OD) δ 7.44 (d, 2H, J=8.46 Hz, ArH-3′ and ArH-5′), 7.15 (d, 2H, J=8.21 Hz, ArH-2′ and ArH-6′), 7.00 (s, 1H, vinyl-H), 3.97 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 2.31 (s, 3H, CCH₃), 2.16-2.24 (m, 9H, adamantyl), 1.74-1.81 (m, 6H, adamantyl).

KHG24236 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₂CH₃, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 80.9%; melting point: 219.2° C.

¹H NMR (300 MHz, CD₃OD) δ 7.46 (d, 2H, J=8.50 Hz, ArH-3′ and ArH-5′), 7.18 (d, 2H, J=8.56 Hz, ArH-2′ and ArH-6′), 7.00 (s, 1H, vinyl-H), 3.97 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 2.62 (q, 2H, 7.60 Hz, CH₂CH₃), 2.20-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl), 1.22 (t, 3H, J=7.60 Hz, CH₂CH₃).

KHG24237 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 96.8%; melting point: 201.9° C.

¹H NMR (300 MHz, CD₃OD) δ 7.58 (dd, 2H, J=9.06, 4.84 Hz, ArH-3′ and ArH-5′), 7.08 (dd, 2H, J=8.78, 8.77 Hz, ArH-2′ and ArH-6′), 6.99 (s, 1H, vinyl-H), 3.99 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 2.20-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl).

KHG24238 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 87.1%; melting point: 228.3° C.

¹H NMR (300 MHz, CD₃OD) δ 7.59 (d, 2H, J=8.81 Hz, ArH-3′ and ArH-5′), 7.33 (d, 2H, J=8.83 Hz, ArH-2′ and ArH-6′), 6.70 (s, 1H, vinyl-H), 4.00 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 2.20-2.24 (m, 9H, adamantyl), 1.73-1.86 (m, 6H, adamantyl).

KHG24239 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 81.9%; melting point: 237.4° C.

¹H NMR (300 MHz, CD₃OD) δ 7.50 (ddd, 4H, J=9.07, 18.48, 4.50 Hz, Ar—H), 6.97 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.62 (s, 3H, NCH₃), 2.20-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl).

KHG24240 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 41.3%; melting point: 238.7° C.

¹H NMR (300 MHz, CD₃OD) δ 7.79 (d, 2H, J=8.60 Hz, ArH-3′ and ArH-5′), 7.64 (d, 2H, J=8.68 Hz, ArH-2′ and ArH-6′), 6.70 (s, 1H, vinyl-H), 4.03 (s, 2H, COCH₂), 3.63 (s, 3H, NCH₃), 2.20-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl).

KHG24241 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 63.0%; melting point: 204.8° C.

¹H NMR (300 MHz, CD₃OD) δ 8.23 (s, 2H, ArH-2′ and ArH-6′), 7.70 (s, 1H, ArH-4′), 7.02 (s, 1H, vinyl-H), 4.07 (s, 2H, COCH₂), 3.65 (s, 3H, NCH₃), 2.21-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl).

KHG24242 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 62.5%; melting point: 232.8° C.

¹H NMR (300 MHz, CD₃OD) δ 7.94 (dd, 1H, J=8.47, 8.57 Hz, ArH-6′), 7.31 (dd, 1H, J=10.62, 2.30 Hz, ArH-4′), 7.21 (ddd, 1H, J=8.75, 2.24, 1.34 Hz, ArH-3′), 7.00 (s, 1H, vinyl-H), 4.06 (s, 2H, COCH₂), 3.63 (s, 3H, CH₃), 2.20-2.24 (m, 9H, adamantyl), 1.81 (br s, 6H, adamantyl).

KHG24243 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 32.9; melting point: 221.4° C.

¹H NMR (300 MHz, CD₃OD) δ 7.29 (d, 2H, J=8.56 Hz, ArH-2′ and ArH-6′), 7.21 (d, 2H, J=8.48 Hz, ArH-3′ and ArH-5′), 6.99 (s, 1H, vinyl-H), 3.98 (s, 2H, COCH₂), 3.63 (s, 3H, CH₃), 2.89 (septet, 1H, J=6.90 Hz, CH₃CH₂CH₃), 2.20-2.24 (m, 9H, adamantyl), 1.77-1.81 (m, 6H, adamantyl), 1.24 (d, 6H, J=6.92 Hz, CH₃CH₂CH₃).

KHG24244 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 72.7%; melting point: 255.1° C.

¹H NMR (300 MHz, CD₃OD) δ 7.56 (d, 2H, J=9.07 Hz, ArH-2′ and ArH-6′), 7.35 (t, 2H, J=6.00 Hz, ArH-3″ and ArH-5″), 7.10 (t, 1H, J=7.41 Hz, ArH-4″), 6.94-7.00 (m, 5H, ArH-3′, ArH-5′, ArH-2″, ArH-4″ and vinyl-H), 3.99 (s, 2H, COCH₂), 3.64 (s, 3H, NCH₃), 2.17-2.24 (m, 9H, adamantyl), 1.77-1.86 (m, 6H, adamantyl).

KHG24261 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₂CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 67.3%; melting point: 226.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.73 (s, 1H, NH), 8.34 (s, 2H, Ar—H), 7.79 (s, 1H, Ar—H), 7.10 (s, 1H, vinyl-H), 4.18-4.13 (m, 2H, N—CH₂CH₃), 4.05 (s, 2H, 4-methylene CH₂), 3.22 (m, 1H, 1-cyclohexyl H), 1.99-1.27 (m, 10H, cyclohexyl-H), 1.21-1.16 (m, 3H, N—CH₂CH₃).

KHG24262 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 61.2%; melting point: 194.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.05 (s, 1H, NH), 7.67 (s, 2H, J=8.9 Hz, Ar—H), 7.38 (s, 2H, J=8.9 Hz, Ar—H), 7.05 (s, 1H, vinyl-H), 4.12 (t, 2H, J≅7.8 Hz, N—CH₂CH₂CH₂CH₃), 3.97 (s, 2H, 4-methylene CH₂), 3.21 (m, 1H, 1-cyclohexyl H), 1.98-1.11 (m, 10H, cyclohexyl-H), 1.39-1.22 (m, 4H, N—CH₂CH₂CH₂CH₃), 0.77 (t, 3H, J=7.3 Hz, N—(CH₂)₃CH₃).

KHG24263 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 63.5%; melting point: 215.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.04 (s, 1H, NH), 7.64-7.49 (m, 4H, Ar—H), 7.05 (s, 1H, vinyl-H), 4.11 (t, 2H, J≅7.8 Hz, N—CH₂CH₂CH₂CH₃), 3.97 (s, 2H, 4-methylene CH₂), 3.08 (m, 1H, 1-cyclohexyl H), 1.98-1.49 (m, 10H, cyclohexyl-H), 1.39-1.25 (m, 4H, N—CH₂CH₂CH₂CH₃), 0.77 (m, 3H, J=7.3 Hz, N—(CH₂)₃CH₃).

KHG24264 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=n-C₄H₉, R₆=C₆H, n=1, m=0, X=Cl]

yield: 11.3%; melting point: 230.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.77 (s, 1H, NH), 8.35 (s, 1H, Ar—H), 7.81 (s, 1H, Ar—H), 7.11 (s, 1H, vinyl-H), 4.13-4.05 (m, 4H, N—CH₂CH₂CH₂CH₃, 4-methylene CH₂), 3.29 (m, 1H, 1-cyclohexyl H), 1.99-1.27 (m, 14H, cyclohexyl-H, N—CH₂CH₂CH₂CH₃), 0.77 (m, 3H, J=7.3 Hz, N—(CH₂)₃CH₃).

KHG24265 [2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 85.0%; melting point: 233.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.82 (s, 1H, NH), 7.59-7.06 (dd, 4H, J≅8.9 Hz, Ar—H), 7.06 (s, 1H, vinyl-H), 4.04 (s, 2H, 4-CH₂), 3.28-3.25 (m, 2H, cyclohexyl-H), 2.26-1.11 (m, 22H, cyclohexyl-H).

KHG24266 [2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₁, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 81.0%; melting point: 244.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.80 (s, 1H, NH), 7.74-7.39 (dd, 4H, Ar—H), 7.06 (s, 1H, vinyl-H), 4.04 (s, 2H, 4-CH₂), 3.28-3.25 (m, 2H, cyclohexyl-H), 2.23-0.89 (m, 22H, cyclohexyl-H).

KHG24267 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 76%; melting point: 197.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.65 (s, 1H, NH), 9.26 (d, 1H, J=8.0 Hz, HCl), 8.36 (s, 2H, Ar—H), 7.79 (s, 1H, Ar—H), 7.03 (s, 1H, vinyl-H), 4.10 (s, 2H, CH₂), 3.28-3.26 (m, 1H, N-cyclohexyl-H), 2.99 (m, 1H, N-cyclopropyl-H), 1.99-1.03 (m, 14H, N-cyclohexyl-H, N-cyclopropyl-H).

KHG24268 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 32.7%; melting point: 240.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.13 (s, 1H, NH), 9.30 (d, 1H, J=6.5 Hz, HCl), 7.85 (d, 2H, J=8.5 Hz, Ar—H), 7.69 (d, 2H, J=8.7 Hz, Ar—H), 7.00 (s, 1H, vinyl-H), 4.07 (s, 2H, CH₂), 2.98 (m, 1H, N-cyclopropyl-H), 1.99-1.04 (m, 14H, N-cyclohexyl-H, N-cyclopropyl-H).

KHG24270 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 8.5%; melting point: 195.6° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.55 (s, 1H, NH), 9.31 (d, 1H, J=8.0 Hz, HCl), 7.51 (d, 2H, J=8.5 Hz, Ar—H), 7.12 (d, 2H, J=8.4 Hz, Ar—H), 6.97 (s, 1H, vinyl-H), 3.98 (s, 2H, CH₂), 3.28-3.24 (m, 1H, N-cyclohexyl-H), 2.99-2.95 (m, 1H, N-cyclopropyl-H), 2.55 (m, 2H, ArCH₂CH₂), 1.53-1.49 (m, 2H, CH₂CH₂CH₂), 1.35-1.32 (m, 2H, CH₂CH₂CH₃), 1.99-1.02 (m, 14H, N-cyclohexyl-H, N-cyclopropyl-H), 0.88 (t, 3H, J=7.3 Hz, CH₂CH₃).

KHG24271 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 76%; melting point: 183.7° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.51 (s, 1H, NH), 9.35 (d, 1H, J=8.1 Hz, HCl), 8.01 (d, 2H, J=6.8 Hz, Ar—H), 7.36 (t, 1H, J=8.8 Hz, Ar—H), 7.26-7.23 (m, 1H, Ar—H), 6.99 (s, 1H, vinyl-H), 4.09 (s, 2H, CH₂), 3.32-3.25 (m, 1H, N-cyclohexyl-H), 3.00-2.96 (m, 1H, N-cyclopropyl-H), 1.99-1.01 (m, 14H, N-cyclohexyl-H, N-cyclopropyl-H).

KHG24272 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 36%; melting point: 194.2° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.51 (s, 1H, NH), 9.28 (d, 1H, J=8.1 Hz, HCl), 7.50 (d, 2H, J=6.5 Hz, Ar—H), 7.15 (d, 2H, J=8.4 Hz, Ar—H), 6.97 (s, 1H, vinyl-H), 3.98 (s, 2H, CH₂), 3.28-3.24 (m, 1H, N-cyclohexyl-H), 2.99-2.95 (m, 1H, N-cyclopropyl-H), 2.53 (q, 2H, J=7.6 Hz, CH₂CH₃), 1.15 (t, 3H, J=7.6 Hz, CH₂CH₃), 1.99-1.02 (m, 14H, N-cyclohexyl-H, N-cyclopropyl-H).

KHG24273 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 24.8%; melting point: 188.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.86 (s, 1H, NH), 9.29 (d, 1H, J=7.9 Hz, HCl), 7.62 (d, 2H, J=8.9 Hz, Ar—H), 7.50 (d, 2H, J=8.9 Hz, Ar—H), 6.98 (s, 1H, vinyl-H), 4.01 (s, 2H, CH₂), 3.27 (m, 1H, N-cyclohexyl-H), 2.98-2.96 (m, 1H, N-cyclopropyl-H), 1.99-1.02 (m, 14H, N-cyclohexyl-H, N-cyclopropyl-H).

KHG24274 [2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 74.0%; melting point: 216.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.22 (s, 1H, NH), 7.55-7.10 (m, 4H, Ar—H), 6.96 (s, 1H, vinyl-H), 3.96 (s, 2H, CH₂), 3.44 (s, 3H, CH₃), 3.27 (m. 1H, cyclopropyl C₁—H), 3.97 (m, 1H, cyclohexyl-H), 2.25 (s, 4H, cyclopropyl-H), 1.83-1.24 (m, 8H, cyclohexyl-H).

KHG24275 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 58.3%; melting point: 218.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.07 (s, 1H, NH), 7.68 (d, 2H, J=8.9 Hz, ArH), 7.37 (d, 2H, J=8.8 Hz, ArH), 7.05 (s, 1H, vinyl H), 4.21-4.19 (m, 2H, NCH₂CH₃), 3.99 (s, 2H, CH₂), 3.22 (br s, 1H, 1-cyclohexyl H), 1.98-1.26 (m, 10H, cyclohexyl-H), 1.19-1.15 (m, 3H, NCH₂CH₃).

KHG24276 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 62.4%; melting point: 160.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.49 (s, 1H, NH), 7.67-7.33 (m, 9H, ArH), 6.74 (s, 1H, vinyl H), 3.74-3.64 (m, 2H, NCH₂CH₃), 3.24-3.22 (m, 1H, 1-cyclohexyl H), 3.85 (s, 2H, CH₂), 1.99-1.02 (m, 10H, cyclohexyl-H), 1.19-1.13 (m, 3H, NCH₂CH₃).

KHG24277 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 57.0%; melting point: 158.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.61 and 10.36 (A:B=0.3:1) (s, 1H, NH), 7.54-7.09 (m, 4H, ArH), 7.71 (s, 1H, 4-OH), 3.73-3.66 (m, 2H, NCH₂CH₃), 3.23-3.20 (m, 1H, 1-cyclohexyl H), 3.86 (ABq, 2H, Japp≅12.0 Hz, CH₂), 3.73-3.50 (m, 2H, ArCH₂CH₂CH₂CH₃) 2.97 (ABq, 2H, J=14.3 Hz, 5-methylene CH₂), 1.99-1.43 (m, 10H, cyclohexyl-H), 1.33-1.05 (m, 7H, ArCH₂CH₂CH₂CH₃), 0.87 (t, 3H, J=7.3 Hz, NCH₂CH₃).

KHG24278 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-NO₂, R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 31.6%; melting point: 177.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.83 and 10.59 (A:B=1.0:1.2) (s, 1H, NH), 8.11-7.53 (m, 3H, ArH), 7.85 (s, 1H, 4-OH), 7.08 (s, 1H, vinyl H), 3.25-3.22 (m, 1H, 1-cyclohexyl H), 3.86 (ABq, 2H, Japp≅12.4 Hz, CH₂), 3.16 (ABq, 2H, J=14.2 Hz, 5-methylene CH₂), 1.98-1.05 (m, 10H, cyclohexyl-H), 1.21-1.14 (m, 3H, NCH₂CH₃).

KHG24279 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 19.1%; melting point: 211.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.65 and 10.39 (A:B=0.3:1) (s, 1H, NH), 7.73 (s, 1H, 4-OH), 7.54-7.09 (m, 4H, Ar—H), 3.73-3.63 (m, 2H, NCH₂CH₃), 3.25-3.22 (m, 1H, 1-cyclohexyl H), 3.83 (ABq, 2H, Japp≅12.0 Hz, CH₂), 2.98 (ABq, 2H, J=14.2 Hz, 5-methylene CH₂), 1.96-1.10 (m, 10H, cyclohexyl-H), 1.20-1.10 (m, 3H, NCH₂CH₃).

KHG24280 [2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 89%; melting point: 191° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.26 (s, 1H, NH), 9.69 (d, 1H, J=7.8 Hz, HCl), 7.85 (d, 2H, J=8.6 Hz, ArH), 7.68 (d, 2H, J=8.64 Hz, ArH), 4.17 (q, 2H, J=7.0 Hz, CH₂CH₃), 3.98 (s, 2H, CH₂), 3.25-3.22 (m, 1H, 1-cyclohexyl CH), 1.98-1.05 (m, 13H, cyclohexyl CH, CH₂CH₃).

KHG24281 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 92.2%; melting point: 213.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.75 (s, 1H, NH), 7.63 (d, 2H, J=9.0 Hz, ArH), 7.39-7.34 (m, 2H, ArH), 7.13-6.94 (m, 5H, ArOC₆H₅, vinyl H), 4.10 (t, 2H, NCH₂CH₂CH₂CH₃), 3.93 (s, 2H, CH₂), 3.25 (m, 1H, 1-cyclohexyl H), 1.99-1.51 (m, 10H, cyclohexyl-H), 1.36-1.26 (m, 4H, NCH₂CH₂CH₂CH₃), 0.79 (t, 3H, J=7.3 Hz, N(CH₂)₃CH₃).

KHG24282 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 96.1%; melting point: 209.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, NH), 7.50 (d, 2H, J=8.4 Hz, ArH), 7.12 (m, 2H, J=8.4 Hz, ArH), 7.04 (s, 1H, vinyl H), 4.11 (t, 2H, J=7.6 Hz, NCH₂CH₂CH₂CH₃), 3.93 (s, 2H, CH₂), 3.28 (m, 1H, 1-cyclohexyl H), 1.98-1.10 (m, 22H, cyclohexyl-H, Ar(CH₂)₃CH₃, NCH₂CH₂CH₂CH₃), 0.87 (t, 3H, Ar(CH₂)₃CH₃), 0.76 (t, 3H, J=7.3 Hz, N(CH₂)₃CH₃).

KHG24283 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃H, R₅ n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 75.6%; melting point: 215.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.66 (s, 1H, NH), 7.52 (d, 2H, J=8.4 Hz, ArH), 7.18 (m, 2H, J=8.4 Hz, ArH), 7.10 (s, 1H, vinyl H), 4.10 (s, 2H, NCH₂CH₂CH₂CH₃), 3.93 (s, 2H, CH₂), 3.22 (m, 1H, 1-cyclohexyl H), 1.92-1.15 (m, 16H, cyclohexyl-H, NCH₂CH₂CH₂CH₃, ArCH(CH₃)₂), 0.78 (t, 3H, J=7.3 Hz, N(CH₂)₃CH₃).

KHG24284 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 69.2%; melting point: 203.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.82 (s, 1H, NH), 7.67-7.13 (m, 4H, ArH), 7.05 (s, 1H, vinyl H), 4.09 (t, 2H, Japp≅7.7 Hz, NCH₂CH₂CH₂CH₃), 3.93 (s, 2H, CH₂), 3.27 (m, 1H, 1-cyclohexyl H), 1.98-1.07 (m, 14H, cyclohexyl-H, NCH₂CH₂CH₂CH₃), 0.78 (t, 3H, Japp≅7.3 Hz, N(CH₂)₃CH₃).

KHG24285 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 84.1%; melting point: 183.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.76 (s, 1H, NH), 7.52 (d, 2H, J=8.4 Hz, ArH), 7.14 (d, 2H, J=8.4 Hz, ArH), 7.05 (s, 1H, vinyl H), 4.15 (t, 2H, Japp≅7.6 Hz, NCH₂CH₂CH₂CH₃), 3.92 (s, 2H, CH₂), 3.23 (m, 1H, 1-cyclohexyl H), 2.25 (s, 3H, ArCH₃), 1.98-1.11 (m, 14H, cyclohexyl-H, NCH₂CH₂CH₂CH₃), 0.78 (t, 3H, Japp≅7.2 Hz, N(CH₂)₃CH₃).

KHG24286 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 69.4%; melting point: 221.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, NH), 7.52 (d, 2H, J=8.4 Hz, ArH), 7.12 (d, 2H, J=8.3 Hz, ArH), 7.03 (s, 1H, vinyl H), 4.12 (s, 2H, NCH₂CH₂CH₂CH₃), 3.95 (s, 2H, CH₂), 3.22 (m, 1H, 1-cyclohexyl H), 2.58-2.53 (m, 2H, ArCH₂CH₃), 1.96-1.25 (m, 13H, cyclohexyl-H, ArCH₂CH₃), 1.19-1.12 (m, 4H, NCH₂CH₂CH₂CH₃), 0.78 (t, 3H, Japp≅7.2 Hz, N(CH₂)₃CH₃).

KHG24287 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 61.6%; melting point: 206.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.04 (s, 1H, NH), 7.66 (m, 2H, ArH), 7.38 (d, 2H, J=8.8 Hz, ArH), 7.06 (s, 1H, vinyl H), 4.09 (t, 2H, Japp≅7.8 Hz, NCH₂CH₂CH₃), 3.97 (s, 2H, CH₂), 3.26 (m, 1H, 1-cyclohexyl H), 1.97-1.06 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.85 (t, 3H, Japp≅7.3 Hz, NCH₂CH₂CH₃).

KHG24288 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 75.7%; melting point: 219.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.02 (d, 1H, NH), 7.61 (m, 2H, ArH), 7.50 (d, 2H, J=8.9 Hz, ArH), 7.05 (s, 1H, vinyl H), 4.09 (t, 2H, Japp≅7.7 Hz, NCH₂CH₂CH₃), 3.97 (s, 2H, CH₂), 3.28 (m, 1H, 1-cyclohexyl), 1.97-1.10 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.85 (t, 3H, Japp≅7.2 Hz, NCH₂CH₂CH₃).

KHG24289 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 61.2%; melting point: 243.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.69 (s, 1H, NH), 8.34 (s, 2H, ArH), 7.82 (s, 1H, ArH), 7.11 (s, 1H, vinyl H), 4.10-4.04 (m, 4H, NCH₂CH₂CH₃, CH₂), 3.26 (m, 1H, 1-cyclohexyl H), 1.99-1.16 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.88 (t, 3H, Japp≅7.3 Hz, NCH₂CH₂CH₃).

KHG24290 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 79.5%; melting point: 230.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.91 (s, 1H, NH), 7.67-7.34 (m, 4H, ArH), 7.12-6.94 (m, 6H, OC₆H₅, vinyl H), 4.13 (t, 2H, NCH₂CH₂CH₃), 3.95 (s, 2H, CH₂), 1.97-1.06 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.87 (t, 3H, Japp≅7.2 Hz, NCH₂CH₂CH₃).

KHG24291 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 72.2%; melting point: 201.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.67 (s, 1H, NH), 7.51 (d, 2H, J=8.4 Hz, ArH), 7.12 (d, 2H, J=8.4 Hz, ArH), 7.04 (s, 1H, vinyl H), 4.10 (t, 2H, Japp≅7.7 Hz, NCH₂CH₂CH₃), 3.92 (s, 2H, CH₂), 3.24 (m, 1H, 1-cyclohexyl H), 1.97-1.11 (m, 19H, cyclohexyl-H, Ar(CH₂)₃CH₃), 0.90-0.84 (m, 5H, NCH₂CH₂CH₃).

KHG24292 (2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl)-N-(4-methylbenzyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 39.3%; melting point: 172.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 8.89 (t, 1H, J=5.8 Hz, NH), 7.18-7.12 (m, 4H, ArH), 6.96 (s, 1H, vinyl H), 4.25-4.24 (d, 2H, J=5.8 Hz, NCH₂C₆H₅), 4.14 (q, 2H, J=7.0 Hz, NCH₂CH₃), 3.74 (s, 2H, CH₂), 3.20 (m, 1H, 1-cyclohexyl H), 2.28 (s, 3H, ArCH₃), 1.97-1.26 (m, 10H, cyclohexylH), 1.13 (t, 3H, J≅6.6 Hz, NCH₂CH₃).

KHG24293 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-methylbenzyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 63.7%; melting point: 189.5-191.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 8.80 (t, 1H, J=5.7 Hz, NH), 7.18-7.12 (m, 4H, ArH), 6.96 (s, 1H, vinyl H), 4.24 (d, 2H, J=5.7 Hz, NCH₂C₆H₅), 4.01 (q, 2H, J=7.8 Hz, NCH₂CH₂CH₂CH₃), 3.71 (s, 2H, 4-CH₂), 2.28 (s, 3H, ArCH₃), 1.98-1.46 (m, 10H, cyclohexyl-H), 1.40-1.24 (m, 4H, NCH₂CH₂CH₂CH₃), 0.88-0.83 (t, 3H, Japp≅7.3 Hz, N—(CH₂)₃CH₃).

KHG24294 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 75.5%; melting point: 207.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.67 (s, 1H, NH), 7.52 (s, 2H, J=8.5 Hz, ArH), 7.18 (m, 2H, J=8.5 Hz, ArH), 7.05 (s, 1H, vinyl H), 4.10 (t, 2H, Japp≅8.3 Hz, NCH₂CH₂CH₃), 3.93 (s, 2H, CH₂), 3.25 (m, 1H, 1-cyclohexyl H), 1.95-1.49 (m, 10H, cyclohexyl-H), 1.33 (q, 2H, Japp≅12.8 Hz, NCH₂CH₂CH₃), 1.17 (d, 6H, J=6.9 Hz, ArCH(CH₃)₂), 0.87 (t, 3H, Japp≅7.3 Hz, NCH₂CH₂CH₃).

KHG24295 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 88.4%; melting point: 139.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.83 (s, 1H, NH), 8.94-8.06 (m, 3H, ArH), 7.08 (s, 1H, vinyl H), 4.14 (s, 2H, NCH₂CH₂CH₃), 4.10 (s, 2H, CH₂), 3.24 (m, 1H, 1-cyclohexyl H), 1.98-1.56 (m, 10H, cyclohexyl-H), 1.33 (q, 2H, Japp≅12.8 Hz, NCH₂CH₂CH₃), 0.89 (t, 3H, Japp≅7.3 Hz, NCH₂CH₂CH₃).

KHG24296 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 75.0%; melting point: 169.7° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.03 (s, 1H, NH), 7.70-7.14 (m, 4H, ArH), 7.07 (s, 1H, vinyl H), 4.14 (t, 2H, J=7.7 Hz, NCH₂CH₂CH₃), 3.97 (s, 2H, 4-CH₂), 3.22 (m, 1H, 1-cyclohexyl H), 1.98-1.52 (m, 10H, cyclohexyl-H), 1.33 (q, 2H, Japp≅12.8 Hz, NCH₂CH₂CH₃), 0.87 (t, 3H, Japp≅7.7 Hz, NCH₂CH₂CH₃).

KHG24297 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 56.5%; melting point: 188.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.71 (s, 1H, NH), 7.50 (d, 2H, J=8.4 Hz, ArH), 7.11 (d, 2H, J=8.4 Hz, ArH), 7.04 (s, 1H, vinyl H), 4.12 (t, 2H, J=7.7 Hz, NCH₂CH₂CH₃), 3.93 (s, 2H, CH₂), 3.23 (m, 1H, 1-cyclohexyl H), 2.24 (s, 1H, ArCH₃), 1.98-1.55 (m, 10H, cyclohexyl-H), 1.33 (q, 2H, J=12.8 Hz, NCH₂CH₂CH₃), 0.86 (t, 3H, Japp≅7.3 Hz, NCH₂CH₂CH₃).

KHG24298 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=n-C₃H₇, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 72.0%; melting point: 221.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.69 (s, 1H, NH), 7.53 (d, 2H, J=8.4 Hz, ArH), 7.15 (d, 2H, J=8.4 Hz, ArH), 7.05 (s, 1H, vinyl H), 4.12 (t, 2H, J=7.7 Hz, NCH₂CH₂CH₃), 3.94 (s, 2H, CH₂), 2.57-2.54 (m, 2H, Japp≅7.6 Hz, ArCH₂CH₃), 1.95-1.55 (m, 10H, cyclohexyl-H), 1.33 (m, 2H, NCH₂CH₂CH₃), 1.15 (t, 3H, J=7.6 Hz, ArCH₂CH₃), 0.87 (t, 3H, Japp≅7.2 Hz, NCH₂CH₂CH₃).

KHG24299 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 39.9%; melting point: 199.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.71 (s, 1H, NH), 7.55-7.07 (m, 10H, ArH, NCH₂C₆H₅, vinyl H), 5.55 (s, 2H, NCH₂C₆H₅), 3.79 (s, 2H, CH₂), 3.29 (m, 1H, 1-cyclohexyl H), 1.94-1.12 (m, 10H, cyclohexyl-H).

KHG24300 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 93.0%; melting point: 181.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.75 (s, 1H, NH), 7.51-7.44 (m, 4H, Japp≅4.3 Hz, ArH), 7.36-7.08 (m, 6H, NCH₂C₆H₅, vinyl H), 5.57 (s, 2H, NCH₂C₆H₅), 3.80 (s, 2H, CH₂), 3.30 (m, 1H, 1-cyclohexyl H), 1.95-1.03 (m, 10H, cyclohexyl-H).

KHG24301 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 76.2%; melting point: 234.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.44 (s, 1H, NH), 8.12 (s, 2H, ArH), 7.74 (m, 1H, ArH), 7.26-7.03 (m, 6H, NCH₂C₆H₅, vinyl H), 5.56 (s, 2H, NCH₂C₆H₅), 3.91 (s, 2H, CH₂), 3.33 (m, 1H, 1-cyclohexyl H), 1.97-1.03 (m, 10H, cyclohexyl-H).

KHG24302 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, 5₃=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 90.2%; melting point: 209.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.57 (s, 1H, NH), 7.54-6.93 (m, 15H, ArH, ArOC₆H₅, NCH₂C₆H₅, vinyl H), 5.57 (s, 2H, NCH₂C₆H₅), 3.77 (s, 2H, CH₂), 3.28 (m, 1H, 1-cyclohexyl H), 1.94-1.02 (m, 10H, cyclohexyl-H).

KHG24303 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 79.5%; melting point: 202.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.42 (s, 1H, NH), 7.44-7.09 (m, 10H, ArH, NCH₂C₆H₅, vinyl H), 5.56 (s, 2H, NCH₂C₆H₅), 3.74 (s, 2H, CH₂), 3.29 (m, 1H, 1-cyclohexyl H), 2.83 (m, 1H, ArCH(CH₃)₂), 1.95-1.26 (m, 10H, cyclohexyl-H), 1.17 (d, 6H, J=6.9 Hz, ArCH(CH₃)₂).

KHG24304 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 86.0%; melting point: 166.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.57 (d, 1H, NH), 8.73-7.53 (m, 3H, ArH), 7.33-7.06 (m, 6H, NCH₂C₆H₅, vinyl H), 5.55 (s, 2H, NCH₂C₆H₅), 3.95 (s, 2H, CH₂), 1.96-1.03 (m, 10H, cyclohexyl-H).

KHG24305 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 74.6%; melting point: 214.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.58 (s, 1H, NH), 7.54-7.08 (m, 10H, ArH, NCH₂C₆H₅, vinyl H), 5.55 (s, 2H, NCH₂C₆H₅), 3.75 (s, 2H, CH₂), 1.95-1.08 (m, 10H, cyclohexyl-H).

KHG24306 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 87.0%; melting point: 146.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.43 (s, 1H, NH), 7.43-7.09 (m, 10H, ArH, NCH₂C₆H₅, vinyl H), 5.56 (s, 2H, NCH₂C₆H₅), 3.75 (s, 2H, CH₂), 2.55-2.49 (m, 2H, ArCH₂CH₃), 1.94-1.25 (m, 10H, cyclohexyl-H), 1.16-1.03 (m, 3H, ArCH₂CH₃).

KHG24307 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 71.4%; melting point: 193.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 12.06 (s, 1H, NH), 8.37 (s, 2H, ArH), 7.79 (s, 1H, ArH), 7.11 (s, 1H, vinyl H), 4.21 (s, 2H, CH₂), 3.27-3.24 (m, 1H, cyclohexyl-H), 1.66-1.28 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H).

KHG24308 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 51.2%; melting point: 199.7° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.79 (s, 1H, NH), 7.52-7.16 (m, 4H, ArH), 7.05 (s, 1H, vinyl H), 4.06 (s, 2H, CH₂), 3.44-3.41 (m, 1H, 3-cyclohexyl-H), 1.98-1.26 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H), 1.17-1.15 (2s, 6H, CH(CH₃)₂).

KHG24309 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 84.9%; melting point: 199.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.99 (s, 1H, NH), 7.66-6.94 (m, 9H, ArH), 7.07 (s, 1H, vinyl H), 4.08 (s, 2H, CH₂), 3.26-3.24 (br s, 1H, 3-cyclohexyl-H), 2.15-1.14 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H).

KHG24310 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 82.09%; melting point: 220.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.50 (s, 1H, NH), 7.89-7.68 (m, 4H, ArH), 7.09 (s, 1H, vinyl H), 4.17 (s, 2H, CH₂), 3.24 (br s, 1H, 3-cyclohexyl-H), 2.17-1.09 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H).

KHG24311 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 65.9%; melting point: 153.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.91 (s, 1H, NH), 7.53-7.10 (m, 4H, ArH), 7.06 (s, 1H, vinyl H), 4.08 (s, 2H, CH₂), 3.23 (br s, 1H, 3-cyclohexyl-H), 2.16-1.04 (m, 23H, CH₃CH₂CH₂CH₂, cyclohexyl-H, 2-cyclohexyl-H), 1.48 (m, 2H, J=7.3 Hz, CH₃CH₂CH₂), 1.28 (m, 2H, J=7.3 Hz, CH₃CH₂CH₂), 0.87 (t, 3H, J=7.3 Hz, CH₃CH₂CH₂).

KHG24312 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-n-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 74.8%; melting point: 244.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.03 (s, 1H, NH), 7.67-7.13 (m, 4H, ArH), 7.06 (s, 1H, vinyl H), 4.07 (s, 2H, CH₂), 3.24 (br s, 1H, 3-cyclohexyl-H), 2.16-1.10 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H).

KHG24313 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 51.2%; melting point: 234.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.78 (s, 1H, NH), 7.50-7.09 (m, 4H, ArH), 7.05 (s, 1H, vinyl H), 4.05 (s, 2H, CH₂), 3.24 (br s, 1H, 3-cyclohexyl-H), 2.24 (s. 3H, CH₃), 2.14-1.10 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H).

KHG24314 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 79.7%; melting point: 222.7° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.74 (s, 1H, NH), 7.52-7.13 (m, 4H, ArH), 7.05 (s, 1H, vinyl H), 4.05 (s, 2H, CH₂), 3.24 (br s, 1H, 3-cyclohexyl-H), 2.54 (q, 2H, J=7.5 Hz, CH₂CH₃), 2.13-1.12 (m, 21H, cyclohexyl-H, 2-cyclohexyl-H), 1.14 (t, 3H, J=7.6 Hz, CH₂CH₃).

KHG24315 (2-cyclohexylimino-3-cyclopropyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 10.3%; melting point: 195.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.71 (s, 1H, NH), 9.32 (d, 1H, J=8.0 Hz, HCl), 7.63 (d, 2H, J=8.8 Hz, ArH), 7.36 (t, 2H, J=7.9 Hz, ArH), 7.10 (t, 1H, J=7.3 Hz, ArH), 6.98 (t, 5H, J=10.2 Hz, ArH, vinyl H), 4.00 (s, 2H, CH₂), 3.25 (m, 1H, cyclohexyl-H), 2.99 (m, 1H, cyclopropyl-H), 1.99-1.03 (m, 14H, cyclohexyl-H, cyclopropyl-H).

KHG24336 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-chlorobenzyl)-carboxamide hydrochloride [R₁=H, R₂=3-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 68%; melting point: 230-231° C.,

¹H NMR (300 MHz, DMSO-d₆) δ 9.10 (br. s, 1H, NH), 7.36-7.27 (m, 4H, ArH), 6.70 (s, 1H, vinyl-H), 4.36 (d, J=5.94 Hz, 2H, benzyl-H), 3.25 (s, 3H, methyl-H), 2.90 (m, 1H, 2-imino N—CH), 1.69-1.43 (m, 12H, cycloheptyl-H).

KHG24337 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorobenzyl)-carboxamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 65%; melting point: 220-222° C.,

¹H NMR (300 MHz, DMSO-d₆) δ 9.10 (br. s, 1H, NH), 7.38 (d, J=8.55 Hz, 2H, ArH), 7.33 (d, J=8.55 Hz, 2H, ArH), 4.34 (d, J=6.03 Hz, 2H, benzyl-H), 3.24 (s, 3H, methyl-H), 2.91-2.89 (m, 1H, 2-imino N—CH), 1.70-1.53 (m, 12H, cyclohexyl-H).

KHG24338 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,4-dichlorobenzyl)-carboxamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 70%; melting point: 218-219° C.,

¹H NMR (300 MHz, DMSO-d₆) δ 9.07 (t, J=5.79 Hz, 1H, NH), 7.61-7.55 (m, 2H, ArH), 7.31-7.27 (m, 1H, ArH), 4.35 (d, J=6.0 Hz, 2H, benzyl-H), 3.24 (s, 3H, methyl-H), 2.88-2.85 (m, 1H, 2-imino N—CH), 1.49-1.36 (m, 12H, cyclohexyl-H).

KHG24339 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methoxybenzyl)-carboxamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 67%; melting point: 156-159° C.,

¹H NMR (300 MHz, DMSO-d₆) δ 7.26 (d, J=8.19 Hz, 2H, ArH), 6.88 (d, J=8.55 Hz, 2H, ArH), 4.46 (d, J=5.70 Hz, 2H, benzyl-H), 3.52 (s, 3H, methyl-H), 2.95-2.91 (m, 1H, 2-imino N—CH), 1.85-1.44 (m, 12H, cyclohexyl-H).

KHG24403 (2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 94.7%; melting point: 196.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.91 (s, 1H, NH), 7.67-7.13 (m, 2H, ArH), 7.19-7.13 (t, 2H, J=8.8 Hz, ArH), 7.05 (s, 1H, vinyl H), 4.20 (q, 2H, Japp≅6.9 Hz, NCH₂CH₃), 3.96 (s, 2H, CH₂), 3.25-3.19 (m, 1H, 1-cyclohexyl H), 1.98-1.11 (m, 10H, cyclohexyl-H), 1.05 (t, 3H, NCH₂CH₃).

KHG24404 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=n-C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 73.2%; melting point: 173.6-174.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.3 (s, 1H, NH), 7.94-7.67 (m, 4H, ArH), 7.08 (s, 1H, vinyl H), 4.12 (t, 2H, J=7.6 Hz, NCH₂CH₂CH₃), 4.03 (s, 2H, CH₂), 3.25 (m, 1H, 1-cyclohexyl H), 1.98-1.10 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.86 (t, 3H, J=7.2 Hz, NCH₂CH₂CH₃).

KHG24405 (2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl)-N-(3-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-CH₃, R₄=H, R₅=n-C₃H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 46.6%; melting point: 204.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.89 (s, 1H, NH), 7.81-7.28 (m, 2H, ArH), 7.05 (s, 1H, vinyl H), 4.08 (t, 2H, J=7.6 Hz, NCH₂CH₂CH₃), 3.94 (s, 2H, CH₂), 3.26 (m, 1H, 1-cyclohexyl H), 2.27 (s, 3H, ArCH₃), 1.98-1.11 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.86 (t, 3H, J=7.2 Hz, NCH₂CH₂CH₃).

KHG24406 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 78.0%; melting point: 156.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.44 (s, 1H, NH), 7.42-7.08 (m, 10H, ArH, NCH₂C₆H₅, vinyl H), 5.57 (s, 2H, NCH₂C₆H₅), 3.75 (s, 2H, CH₂), 3.35-3.31 (m, 1H, 1-cyclohexyl H), 2.53-2.50 (m, 2H, CH₂CH₂CH₂CH₃), 1.94-1.08 (m, 14H, cyclohexyl-H, CH₂CH₂CH₂CH₃), 0.88 (t, 3H, J=7.2 Hz, N(CH₂)₃CH₃).

KHG24407 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 61.9%; melting point: 238.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.98 (s, 1H, NH), 7.73-7.63 (m, 4H, ArH), 7.35-7.07 (m, 6H, NCH₂C₆H₅, vinyl H), 5.56 (s, 2H, NCH₂C₆H₅), 3.85 (s, 2H, CH₂), 3.37-3.29 (m, 1H, 1-cyclohexyl H), 1.95-1.08 (m, 10H, cyclohexyl-H).

KHG24408 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 69.8%; melting point: 194.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.35 (s, 1H, NH), 7.80-7.77 (m, 1H, ArH), 7.37-7.07 (m, 8H, ArH, NCH₂C₆H₅, vinyl H), 5.56 (s, 2H, NCH₂C₆H₅), 3.90 (s, 2H, CH₂), 3.31 (m, 1H, 1-cyclohexyl H), 1.95-1.09 (m, 10H, cyclohexyl-H).

KHG24409 [2-(1-adamantylimino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 76%; melting point: 178.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.54 (s, 1H, NH), 7.51-7.11 (m, 4H, ArH, vinyl H), 3.98 (s, 2H, CH₂), 3.59 (s, 3H, NCH₃), 2.16-1.21 (m, 15H, adamantyl-H), 0.91-0.85 (m, 3H, (CH₂)₃CH₃).

KHG24410 [2-(1-adamantylimino-3-methyl-1,3-thiazolidine-4-yl]-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 96.2%; melting point: 231.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.23 (s, 1H, NH), 7.70-7.42 (m, 3H, ArH), 7.13 (s, 1H, vinyl H), 4.08 (s, 2H, CH₂), 3.61 (s, 3H, NCH₃), 2.16-1.63 (m, 15H, adamantyl-H).

KHG24411 [2-(1-adamantylimino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 68.5%; melting point: 211.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.41 (s, 1H, NH), 7.89-7.26 (m, 3H, ArH), 7.12 (s, 1H, vinyl H), 4.07 (s, 2H, CH₂), 3.59 (s, 3H, NCH₃), 2.16-1.63 (m, 15H, adamantyl-H).

KHG24412 [2-(1-adamantylimino-3-methyl-1,3-thiazolidine-4-yl]-N-phenyl-acetamide hydrochloride [R₁=H, R₂=R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 88%; melting point: 232-234° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.82 (s, 1H, HCl), 8.59 (br. s, 1H, NH), 7.63-7.03 (m, 5H, ArH), 7.05 (s, 1H, vinyl-H), 4.03 (s, 2H, 4-CH₂), 3.62 (s, 3H, N—CH₃), 2.15-1.53 (m, 17H, adamantyl).

KHG24413 [2-(1-adamantylimino-3-methyl-1,3-thiazolidine-4-yl]-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 90.1%; melting point: 151.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.03 (s, 1H, NH), 7.49-7.12 (m, 4H, ArH, vinyl H), 4.03 (s, 2H, CH₂), 3.62 (s, 3H, NCH₃), 2.29 (s, 3H, ArCH₃), 2.16-1.63 (m, 15H, adamantyl-H).

KHG24414 (2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: %; melting point: 100.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.27 (s, 1H, NH), 7.71-7.42 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl H), 4.21-4.17 (m, 2H, NCH₂CH₃), 4.04 (s, 2H, CH₂), 3.25-3.23 (m, 1H, 1-cyclohexyl H), 1.98-1.15 (m, 10H, cyclohexyl-H), 1.07-1.02 (m, 3H, NCH₂CH₃).

KHG24415 [2-cyclohexylimino-3-(n-propyl)-1,3-thiazolidine-4-yl]-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=n-C₃H₇, R₆=C₆H, n=1, m=0, X=Cl]

yield: 64.2%; melting point: 109.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.25 (s, 1H, NH), 7.71-7.42 (m, 3H, Ar—H), 7.05 (s, 1H, vinyl H), 4.13-4.08 (m, 2H, NCH₂CH₂CH₃), 4.03 (s, 2H, CH₂), 3.25-3.22 (m, 1H, 1-cyclohexyl H), 1.97-0.99 (m, 12H, cyclohexyl-H, NCH₂CH₂CH₃), 0.93-0.88 (m, 3H, NCH₂CH₂CH₃).

KHG24416 [2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 74%; melting point: 153-154° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.28 (s, 1H, HCl), 9.96 (br. s, 1H, NH), 7.70-7.35 (m, 3H, ArH), 7.05 (s, 1H, vinyl-H), 4.03 (s, 2H, 4-CH₂), 3.41 (s, 3H, N—CH₃), 3.32 (br. s, 1H, cyclohexyl-C₁H), 1.95-1.02 (m, 16H, butyl-(CH₂)₃ and cyclohexyl), 0.84 (t, J=5.42 Hz, 3H, N-butyl-CH₃).

KHG24417 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 91%; melting point: 238-240° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.26 (s, 1H, HCl), 8.58 (br. s, 1H, NH), 7.68-7.41 (m, 3H, ArH), 7.13 (s, 1H, vinyl-H), 4.07 (s, 2H, 4-CH₂), 3.61 (s, 3H, N—CH₃), 2.15-1.53 (m, 17H, adamantyl).

KHG24418 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

(R₁=H, R₂=2-Cl, 5-CH₃, R₃=CH₃, R₄=adamantyl, n=1, m=0, X=HCl)

yield: 75%; melting point: 234-236° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.11 (s, 1H, HCl), 8.43 (br. s, 1H, NH), 7.65-6.89 (m, 3H, ArH), 7.10 (s, 1H, vinyl-H), 4.01 (s, 2H, 4-CH₂), 3.57 (s, 3H, N—CH₃), 2.31-1.63 (m, 17H, adamantyl).

KHG24419 [2-(1-adamantyl)imino-3-methyl-1,3-thiazolidine-4-yl]-N-(4-methoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 69%; melting point: 227-229° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.49 (s, 1H, HCl), 8.48 (br. s, 1H, NH), 7.51-6.86 (m, 4H, ArH), 7.10 (s, 1H, vinyl-H), 3.96 (s, 2H, 4-CH₂), 3.70 (s, 3H, OCH₃), 3.59 (s, 3H, N—CH₃), 2.15-1.67 (m, 17H, adamantyl).

KHG24420 (2-cyclohexylimino-3-ethyl-1,3-thiazolidine-4-yl)-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=C₂H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 82%; melting point: 115° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.90 (s, 1H, HCl), 9.61 (br. s, 1H, NH), 7.80-7.21 (m, 3H, ArH), 7.04 (s, 1H, vinyl-H), 4.20-4.11 (m, 2H, ethyl-CH₂), 3.95 (s, 2H, 4-CH₂), 3.35 (s, 3H, N—CH₃), 3.22 (br. s. 1H, adamantyl C₁H), 2.25 (s, 3H, CH₃), 1.97-1.26 (m, 17H, adamantyl), 1.16 (t, 3H, J=5.40 Hz, ethyl-CH₃).

KHG24421 (2-cyclohexylimino-3-(n-butyl)-1,3-thiazolidine-4-yl)-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=n-C₄H₉, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 74%; melting point: 143-144° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.11 (s, 1H, HCl), 9.79 (d, J=5.8 Hz, 1H, NH), 7.81-7.26 (m, 3H, ArH), 7.05 (s, 1H, vinyl-H), 4.13 (t, 2H, J=5.72 Hz, N-butyl-CH₂), 3.97 (s, 2H, 4-CH₂), 3.34 (s, 3H, N—CH₃), 3.22 (br. s, 1H, cyclohexyl-C₁H), 2.25 (s, 3H, p-CH₃), 1.95-1.07 (m, 14H, N-butyl-(CH₂)₂ and cyclohexyl), 0.76 (t, J=5.36 Hz, 3H, N-butyl-CH₃).

KHG24422 (2-cyclohexylimino-3-benzyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₂C₆H₅, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 63%; melting point: 178-179° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.07 (s, 1H, HCl), 10.03 (d, J=5.5 Hz, 1H, NH), 7.65-7.08 (m, 8H, ArH), 7.15 (s, 1H, vinyl-H), 5.55 (s, 3H, N-benzyl-CH₂), 3.86 (s, 2H, 4-CH₂), 3.34 (s, 3H, N—CH₃), 3.25 (br. s, 1H, cyclohexyl-C₁H), 1.93-1.04 (m, 10H, cyclohexyl).

KHG24445 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=4-NO₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 74%; melting point: 242° C.

¹H NMR (300 MHz, CD₃OD) δ 8.23-7.81 (m, 4H, Ar—H), 6.96 (s, 1H, vinyl-H), 4.03 (s, 2H, 4-CH₂), 3.59 (s, 3H, N—CH₃), 3.51-3.48 (m, 1H, cycloheptyl-C₁H), 2.14-1.54 (m, 12H, cycloheptyl-H).

KHG24446 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-aminophenyl)-acetamide hydrochloride [R₁=H, R₂=4—NH₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=, X=Cl]

yield: 77%; melting point: 77° C.

¹H NMR (300 MHz, CD₃OD) δ 7.29-6.68 (m, 4H, Ar—H), 6.87 (s, 1H, vinyl-H), 3.89 (s, 2H, 4-CH₂), 3.57 (s, 3H, N—CH₃), 3.52-3.41 (m, 1H, cycloheptyl-C₁H), 2.10-1.57 (m, 12H, cycloheptyl-H).

KHG24447 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-aminophenyl)-acetamide hydrochloride [R₁=H, R₂=4—NHMs, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 31%; melting point: 176° C.

¹H NMR (300 MHz, CD₃OD) δ 7.60-7.00 (m, 8H, Ar—H), 6.73 (s, 1H, vinyl-H), 3.85 (s, 2H, 4-CH₂), 3.49 (s, 3H, N—CH₃), 3.56-3.45 (m, 1H, cycloheptyl-C₁H), 2.03-1.52 (m, 12H, cycloheptyl-H), 2.01 (s, 3H, —CH₃).

KHG24448 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-aminophenyl)-acetamide hydrochloride [R₁=H, R₂=4-NHTs, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 8%; melting point: 130° C.

¹H NMR (300 MHz, CD₃OD) δ 7.76-7.12 (m, 8H, Ar—H), 6.94 (s, 1H, vinyl-H), 3.96 (s, 2H, 4-CH₂), 3.54-3.47 (m, 1H, cycloheptyl-C₁H), 3.60 (s, 3H, N—CH₃), 2.92 (s, 3H, p-CH₃), 2.16-1.58 (m, 12H, cycloheptyl-H).

KHG24449 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-aminobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-NHTs, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=1, X=Cl]

yield: 83%; melting point: 143° C.

¹H NMR (300 MHz, CD₃OD) δ 7.64-7.04 (m, 8H, Ar—H), 6.78 (s, 1H, vinyl-H), 4.29 (s, 2H, benzyl-CH₂), 3.74 (s, 2H, 4-CH₂), 3.52-3.38 (m, 1H, cycloheptyl-C₁H), 3.48 (s, 3H, N—CH₃), 2.36 (s, 3H, p-CH₃), 2.08-1.53 (m, 12H, cycloheptyl-H).

KHG24450 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-aminobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-NHMs, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=1, X=Cl]

yield: 82%; melting point: 68° C.

¹H NMR (300 MHz, CD₃OD) δ 7.31-7.20 (m, 4H, Ar—H), 6.85 (s, 1H, vinyl-H), 4.37 (s, 2H, benzyl-CH₂), 3.79 (s, 2H, 4-CH₂), 3.62-3.48 (m, 1H, cycloheptyl-C₁H), 3.35 (s, 3H, N—CH₃), 2.93 (s, 3H, CH₃), 1.83-1.60 (m, 12H, cycloheptyl-H).

KHG24480 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide [R₁=CH₃, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0]

yield: 66%; melting point: 262-264° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.60 (s, 1H, HCl), 9.34 (s, 1H, NH), 7.63-7.36 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.52 (s, 3H, N—CH₃), 3.19 (m, 1H, cyclohexyl C₁-H), 2.29 (s, 3H, 5-CH₃), 2.00-1.16 (m, 10H, cyclohexyl-H).

KHG24481 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-methoxyphenyl)-acetamide [R₁=CH₃, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0]

yield: 24%; melting point: 258-260° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.39 (s, 1H, HCl), 9.40 (s, 1H, NH), 7.52-6.87 (m, 4H, ArH), 3.90 (s, 2H, CH₂), 3.71 (s, 3H, OCH₃), 3.56 (s, 3H, N—CH₃), 3.19 (m, 1H, cyclohexyl C₁—H), 2.30 (s, 3H, 5-CH₃), 1.99-1.13 (m, 10H, cyclohexyl-H).

KHG24482 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide [R₁=CH₃, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0]

yield: 50%; melting point: 260-262° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.60 (s, 1H, HCl), 9.34 (s, 1H, NH), 7.58-7.49 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.20 (m, 1H, cyclohexyl C₁-H), 2.29 (s, 3H, 5-CH₃), 1.99-1.13 (m, 10H, cyclohexyl-H).

KHG24483 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide [R₁=CH₃, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0]

yield: 32%; melting point: 264-265° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.01 (s, 1H, HCl), 9.39 (s, 1H, NH), 7.70-7.31 (m, 3H, ArH), 3.96 (s, 2H, CH₂), 3.53 (s, 3H, NCH₃), 3.21 (m, 1H, cyclohexyl C₁-H), 2.30 (s, 3H, 5-CH₃), 1.99-1.10 (m, 10H, cyclohexyl-H).

KHG24484 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide [R₁=CH₃, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0]

yield: 5%; melting point: 249-251° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, HCl), 9.47 (s, 1H, NH), 8.98-7.59 (m, 3H, ArH), 4.08 (s, 2H, CH₂), 3.56 (s, 3H, NCH₃), 3.24 (m, 1H, cyclohexyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.00-1.13 (m, 10H, cyclohexyl-H).

KHG24485 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-methoxyphenyl)-acetamide [R₁=CH₃, R₂=4-OCH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0]

yield: 20%; melting point: 250-251° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.32 (s, 1H, HCl), 9.38 (s, 1H, NH), 7.51-6.88 (m, 4H, ArH), 3.87 (s, 2H, CH₂), 3.71 (s, 3H, OCH₃), 3.54 (s, 3H, NCH₃), 3.39 (m, 1H, cycloheptyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.00-1.43 (m, 10H, cycloheptyl-H).

KHG24486 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide [R₁=CH₃, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0]

yield: 28%; melting point: 253-254° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.80 (s, 1H, HCl), 9.48 (s, 1H, NH), 7.61-7.49 (m, 4H, ArH), 3.95 (s, 2H, CH₂), 3.55 (s, 3H, NCH₃), 3.39 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.00-1.46 (m, 10H, cycloheptyl-H).

KHG24516 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 20%; melting point: 247-249° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.28 (s, 1H, HCl), 9.29 (s, 1H, NH), 7.48-7.12 (m, 4H, ArH), 3.88 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.39 (m, 1H, cycloheptyl C₁-H), 2.54 (m, 2H, CH₂CH₂CH₂CH₃), 2.30 (s, 3H, 5-CH₃), 2.01-1.43 (m, 12H, cycloheptyl-H), 1.50 (m, 2H, CH₂CH₂CH₂CH₃), 1.28 (m, J=5.5 Hz, 2H, CH₂CH₂CH₂CH₃), 0.88 (t, 3H, J=5.4 Hz, CH₂CH₂CH₂CH₃).

KHG24517 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-C₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 25%; melting point: 262-264° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.29 (s, 1H, HCl), 9.29 (s, 1H, NH), 7.49-7.14 (m, 4H, ArH), 3.88 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.39 (m, 1H, cycloheptyl C₁-H), 2.53 (m, 2H, J=7.5 Hz, CH₂CH₃), 2.30 (s, 3H, 5-CH₃), 1.99-1.47 (m, 12H, cycloheptyl-H), 1.14 (t, 3H, J=7.5 Hz, CH₂CH₃).

KHG24518 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 17%; melting point: 229-231° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.45 (s, 1H, HCl), 9.30 (s, 1H, NH), 7.62-7.14 (m, 4H, ArH), 3.89 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.37 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.00-1.44 (m, 12H, cycloheptyl-H).

KHG24519 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 15%; melting point: 260-262° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.35 (s, 1H, HCl), 9.32 (s, 1H, NH), 7.50-7.17 (m, 4H, ArH), 3.89 (s, 2H, CH₂), 3.53 (s, 3H, NCH₃), 3.39 (m, 1H, cycloheptyl C₁-H), 2.84 (m, 1H, J=5.1 Hz, isopropyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.00-1.44 (m, 12H, cycloheptyl-H), 1.17 (d, 6H, J=5.1 Hz, 2

isopropyl-CH₃).

KHG24520 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 16%; melting point: 261-263° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.83 (s, 1H, HCl), 9.34 (s, 1H, NH), 7.69-7.83 (m, 4H, ArH), 3.97 (s, 2H, CH₂), 3.51 (s, 3H, NCH₃), 3.37 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 1.44-1.98 (m, 12H, cycloheptyl-H).

KHG24521 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 18%; melting point: 239-241° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.30 (s, 1H, HCl), 9.28 (s, 1H, NH), 7.50-7.32 (m, 4H, ArH), 3.88 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.01-1.42 (m, 12H, cycloheptyl-H), 1.25 (s, 9H, tert-butyl-H).

KHG24522 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3,5-difluoromethylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 20%; melting point: 244-246° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.29 (s, 1H, HCl), 9.37 (s, 1H, NH), 8.29 (s, 2H, ArH), 7.82 (s, 1H, ArH), 3.99 (s, 2H, CH₂), 3.53 (s, 3H, NCH₃), 3.22 (m, 1H, cyclohexyl C₁—H), 2.31 (s, 3H, 5-CH₃), 2.00-1.31 (m, 10H, cyclohexyl-H).

KHG24523 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-C₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 15%; melting point: 265-266° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.44 (s, 1H, HCl), 9.42 (s, 1H, NH), 7.51-7.13 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.55 (s, 3H, NCH₃), 3.19 (m, 1H, cyclohexyl C₁-H), 2.55 (q, 2H, J=7.5 Hz, CH₂CH₃), 2.30 (s, 3H, 5-CH₃), 2.00-1.26 (m, 10H, cyclohexyl-H), 1.14 (t, 3H, J=7.5 Hz, CH₂CH₃).

KHG24524 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethoxyphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-OCF₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 20%; melting point: 178-180° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.57 (s, 1H, HCl), 9.36 (s, 1H, NH), 7.71-7.32 (m, 4H, ArH), 3.79 (s, 2H, CH₂), 3.32 (s, 3H, NCH₃), 2.96 (m, 1H, cyclohexyl C₁-H), 2.19 (s, 3H, 5-CH₃), 1.84-1.15 (m, 10H, cyclohexyl-H).

KHG24525 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 33%; melting point: 267-269° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.56 (s, 1H, HCl), 9.38 (s, 1H, NH), 7.64-7.13 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.54 (s, 3H, NCH₃), 3.20 (m, 1H, cyclohexyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.00-1.30 (m, 10H, cyclohexyl-H).

KHG24526 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 47%; melting point: 265-267° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.38 (s, 1H, HCl), 9.37 (s, 1H, NH), 7.51-7.17 (m, 4H, ArH), 3.89 (s, 2H, CH₂), 3.54 (s, 3H, N—CH₃), 3.20 (m, 1H, cyclohexyl C₁—H), 2.83 (m, 1H, J=6.7 Hz, isopropyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.00-1.26 (m, 10H, cyclohexyl-H), 1.17 (d, 6H, J=6.7 Hz, 2

isopropyl-CH₃).

KHG24527 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 8%; melting point: 190-192° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.77 (s, 1H, HCl), 9.40 (s, 1H, NH), 7.82-7.68 (m, 4H, ArH), 3.84 (s, 2H, CH₂), 3.39 (s, 3H, NCH₃), 2.97 (m, 1H, cyclohexyl C₁—H), 2.20 (s, 3H, 5-CH₃), 1.88-1.24 (m, 10H, cyclohexyl-H).

KHG24528 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 95%; melting point: 160° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.58 (s, 1H, HCl), 9.64 (s, 1H, NH), 7.52-6.94 (m, 4H, ArH), 7.04 (s, 1H, vinyl H), 3.96 (s, 2H, CH₂), 3.58 (s, 3H, NCH₃), 3.28 (m, 1H, cyclohexyl CH), 2.83 (septet, 1H, J=6.9 Hz, isopropyl C—H), 1.99-1.27 (m, 10H, cyclohexyl-H), 1.17 (d, 6H, J=6.9 Hz, isopropyl-H).

KHG24529 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 14%; melting point: 144° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.39 (s, 1H, HCl), 9.45 (m, 1H, NH), 8.30 (s, 2H, ArH), 7.81 (s, 1H, ArH), 7.08 (s, 1H, vinyl H), 4.05 (s, 2H, CH₂), 3.54 (s, 3H, N—CH₃), 3.27-3.15 (m, 1H, cyclohexyl-CH), 1.99-1.08 (m, 10H, cyclohexyl-H).

KHG24530 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,3-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=3-Cl, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 89%; melting point: 215° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.24 (s, 1H, HCl), 9.55 (s, 1H, NH), 7.67-7.34 (m, 3H, ArH), 7.05 (s, 1H, vinyl H), 4.04 (s, 2H, CH₂), 3.56 (s, 3H, CH₃), 3.27-3.21 (m, 1H, cyclohexyl C—H), 1.99-1.03 (m, 10H, cyclohexyl-H).

KHG24531 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,4-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-Cl, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 95%; melting point: 223° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.12 (s, 1H, HCl), 9.58 (s, 1H, NH), 8.05-7.55 (m, 3H, ArH), 4.54 (s, 2H, CH₂), 3.58 (s, 3H, CH₃), 3.31-3.21 (m, 1H, cyclohexyl C—H), 2.02-1.11 (m, 10H, cyclohexyl-H).

KHG24532 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 88%; melting point: 208° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.18 (s, 1H, HCl), 9.55 (s, 1H, NH), 7.87 (d, 1H, J=2.4 Hz, ArH), 7.55 (d, 1H, J=8.7 Hz, ArH), 7.29 (dd, 1H, J=8.7, 2.4 Hz, ArH), 7.06 (s, 1H, vinyl H), 4.05 (s, 2H, CH₂), 3.57 (s, 3H, CH₃), 3.31-3.20 (m, 1H, cyclohexyl CH), 1.03-2.00 (m, 10H, cyclohexyl-H).

KHG24533 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,4,5-trichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-Cl, R₄=5-Cl, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 99%; melting point: 186° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.25 (s, 1H, HCl), 9.50 (s, 1H, NH), 8.08 (s, 1H, ArH), 7.95 (s, 1H, ArH), 7.06 (s, 1H, vinyl H), 4.06 (s, 2H, CH₂), 3.55 (s, 3H, CH₃), 3.31-3.19 (m, 1H, cyclohexyl C—H), 1.96-1.13 (m, 10H, cyclohexyl-H).

KHG24534 (2-cyclohexylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-difluorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-F, R₃=5-F, R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 96%; melting point: 240° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.14 (s, 1H, HCl), 9.48 (s, 1H, NH), 7.35 (m, 2H, ArH), 7.05 (s, 1H, vinyl H), 6.93 (m, 1H, ArH), 4.00 (s, 2H, CH₂), 3.53 (s, 3H, CH₃), 3.31-3.21 (m, 1H, cyclohexyl C—H), 2.02-1.02 (m, 10H, cyclohexyl-H).

KHG24535 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 94%; melting point: 251° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.58 (s, 1H, HCl), 7.49-7.11 (m, 4H, ArH), 7.05 (s, 1H, vinyl H), 4.02 (s, 2H, CH₂), 3.30-3.20 (m, 2H, cyclohexyl-CH), 2.25 (s, 3H, ArCH₃), 1.94-1.15 (m, 20H, cyclohexyl-H).

KHG24536 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 91%; melting point: 256° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.79 (s, 1H, HCl), 7.68-7.12 (m, 4H, ArH), 7.05 (s, 1H, vinyl H), 4.05 (s, 2H, CH₂), 3.30-3.22 (m, 2H, cyclohexyl-CH), 2.05-1.10 (m, 20H, cyclohexyl-H).

KHG24537 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(3-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=4-CH₃, R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 99%; melting point: 173° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.10 (s, 1H, HCl), 7.82-7.25 (m, 3H, ArH), 7.08 (s, 1H, vinyl H), 4.11 (s, 2H, CH₂), 3.36-3.22 (m, 2H, cyclohexyl-CH), 2.27 (s, 3H, CH₃), 2.02-1.12 (m, 20H, cyclohexyl-H).

KHG24538 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 91%; melting point: 236° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.59 (s, 1H, HCl), 7.55-7.15 (m, 4H, ArH), 7.08 (s, 1H, vinyl H), 4.10 (s, 2H, CH₂), 3.35-3.31 (m, 2H, cyclohexyl-CH), 2.60 (m, 2H, CH₂CH₃), 2.09-1.21 (m, 20H, cyclohexyl-H), 1.18 (m, 3H, CH₂CH₃).

KHG24539 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 99%; melting point: 231° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.78 (s, 1H, HCl), 7.69-7.38 (m, 4H, ArH), 7.08 (s, 1H, vinyl H), 4.08 (s, 2H, CH₂), 3.39-3.31 (m, 2H, cyclohexyl-CH), 2.02-1.03 (m, 20H, cyclohexyl-H).

KHG24540

(2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 96%; melting point: 158° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.59 (s, 1H, HCl), 7.98-7.22 (m, 3H, ArH), 7.05 (s, 1H, vinyl H), 4.21 (s, 2H, CH₂), 3.28-3.20 (m, 2H, cyclohexyl-CH), 2.01-0.85 (m, 20H, cyclohexyl-H).

KHG24541 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 89%; melting point: 226° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.79 (s, 1H, HCl), 7.52-7.11 (m, 4H, ArH), 7.06 (s, 1H, vinyl H), 3.32-3.21 (m, 2H, cyclohexyl-CH), 1.96-0.86 (m, 20H, cyclohexyl-H), 1.07-1.02 (m, 11H, butyl-H).

KHG24542 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 80%; melting point: 264° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, HCl), 7.55-7.53 (m, 4H, ArH), 7.06 (s, 1H, vinyl H), 4.03 (s, 2H, CH₂), 3.31-3.28 (m, 2H, cyclohexyl-CH), 2.02-1.31 (m, 20H, cyclohexyl-H).

KHG24543 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield 91%; melting point: 232° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, HCl), 7.52-7.32 (m, 4H, ArH), 7.06 (s, 1H, vinyl H), 4.04 (s, 1H, CH₂), 3.35-3.21 (m, 2H, cyclohexyl-CH), 2.01-1.02 (m, 20H, cyclohexyl-H).

KHG24544

(2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-chlorobenzyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 96%; melting point: 152° C.

¹H NMR (300 MHz, DMSO-d₆) δ 8.99 (s, 1H, NH), 7.50-7.31 (m, 4H, ArH), 6.99 (s, 1H, vinyl H), 4.27 (s, 2H, CH₂), 3.86 (s, 2H, CH₂C₆H₅), 3.35-3.21 (m, 2H, cyclohexyl-CH), 1.96-1.12 (m, 20H, cyclohexyl-H).

KHG24545

(2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 91%; melting point: 244° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.69 (s, 1H, HCl), 7.53-7.32 (m, 4H, ArH), 7.06 (s, 1H, vinyl H), 4.05 (s, 2H, CH₂), 3.33-3.21 (m, 2H, cyclohexyl-CH), 1.26 (s, 9H, C(CH₃)₃), 1.94-1.03 (m, 20H, cyclohexyl-H).

KHG24546 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield 99%; melting point: 160° C.

¹H NMR (300 MHz, DMSO-d₆) δ 12.01 (s, 1H, HCl), 8.44-7.91 (m, 3H, ArH), 7.09 (s, 1H, vinyl H), 4.21 (s, 2H, CH₂), 3.39-3.20 (m, 2H, cyclohexyl-CH), 2.21-1.12 (m, 20H, cyclohexyl-H).

KHG24547 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(2-trifluoromethylbenzyl)-acetamide hydrochloride [R₁=H, R₂=2-CF₃, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=1, X=Cl]

yield: 91%; melting point: 180° C.

¹H NMR (300 MHz, DMSO-d₆) δ 8.91 (s, 1H, NH), 7.74-7.47 (m, 4H, ArH), 7.00 (s, 1H, vinyl H), 4.68 (s, 2H, CH₂), 3.90 (s, 2H, benzyl-CH₂), 3.33-3.21 (m, 2H, cyclohexyl-CH), 1.92-1.11 (m, 20H, cyclohexyl-H).

KHG24548 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 97%; melting point: 206° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.95 (s, 1H, HCl), 7.66-7.08 (m, 9H, ArH), 6.98 (s, 1H, vinyl H), 4.08 (s, 2H, CH₂), 3.25-3.21 (m, 2H, cyclohexyl-CH), 2.15-1.09 (m, 20H, cyclohexyl-H).

KHG24549 (2-cyclohexylimino-3-cyclohexyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, =H, R₅=C₆H₁₁, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 99%; melting point: 202° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.96 (s, 1H, HCl), 7.77-7.29 (m, 3H, ArH), 7.09 (s, 1H, vinyl H), 4.16 (s, 1H, CH₂), 3.26-3.21 (m, 2H, cyclohexyl-CH), 1.03-1.97 (m, 20H, cyclohexyl-H).

KHG24622 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-phenyl-carboxamide [R₁=H, R₂=R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 59.3% melting point: 208° C.

¹H NMR (300 MHz, CDCl₃) δ 7.37-7.27 (m, 5H, ArH), 6.65 (s, 1H, NH), 6.26 (s, 1H, vinyl H), 4.49 (d, 2H, J=5.79 Hz, CH₂NH), 3.40 (s, 3H, NCH₃), 2.89-2.85 (m, 1H, cycloheptyl-H), 1.82-1.27 (m, 12H, cycloheptyl-H).

KHG24623 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-phenyl-carboxamide hydrochloride [R₁=H, R₂=R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 100.0%; melting point: 211.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.98 (d, 1H, J=7.62 Hz, HCl), 9.69 (t, 1H, J=5.78 Hz, NH), 7.70 (s, 1H, vinyl H), 7.36-7.24 (m, 5H, ArH), 4.41 (d, 2H, J=5.88 Hz, CH₂NH), 3.78 (s, 3H, NCH₃), 3.50-3.43 (m, 1H, cycloheptyl-H), 2.00-1.42 (m, 12H, cycloheptyl-H).

KHG24624 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-chlorophenyl)-carboxamide [R₁=H, R₂=2-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 60.3%; melting point: 198.4° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.04 (t, 1H, J=5.52 Hz, NH), 7.47-7.28 (m, 5H, ArH), 6.74 (s, 1H, vinyl H), 4.43 (d, 2H, J=5.67 Hz, CH₂NH), 3.25 (s, 3H, NCH₃), 2.88 (m, 1H, cycloheptyl-H), 1.72-1.43 (m, 12H, cycloheptyl-H).

KHG24625 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,5-difluorophenyl)-carboxamide [R₁=H, R₂=2-F, R₃=5-F, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 78.6%; melting point: 184.2° C.

¹H NMR (300 MHz, CDCl₃) δ 7.12-6.93 (m, 4H, ArH and NH), 6.63 (s, 1H, vinyl H), 4.54 (d, 2H, J=5.97 Hz, CH₂), 3.54 (s, 3H, NCH₃), 2.98-2.97 (m, 1H, cycloheptyl-H), 1.83-1.13 (m, 12H, cycloheptyl-H).

KHG24626 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2,5-difluorophenyl)-carboxamide hydrochloride [R₁=H, R₂=2-F, R₃=5-F, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 95.1%; melting point: 187.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.00 (d, 1H, HCl), 9.74 (t, 1H, J=4.71 Hz, NH), 7.77 (s, 1H, vinyl H), 7.28-7.14 (m, 3H, ArH), 4.43 (d, 2H, J=5.52 Hz, CH₂NH), 3.72 (s, 3H, NCH₃), 3.44 (m, 1H, cycloheptyl-H), 2.07-1.42 (m, 12H, cycloheptyl-H).

KHG24627 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,4-difluorophenyl)-carboxamide [R₁=H, R₂=3-F, R₃=4-F, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 24.5%; melting point: 209.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.84 (d, 1H, J=4.98 Hz, HCl), 9.70 (t, 1H, J=5.40 Hz, NH), 7.72 (s, 1H, vinyl H), 7.43-7.19 (m, 3H, ArH), 4.40 (d, 2H, J=5.73 Hz, CH₂NH), 3.71 (s, 3H, NCH₃), 3.46 (m, 1H, cycloheptyl-H), 2.00-1.43 (m, 12H, cycloheptyl-H).

KHG24628 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-carboxamide [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 69.1%; melting point: 114.9° C.

¹H NMR (300 MHz, CDCl₃) δ 7.20 (d, 2H, J=8.19 Hz, ArH-2′ and ArH-6′), 7.16 (d, 2H, J=8.15 Hz, ArH-3′ and ArH-5′), 6.43 (s, 1H, NH), 6.29 (s, 1H, vinyl H), 4.48 (d, 2H, J=5.71 Hz, CH₂NH), 3.45 (s, 3H, NCH₃), 2.35 (s, 3H, CH₃), 2.93-2.87 (m, 1H, cycloheptyl-H), 1.84-1.42 (m, 12H, cycloheptyl-H).

KHG24629 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-carboxamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 73.3%; melting point: 202.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.95 (s, 1H, HCl), 9.62 (t, 1H, NH), 7.66 (s, 1H, vinyl H), 7.21 (d, 2H, J=7.88 Hz, ArH-2′ and ArH-6′), 7.13 (d, 2H, J=7.85 Hz, ArH-3′ and ArH-5′), 4.36 (d, 2H, J=5.78 Hz, CH₂NH), 3.73 (s, 3H, NCH₃), 3.44-3.42 (m, 1H, cycloheptyl-H), 2.27 (s, 3H, CH₃), 2.00-1.42 (m, 12H, cycloheptyl-H).

KHG24630 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-carboxamide [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 74.4%; melting point: 124.8° C.

¹H NMR (300 MHz, CDCl₃) δ 7.82 (s, 1H, ArH-4′), 7.79 (s, 2H, ArH-2′ and ArH-6′), 6.92 (s, 1H, NH), 6.51 (s, 1H, vinyl H), 4.66 (d, 2H, J=6.09 Hz, CH₂NH), 3.50 (s, 3H, NCH₃), 2.94-2.91 (m, 1H, cycloheptyl-H), 1.84-1.45 (m, 12H, cycloheptyl-H).

KHG24631 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-carboxamide [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 79.4%; melting point: 169.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.46 (s, 1H, NH), 7.72 (s, 1H, vinyl H), 7.64 (d, 1H, ArH-3′), 7.40-7.35 (m, 2H, ArH-4′ and ArH-6′), 7.27-7.22 (m, 1H, ArH-5′), 4.45 (d, 2H, J=5.59 Hz, CH₂NH), 3.72 (s, 3H, NCH₃), 3.45-3.40 (m, 1H, cycloheptyl-H), 2.01-1.43 (m, 12H, cycloheptyl-H).

KHG24632 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-carboxamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 91.5%; melting point: 202.0° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.06 (s, 1H, HCl), 9.99 (t, 1H, NH), 8.06 (s, 2H, ArH-2′ and ArH-6′), 7.99 (s, 1H, ArH-4′), 7.82 (s, 1H, vinyl H), 4.60 (d, 2H, J=5.66 Hz, CH₂NH), 3.73 (s, 3H, NCH₃), 3.45-3.40 (m, 1H, cycloheptyl-H), 1.99-1.42 (m, 12H, cycloheptyl-H).

KHG24633

(2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-bromophenyl)-carboxamide [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 67.1%; melting point: 109.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.87 (br. s, 1H, HCl), 9.66-9.62 (t, 1H, J=5.5 Hz, NH), 7.21-7.65 (m, 4H, Ar—H), 7.21 (s, 1H, vinyl-H), 4.45 (d, 2H, J=5.5 Hz, benzyl-CH₂), 3.47-3.36 (m, 1H, cycloheptyl-C₁H), 3.35 (s, 3H, N—CH₃), 2.00-1.43 (m, 12H, cycloheptyl-H).

KHG24634 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-bromophenyl)-carboxamide hydrochloride [R₁=H, R₂=2-Br, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 87.1%; melting point: 232.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.88 (s, 1H, HCl), 9.65 (t, 1H, J=5.50 Hz, NH), 7.72 (s, 1H, vinyl H), 7.64 (d, 1H, ArH-3′), 7.40-7.35 (m, 2H, ArH-4′ and ArH-6′), 7.27-7.22 (m, 1H, ArH-5′), 4.45 (d, 2H, J=5.59 Hz, CH₂NH), 3.72 (s, 3H, NCH₃), 3.45-3.40 (m, 1H, cycloheptyl-H), 2.01-1.43 (m, 12H, cycloheptyl-H).

KHG24635 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-phenyl-acetamide hydrochloride [R₁=CH₃, R₂=R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 38%; melting point: 231-234° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.50 (s, 1H, HCl), 9.45 (s, 1H, NH), 7.61-7.05 (m, 5H, ArH), 3.91 (s, 2H, CH₂), 3.54 (s, 3H, NCH₃), 3.22 (m, 1H, cyclohexyl C₁-H), 1.98-1.26 (m, 10H, cyclohexyl-H), 2.29 (s, 3H, 5-CH₃).

KHG24636 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3-fluorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=3-F, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 33%; melting point: 257-259° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.84 (s, 1H, HCl), 9.45 (s, 1H, NH), 7.62-6.88 (m, 4H, ArH), 3.95 (s, 2H, CH₂), 3.54 (s, 3H, NCH₃), 3.22 (m, 1H, cyclohexyl C₁-H), 2.29 (s, 3H, 5-CH₃), 1.98-1.26 (m, 10H, cyclohexyl-H).

KHG24637 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield: 2%; melting point: 255-257° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.37 (s, 1H, HCl), 9.39 (s, 1H, NH), 7.52-7.30 (m, 4H, ArH), 3.89 (s, 2H, CH₂), 3.53 (s, 3H, NCH₃), 3.19 (m, 1H, cyclohexyl C₁-H), 2.29 (s, 3H, 5-CH₃), 1.99-1.30 (m, 10H, cyclohexyl-H), 1.24 (s, 9H, t-butyl).

KHG24638 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-phenyl-acetamide hydrochloride [R₁=CH₃, R₂=R₃=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 99%; melting point: 236-238° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.62 (s, 1H, NH), 7.62-7.04 (m, 5H, Ar—H), 3.64 (s, 2H, CH₂), 3.56 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.00-1.40 (m, 12H, cycloheptyl-H), 10.59 (s, 1H, HCl).

KHG24639 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 60%; melting point: 248-250° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.45 (d, 1H, NH), 7.49-7.10 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.55 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.25 (s, 3H, ArCH₃), 2.00-1.40 (m, 12H, cycloheptyl-H), 10.45 (s, 1H, HC1).

KHG24640 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(2-fluorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=2-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 49%; melting point: 197-199° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.29 (s, 1H, HCl), 9.73 (s, 1H, NH), 7.85-7.15 (m, 4H, ArH), 4.01 (s, 2H, CH₂), 3.60 (s, 3H, NCH₃), 3.39 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 1.99-1.41 (m, 12H, cycloheptyl-H).

KHG24641 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3-fluorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=3-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 44%; melting point: 247-249° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.97 (s, 1H, HCl), 9.54 (s, 1H, NH), 7.63-6.86 (m, 4H, ArH), 3.97 (s, 2H, CH₂), 3.57 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.00-1.43 (m, 12H, cycloheptyl-H).

KHG24642 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-nitrophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-NO₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=1, X=Cl]

yield: 78%; melting point: 255-258° C.

¹H NMR (400 MHz, DMSO-d₆) δ 11.35 (s, 1H, HCl), 9.49 (s, 1H, NH), 8.26-7.86 (m, 4H, ArH), 4.04 (s, 2H, CH₂), 3.55 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁-H), 2.31 (s, 3H, 5-CH₃), 2.00-1.46 (m, 12H, cycloheptyl-H).

KHG24643 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 60%; melting point: 240-242° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.59 (s, 1H, HCl), 9.34 (s, 1H, NH), 7.63-7.37 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 2.00-1.46 (m, 12H, cycloheptyl-H).

KHG24644 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=3-Cl, R₃=5-Cl, =H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 61%; melting point: 248-250° C.

¹H NMR (400 MHz, DMSO-d₆) δ 11.08 (s, 1H, HCl), 9.42 (s, 1H, NH), 7.70-7.31 (m, 3H, ArH), 3.97 (s, 2H, CH₂), 3.53 (s, 3H, NCH₃), 3.37 (m, 1H, cycloheptyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.00-1.45 (m, 12H, cycloheptyl-H).

KHG24645 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 4%; melting point: 248-251° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.65 (s, 1H, HCl), 9.39 (s, 1H, NH), 8.99-7.59 (m, 3H, ArH), 4.07 (s, 2H, CH₂), 3.53 (s, 3H, NCH₃), 3.37 (m, 1H, cycloheptyl C₁—H), 2.30 (s, 3H, 5-CH₃), 2.00-1.44 (m, 12H, cycloheptyl-H).

KHG24646 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 57%; melting point: 217-219° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.54 (s, 1H, HCl), 9.46 (s, 1H, NH), 8.32-7.79 (m, 3H, ArH), 4.02 (s, 2H, CH₂), 3.56 (s, 3H, NCH₃), 3.37 (m, 1H, cycloheptyl C₁-H), 2.31 (s, 3H, 5-CH₃), 2.00-1.40 (m, 12H, cycloheptyl-H).

KHG24647 (2-cycloheptylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-trifluoromethoxyphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-OCF₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=1, m=0, X=Cl]

yield: 49%; melting point 247-271° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.64 (s, 1H, HCl), 9.34 (s, 1H, NH), 7.71-7.33 (m, 4H, ArH), 3.92 (s, 2H, CH₂), 3.52 (s, 3H, NCH₃), 3.38 (m, 1H, cycloheptyl C₁-H), 2.30 (s, 3H, 5-CH₃), 1.99-1.44 (m, 12H, cycloheptyl-H).

KHG24653 (2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-phenyl-acetamide hydrochloride [R₁=CH₃, R₂=R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 50%; melting point 186-188° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.57 (s, 1H, HCl), 9.48 (s, 1H, NH), 7.62-7.04 (m, 5H, ArH), 3.95 (s, 2H, CH₂), 3.80 (m, 1H, cycloheptyl C₁—H), 3.58 (s, 3H, NCH₃), 2.31 (s, 3H, 5-CH₃), 2.07-1.59 (m, 8H, cycloheptyl-H).

KHG24654 (2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 66%; melting point: 228-229° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.49 (s, 1H, HCl), 9.50 (s, 1H, NH), 7.50-7.09 (m, 4H, ArH), 3.92 (s, 2H, CH₂), 3.77 (m, 1H, cyclopentyl C₁—H), 3.58 (s, 3H, NCH₃), 2.30 (s, 3H, 5-CH₃), 2.24 (s, 3H, Ar—CH₃), 2.07-1.58 (m, 8H, cycloheptyl-H).

KHG24655 (2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(3-fluoro)-acetamide hydrochloride [R₁=CH₃, R₂=3-F, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 68%; melting point: 213-215° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.89 (s, 1H, HCl), 9.49 (s, 1H, NH), 7.63-6.88 (m, 4H, ArH), 3.98 (s, 2H, CH₂), 3.78 (m, 1H, cyclopentyl C₁—H), 3.58 (s, 3H, NCH₃), 2.31 (s, 3H, 5-CH₃), 2.07-1.59 (m, 8H, cycloheptyl-H).

KHG24656 (2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 57%; melting point: 220-223° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.42 (s, 1H, HCl), 9.42 (s, 1H, NH), 7.52-7.30 (m, 4H, ArH), 3.91 (s, 2H, CH₂), 3.77 (m, 1H, cyclopentyl C₁—H), 3.56 (s, 3H, NCH₃), 2.30 (s, 3H, 5-CH₃), 2.04-1.58 (m, 8H, cycloheptyl-H).

KHG24657 (2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 5%; melting point: 201-203° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.66 (s, 1H, HCl), 9.39 (s, 1H, NH), 7.64-7.36 (m, 4H, ArH), 3.93 (s, 2H, CH₂), 3.77 (m, 1H, cyclopentyl C₁—H), 3.55 (s, 3H, NCH₃), 2.30 (s, 3H, 5-CH₃), 2.08-1.00 (m, 8H, cycloheptyl-H).

KHG24658 (2-cyclohexylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(4-nitrophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=4-NO₂, R₃=R₄=H, R₅=CH₃, R₆=C₆H₁₁, n=1, m=0, X=Cl]

yield 27%; melting point: 215-217° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.20 (s, 1H, HCl), 9.61 (s, 1H, NH), 8.68-7.85 (m, 4H, ArH), 3.94 (s, 2H, CH₂), 3.42 (s, 3H, NCH₃), 3.04 (m, 1H, cyclopentyl C₁—H), 2.23 (s, 3H, 5-CH₃), 1.88-1.13 (m, 8H, cycloheptyl-H).

KHG24659 (2-cyclopentylimino-3,5-dimethyl-1,3-thiazolidine-4-yl)-N-(2-fluorophenyl)-acetamide hydrochloride [R₁=CH₃, R₂=2-F, R₃=R₄=H, R₅=CH₃, R₆=C₅H₉, n=1, m=0, X=Cl]

yield: 47%; melting point: 153-153° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.18 (s, 1H, HCl), 9.46 (s, 1H, NH), 7.88-7.16 (m, 4H, ArH), 4.00 (s, 2H, CH₂), 3.78 (m, 1H, cyclopentyl C₁—H), 3.57 (s, 3H, NCH₃), 2.31 (s, 3H, 5-CH₃), 2.08-1.59 (m, 8H, cycloheptyl-H).

KHG24660 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-carboxamide hydrobromide [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 48.9%; melting point: 264.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.07 (s, 1H, NH), 9.63 (s, 1H, HBr), 7.89 (s, 1H, vinyl H), 8.66-7.63 (m, 3H, ArH), 3.79 (s, 3H, NCH₃), 3.52 (m, 1H, cycloheptyl-H), 2.03-1.51 (m, 12H, cycloheptyl-H).

KHG24661 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-fluoro-5-nitrophenyl)-carboxamide [R₁=H, R₂=2-F, R₃=5-NO₂, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield 85%; melting point: 151.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.01 (s, 1H, NH), 7.12 (s, 1H, vinyl H), 8.60-7.60 (m, 3H, ArH), 3.59 (s, 3H, NCH₃), 3.50 (m, 1H, cycloheptyl-H), 2.10-1.43 (m, 12H, cycloheptyl-H).

KHG24662 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-fluorophenyl)-carboxamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Cl]

yield: 93.4%; melting point: 265.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.14 (s, 1H, HCl), 10.05 (s, 1H, NH), 7.88 (s, 1H, vinyl H), 7.80-7.76 (m, 2H, ArH-3′ and ArH-5′), 7.25-7.19 (m, 2H, ArH-2′ and ArH-6′), 3.75 (s, 3H, NCH₃), 3.40-3.45 (m, 1H, cycloheptyl-H), 1.44-2.02 (m, 12H, cycloheptyl-H).

KHG24663 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-carboxamide hydrobromide [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 46%; melting point: 278-279° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.83 (s, 1H, HBr), 9.64 (br. s, 1H, NH), 7.56-7.11 (m, 4H, Ar—H), 6.92 (s, 1H, vinyl-H), 3.35 (s, 3H, N—CH₃), 3.32 (br. s, 1H, cycloheptyl-C₁H), 2.58 (q, 2H, J=5.5 Hz, ethyl CH₂), 1.77-1.38 (m, 12H, cycloheptyl-H), 1.24 (t, 3H, J=5.5 Hz, ethyl CH₃).

KHG24664 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-ethylphenyl)-carboxamide [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n 0, m=0]

yield: 84%; melting point: 194-195° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.32 (br. s, 1H, NH), 7.57-7.15 (m, 4H, Ar—H), 6.83 (s, 1H, vinyl-H), 3.31 (s, 3H, N—CH₃), 3.24 (br. s, 1H, cycloheptyl-C₁H), 2.57 (q, 2H, J=5.5 Hz, ethyl CH₂), 1.73-1.41 (m, 12H, cycloheptyl-H), 1.14 (t, 3H, J=5.5 Hz, ethyl CH₃).

KHG24666 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-fluorobenzyl)-carboxamide hydrochloride [R₁=H, R₂=3-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Cl]

yield: 89.0%; melting point: 226.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.96 (s, 1H, HCl), 9.65 (t, 1H, J=5.86 Hz, NH), 7.74 (s, 1H, vinyl H), 7.41-7.06 (m, 4H, ArH), 4.42 (d, 2H, J=5.88 Hz, CH₂NH), 3.73 (s, 3H, NCH₃), 3.45 (m, 1H, cycloheptyl-H), 2.00-1.42 (m, 12H, cycloheptyl-H).

KHG24667 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-fluorobenzyl)-carboxamide [R₁=H, R₂=3-F, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 67.1%; melting point: 140.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.07 (t, 1H, J=5.97 Hz, NH), 7.41-7.05 (m, 4H, ArH), 6.72 (s, 1H, vinyl H), 4.38 (d, 2H, J=5.94 Hz, CH₂NH), 3.25 (s, 3H, NCH₃), 2.90-2.84 (m, 1H, cycloheptyl-H), 1.71-1.40 (m, 12H, cycloheptyl-H).

KHG24668 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-bromobenzyl)-carboxamide hydrobromide [R₁=H, R₂=3-Br, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Br]

yield: 58.5%; melting point: 197.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 9.72 (t, 1H, J=5.86 Hz, NH), 7.71 (s, 1H, vinyl H), 7.53-7.27 (m, 4H, ArH), 4.41 (d, 2H, J=5.83 Hz, CH₂NH), 3.71 (s, 3H, NCH₃), 3.47-3.40 (m, 1H, cycloheptyl-H), 2.00-1.42 (m, 12H, cycloheptyl-H).

KHG24669 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3-bromobenzyl)-carboxamide [R₁=H, R₂=3-Br, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 77.1%; melting point: 133.0° C.

¹H NMR (400 MHz, DMSO-d₆) δ 9.10 (s, 1H, NH), 7.64-7.27 (m, 4H, ArH), 6.69 (s, 1H, vinyl H), 4.34 (s, 2H, CH₂NH), 3.30 (s, 3H, NCH₃), 2.78 (m, 1H, cycloheptyl-H), 1.66-1.40 (m, 12H, cycloheptyl-H).

KHG24670 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-trifluoromethylbenzyl)-carboxamide hydrobromide [R₁=H, R₂=2-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1, X=Br]

yield: 67.9%; melting point: 236.9° C.

¹H NMR (300 MHz, CDCl₃) δ 9.62-9.56 (m, 2H, NH and HBr), 7.76-7.48 (m, 4H, ArH), 7.71 (s, 1H, vinyl H), 4.60 (d, 2H, J=5.28 Hz, CH₂NH), 3.69 (s, 3H, NCH₃), 3.46 (br s, 1H, cycloheptyl-H), 2.01-1.49 (m, 12H, cycloheptyl-H).

KHG24671 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(2-trifluoromethylbenzyl)-carboxamide [R₁=H, R₂=2-CF₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=1]

yield: 79.0%; melting point: 223° C.

¹H NMR (300 MHz, CDCl₃) δ 7.69-7.39 (m, 4H, ArH), 6.28 (s, 1H, vinyl H), 4.70 (d, 2H, J=6.03 Hz, CH₂NH), 3.41 (s, 3H, NCH₃), 2.89-2.83 (m, 1H, cycloheptyl-H), 1.79-1.40 (m, 12H, cycloheptyl-H).

KHG24672 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-carboxamide hydrobromide [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 60.5%; melting point: 278.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.74 (s, 1H, NH), 9.57 (s, 1H, HBr), 7.75 (s, 1H, vinyl H), 7.57 (d, 2H, J=8.28 Hz, ArH-2′ and ArH-6′), 7.18 (d, 2H, J=8.37 Hz, ArH-3′ and ArH-5′), 3.69 (s, 3H, NCH₃), 3.48 (m, 1H, cycloheptyl-H), 2.24 (s, 3H, CH₃), 2.03-1.41 (m, 12H, cycloheptyl-H).

KHG24673 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-methylphenyl)-carboxamide [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 78.4%; melting point: 191.1° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.30 (s, 1H, NH), 7.54 (d, 2H, J=7.80 Hz, ArH-2′ and ArH-6′), 7.12 (d, 2H, J=7.72 Hz, ArH-3′ and ArH-5′), 6.71 (s, 1H, vinyl H), 3.25 (s, 3H, NCH₃), 2.90-2.86 (m, 1H, cycloheptyl-H), 2.24 (s, 3H, CH₃), 1.71-1.40 (m, 12H, cycloheptyl-H).

KHG24674 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-carboxamide [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 76.6%; melting point: 191.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, NH), 7.76 (s, 2H, ArH-2′ and ArH-6′), 7.34 (s, 1H, ArH-4′), 6.96 (s, 1H, vinyl H), 3.27 (s, 3H, NCH₃), 2.90-2.86 (m, 1H, cycloheptyl-H), 1.73-1.41 (m, 12H, cycloheptyl-H).

KHG24675

(2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-dichlorophenyl)-carboxamide hydrobromide [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 83.3%; melting point: 275.2° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.97 (s, 1H, NH), 9.60 (s, 1H, HBr), 7.84 (s, 1H, vinyl H), 7.79 (s, 2H, ArH-2′ and ArH-6′), 7.39 (s, 1H, ArH-4′), 3.68 (s, 3H, NCH₃), 3.50-3.48 (m, 1H, cycloheptyl-H), 2.03-1.24 (m, 12H, cycloheptyl-H).

KHG24676 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-carboxamide hydrobromide [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 71.7%; melting point: 286.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.95 (s, 1H, NH), 9.61 (s, 1H, HBr), 7.80 (s, 1H, vinyl H), 7.74 (d, 2H, J=8.79 Hz, ArH-2′ and ArH-6′), 7.44 (d, 2H, J=8.76 Hz, ArH-3′ and ArH-5′), 3.70 (s, 3H, NCH₃), 3.50-3.48 (m, 1H, cycloheptyl-H), 2.03-1.41 (m, 12H, cycloheptyl-H).

KHG24677 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-chlorophenyl)-carboxamide [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 87.2%; melting point: 199.7° C.

¹H NMR (400 MHz, DMSO-d₆) δ 10.51 (s, 1H, NH), 7.69 (d, 2H, J=7.80 Hz, ArH-2′ and ArH-6′), 7.38 (d, 2H, J=7.96 Hz, ArH-3′ and ArH-5′), 6.88 (s, 1H, vinyl H), 3.25 (s, 3H, NCH₃), 2.88 (m, 1H, cycloheptyl-H), 1.80-1.40 (m, 12H, cycloheptyl-H).

KHG24678 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-carboxamide hydrobromide [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 64.6%; melting point: 240.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.76 (s, 1H, NH), 9.60 (s, 1H, HBr), 7.77 (s, 1H, vinyl H), 7.60 (d, 2H, J=8.40 Hz, ArH-2′ and ArH-6′), 7.19 (d, 2H, J=8.46 Hz, ArH-3′ and ArH-5′), 3.70 (s, 3H, NCH₃), 3.50-3.48 (m, 1H, cycloheptyl-H), 2.55 (t, 2H, J=7.58 Hz, CH₂CH₂CH₂CH₃), 1.24-2.03 (m, 16H, cycloheptyl-H and CH₂CH₂CH₂CH₃), 0.88 (t, 3H, J=7.28 Hz, CH₂CH₂CH₂CH₃).

KHG24679 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-carboxamide hydrobromide [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 74.0%; melting point: 282.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.76 (s, 1H, NH), 9.59 (s, 1H, HBr), 7.77 (s, 1H, vinyl H), 7.61 (d, 2H, J=8.61 Hz, ArH-2′ and ArH-6′), 7.39 (d, 2H, J=8.58 Hz, ArH-3′ and ArH-5′), 3.71 (s, 3H, NCH₃), 3.50-3.48 (m, 1H, cycloheptyl-H), 2.91-2.82 (m, 1H, J=6.86 Hz, CH(CH₃)₂), 2.04-1.42 (m, 12H, cycloheptyl-H), 1.19 (d, 6H, J=6.88 Hz, CH(CH₃)₂).

KHG24680 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-isopropylphenyl)-carboxamide [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 69.3%; melting point: 207.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.33 (s, 1H, NH), 7.57 (d, 2H, J=8.46 Hz, ArH-2′ and ArH-6′), 7.20 (d, 2H, J=8.46 Hz, ArH-3′ and ArH-5′), 6.83 (s, 1H, vinyl H), 3.27 (s, 3H, NCH₃), 2.89-2.80 (m, 2H, J=7.02 Hz, CH(CH₃)₂ and cycloheptyl-H), 1.74-1.42 (m, 12H, cycloheptyl-H), 1.20 (d, 6H, J=11.15 Hz, CH(CH₃)₂).

KHG24681 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-carboxamide hydrobromide [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 69.9%; melting point: 149.5° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.86 (s, 1H, NH), 9.58 (s, 1H, HBr), 7.78 (s, 1H, vinyl H), 7.78-6.97 (m, 9H, ArH), 3.71 (s, 3H, NCH₃), 3.49 (m, 1H, cycloheptyl-H), 2.04-1.42 (m, 12H, cycloheptyl-H).

KHG24682 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-phenoxyphenyl)-carboxamide [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 75.7%; melting point: 278.6° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.44 (s, 1H, NH), 7.78-6.97 (m, 9H, ArH), 6.85 (s, 1H, vinyl H), 3.31 (s, 3H, NCH₃), 2.92-2.87 (m, 1H, cycloheptyl-H), 1.73-1.37 (m, 12H, cycloheptyl-H).

KHG24683 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-carboxamide hydrobromide [R₁=H, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 66.7%; melting point: 169.9° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.76 (s, 1H, NH), 9.59 (s, 1H, HBr), 7.76 (s, 1H, vinyl H), 7.61 (d, 2H, J=8.61 Hz, ArH-2′ and ArH-6′), 7.39 (d, 2H, J=8.58 Hz, ArH-3′ and ArH-5′), 3.70 (s, 3H, N—CH₃), 3.50-3.47 (m, 1H, cycloheptyl-H), 2.03-1.45 (m, 12H, cycloheptyl-H), 1.26 (s, 9H, C(CH₃)₃).

KHG24684 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-t-butylphenyl)-carboxamide [R₁=H, R₂=4-t-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 87.5%; melting point: 170.8° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.34 (s, 1H, NH), 7.58 (d, 2H, J=8.58 Hz, ArH-2′ and ArH-6′), 7.34 (d, 2H, J=8.61 Hz, ArH-3′ and ArH-5′), 6.82 (s, 1H, vinyl H), 3.27 (s, 3H, NCH₃), 2.90 (m, 1H, cycloheptyl-H), 1.73-1.42 (m, 12H, cycloheptyl-H), 1.26 (s, 9H, C(CH₃)₃).

KHG24685 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-carboxamide hydrobromide [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 63.5%; melting point: 262.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.85 (s, 1H, NH), 9.61 (s, 1H, HBr), 7.84 (s, 1H, ArH-6′), 7.77 (m, 1H, ArH-3′), 7.41 (m, 1H, ArH-4′), 7.95 (s, 1H, ArH-4′), 7.38 (s, 1H, vinyl H), 3.70 (s, 3H, NCH₃), 3.50 (m, 1H, cycloheptyl-H), 2.03-1.45 (m, 12H, cycloheptyl-H).

KHG24686 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(5-chloro-2-fluorophenyl)-carboxamide [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 77.1%; melting point: 241.2° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.85 (s, 1H, NH), 7.76-7.73 (m, 1H, ArH-3′), 7.39-7.32 (m, 1H, ArH-4′), 7.30 (s, 1H, ArH-6′), 6.96 (s, 1H, vinyl H), 3.32 (s, 3H, CH₃), 2.90-2.87 (m, 1H, cycloheptyl-H), 1.73-1.41 (m, 12H, cycloheptyl-H).

KHG24687 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-carboxamide hydrobromide [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0, X=Br]

yield: 73.7%; melting point: 274.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.40 (s, 1H, NH), 9.66 (s, 1H, HBr), 8.42 (s, 2H, ArH-2′ and ArH-6′), 7.95 (m, 1H, ArH-4′), 7.89 (s, 1H, vinyl H), 3.74 (s, 3H, NCH₃), 3.50 (m, 1H, cycloheptyl-H), 2.04-1.45 (m, 12H, cycloheptyl-H).

KHG24688 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(3,5-ditrifluoromethylphenyl)-carboxamide [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 80.7%; melting point: 193.1° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.40 (s, 1H, NH),

8.42-7.90 (m, 3H, ArH), 7.85 (s, 1H, vinyl H), 3.67 (s, 3H, NCH₃), 3.40 (m, 1H, cycloheptyl-H), 2.03-0.97 (m, 12H, cycloheptyl-H).

KHG24689 (2-cycloheptylimino-3-methyl-1,3-thiazolidine-4-yl)-N-(4-n-butylphenyl)-carboxamide [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=C₇H₁₃, n=0, m=0]

yield: 69.3%; melting point: 173.3° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.31 (s, 1H, NH), 7.56 (d, 2H, J=8.40 Hz, ArH-2′ and ArH-6′), 7.14 (d, 2H, J=8.40 Hz, ArH-3′ and ArH-5′), 6.82 (s, 1H, vinyl H), 3.27 (s, 3H, CH₃), 2.91-2.87 (m, 1H, cycloheptyl-H), 2.55 (t, 2H, J=7.45 Hz, CH₂CH₂CH₂CH₃), 1.74-1.42 (m, 16H, cycloheptyl-H and CH₂CH₂CH₂CH₃), 0.88 (t, 3H, J=7.28 Hz, CH₂CH₂CH₂CH₃).

KHG24775 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 72%; melting point: 158° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.04 (s, 1H, HCl), 8.50 (s, 1H, NH), 7.64-7.35 (d, 4H, J=6.9 Hz, ArH), 7.12 (s, 1H, vinyl-H), 4.27-4.21 (m, 2H, CH₂CH₂CH₂CH₃), 4.00 (s, 2H, CH₂), 2.15-2.07 (m, 15H, adamantyl), 1.58-1.42 (m, 2H, CH₂CH₂CH₂CH₃), 1.31-1.18 (m, 2H, CH₂CH₂CH₂CH₃), 0.79-0.75 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24776 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 80%; melting point: 169° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.64 (s, 1H, HCl), 8.47 (s, 1H, NH), 7.51-7.48 (d, 2H, J=8.4 Hz, ArH), 7.13-7.10 (d, 2H, J=7.8 Hz, ArH), 7.10 (s, 1H, vinyl-H), 4.24-4.19 (m, 2H, N—CH₂CH₂CH₂CH₃), 3.94 (s, 2H, CH₂), 3.09-3.02 (m, 2H, Ar—CH₂CH₂CH₂CH₃), 2.21-1.66 (m, 15H, adamantyl), 1.56-1.44 (m, 2H, N—CH₂CH₂CH₂CH₃), 1.56-1.44 (m, 2H, Ar—CH₂CH₂CH₂CH₃), 1.51-1.21 (m, 2H, N—CH₂CH₂CH₂CH₃), 1.51-1.21 (m, 2H, Ar—CH₂CH₂CH₂CH₃), 0.88-0.84 (m, 3H, N—CH₂CH₂CH₂CH₃), 0.80-0.75 (m, 3H, Ar—CH₂CH₂CH₂CH₃).

KHG24777 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅ n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 71%; melting point: 220° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.47 (s, 1H, HCl), 8.61 (s, 1H, NH), 7.89-7.66 (d, 4H, J=8.7 Hz, ArH), 7.15 (s, 1H, vinyl-H), 4.34-4.26 (m, 2H, CH₂CH₂CH₂CH₃), 4.08 (s, 2H, CH₂), 2.13-1.66 (m, 15H, adamantyl), 1.57-1.45 (m, 2H, CH₂CH₂CH₂CH₃), 1.33-1.10 (m, 2H, CH₂CH₂CH₂CH₃), 0.78-0.73 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24778 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 81%; melting point: 164° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.50 (s, 1H, HCl), 8.49 (s, 1H, NH), 7.75 (s, 2H, ArH), 7.32 (s, 1H, ArH), 7.16 (s, 1H, vinyl-H), 4.29-4.21 (m, 2H, CH₂CH₂CH₂CH₃), 4.05 (s, 2H, CH₂), 2.17-1.68 (m, 15H, adamantyl), 1.58-1.46 (m, 2H, CH₂CH₂CH₂CH₃), 1.34-1.21 (m, 2H, CH₂CH₂CH₂CH₃), 0.82-0.77 (t, 3H, J=7.2 Hz, CH₂CH₂CH₂CH₃).

KHG24779 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(3,5-difluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 86%; melting point: 252° C.

¹H NMR (300 MHz, DMSO-d₆) δ 8.51 (s, 1H, NH), 8.36 (s, 2H, ArH), 7.79 (s, 1H, ArH), 7.17 (s, 1H, vinyl-H), 4.32-4.22 (m, 2H, CH₂CH₂CH₂CH₃), 4.09 (s, 2H, CH₂), 2.15-1.66 (m, 15H, adamantyl), 1.58-1.44 (m, 2H, CH₂CH₂CH₂CH₃), 1.33-1.20 (m, 2H, CH₂CH₂CH₂CH₃), 0.77-0.72 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24780 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 86%; melting point: 163° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.91 (s, 1H, HCl), 8.49 (s, 1H, NH), 7.67-7.15 (m, 4H, ArH), 7.12 (s, 1H, vinyl-H), 4.29-4.21 (m, 2H, CH₂CH₂CH₂CH₃), 3.97 (s, 2H, CH₂), 2.15-1.66 (m, 15H, adamantyl), 1.57-1.45 (m, 2H, CH₂CH₂CH₂CH₃), 1.33-1.19 (m, 2H, CH₂CH₂CH₂CH₃), 0.80-0.75 (t, 3H, J=7.2 Hz, CH₂CH₂CH₂CH₃).

KHG24781 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 79%; melting point: 164° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.67 (s, 1H, HCl), 8.50 (s, 1H, NH), 7.50-7.47 (d, 2H, J=8.1 Hz, ArH), 7.11-7.09 (d, 2H, J=8.4 Hz, ArH), 7.11 (s, 1H, vinyl-H), 4.30-4.20 (m, 2H, CH₂CH₂CH₂CH₃), 3.95 (s, 2H, CH₂), 2.23 (s, 3H, Ar—CH₃), 2.07-1.66 (m, 15H, adamantyl), 1.58-1.47 (m, 2H, CH₂CH₂CH₂CH₃), 1.32-1.16 (m, 2H, CH₂CH₂CH₂CH₃), 0.81-0.76 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24782 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 51%; melting point: 156° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.68 (s, 1H, HCl), 8.51 (s, 1H, NH), 7.52-7.12 (d, 4H, J=8.7 Hz, ArH), 7.12 (s, 1H, vinyl-H), 4.29-4.21 (m, 2H, CH₂CH₂CH₂CH₃), 3.94 (s, 2H, CH₂), 2.59-2.46 (m, 2H, CH₂CH₃), 2.15-1.66 (m, 15H, adamantyl), 1.58-1.46 (m, 2H, CH₂CH₂CH₂CH₃), 1.31-1.17 (m, 2H, CH₂CH₂CH₂CH₃), 1.16-1.13 (m, 3H, CH₂CH₃), 0.81-0.76 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24783 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-C₁, R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 72%; melting point: 161° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.51 (s, 1H, HCl), 8.63 (s, 1H, NH), 7.90-7.26 (m, 3H, ArH), 7.12 (s, 1H, vinyl-H), 4.28-4.23 (m, 2H, CH₂CH₂CH₂CH₃), 4.05 (s, 2H, CH₂), 2.15-1.66 (m, 15H, adamantyl), 1.59-1.47 (m, 2H, CH₂CH₂CH₂CH₃), 1.34-1.21 (m, 2H, CH₂CH₂CH₂CH₃), 0.85-0.80 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24784 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X═Cl]

yield: 89%; melting point: 172° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.87 (s, 1H, HCl), 8.42 (s, 1H, NH), 7.60-7.58 (d, 2H, J=7.2 Hz, ArH), 7.52-7.50 (d, 2H, J=6.9 Hz, ArH), 7.12 (s, 1H, vinyl-H), 4.23-4.18 (m, 2H, CH₂CH₂CH₂CH₃), 3.98 (s, 2H, CH₂), 2.16-1.68 (m, 15H, adamantyl), 1.58-1.46 (m, 2H, CH₂CH₂CH₂CH₃), 1.33-1.20 (m, 2H, CH₂CH₂CH₂CH₃), 0.82-0.77 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24785 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-C₁, R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 78%; melting point: 156° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.54 (s, 1H, HCl), 8.53 (s, 1H, NH), 8.03-7.22 (m, 3H, ArH), 7.13 (s, 1H, vinyl-H), 4.27-4.20 (m, 2H, CH₂CH₂CH₂CH₃), 4.06 (s, 2H, CH₂), 2.16-1.67 (m, 15H, adamantyl), 1.58-1.49 (m, 2H, CH₂CH₂CH₂CH₃), 1.32-1.20 (m, 2H, CH₂CH₂CH₂CH₃), 0.86-0.81 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24788 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 74%; melting point: 237° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.56 (s, 1H, HCl), 8.51 (s, 1H, NH), 7.37-7.16 (d, 4H, J=8.7 Hz, ArH), 7.03 (s, 1H, vinyl-H), 4.15 (s, 2H, CH₂), 3.07-2.99 (m, 1H, cyclopropyl-CH), 2.89-2.78 (m, 1H, isopropyl-CH), 2.17-1.68 (m, 15H, adamantyl), 1.28-1.21 (m, 2H, cyclopropyl-CH₂), 1.82-1.15 (d, 6H, J=6.9 Hz, isopropyl-CH₃), 1.08-1.02 (m, 2H, cyclopropyl-CH₂).

KHG24789 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 87%; melting point: 263° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.52 (s, 1H, HCl), 8.49 (s, 1H, NH), 7.51-7.49 (d, 2H, J=8.4 Hz, ArH), 7.14-7.11 (d, 2H, J=8.1 Hz, ArH), 7.03 (s, 1H, vinyl-H), 4.00 (s, 2H, CH₂), 3.07-2.98 (m, 1H, cyclopropyl-CH), 2.55-2.50 (m, 1H, CH₂CH₂CH₂CH₃), 2.16-1.68 (m, 15H, adamantyl), 1.57-1.46 (m, 2H, CH₂CH₂CH₂CH₃), 1.34-1.12 (m, 2H, CH₂CH₂CH₂CH₃), 1.34-1.12 (m, 2H, cyclopropyl-CH₂), 1.07-1.01 (m, 2H, cyclopropyl-CH₂), 0.90-0.87 (t, 3H, J=7.2 Hz, CH₂CH₂CH₂CH₃).

KHG24790 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 79%; melting point: 267° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.24 (s, 1H, HCl), 8.54 (s, 1H, NH), 7.88-7.85 (d, 2H, J=8.4 Hz, ArH), 7.70-7.68 (d, 2H, J=8.4 Hz, ArH), 7.06 (s, 1H, vinyl-H), 4.10 (s, 2H, CH₂), 3.10-3.01 (m, 1H, cyclopropyl-CH), 2.16-1.68 (m, 15H, adamantyl), 1.30-1.22 (m, 2H, cyclopropyl-CH₂), 1.09-1.02 (m, 2H, cyclopropyl-CH₂).

KHG24792 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF₃, R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 89%; melting point: 258° C.

¹H NMR (300 MHz, DMSO-d₆) δ 8.51 (s, 1H, NH), 8.38 (s, 2H, ArH), 7.79 (s, 1H, ArH), 7.09 (s, 1H, vinyl-H), 4.14 (s, 2H, CH₂), 3.11-3.18 (m, 1H, cyclopropyl-CH), 2.17-1.68 (m, 15H, adamantyl), 1.33-1.24 (m, 2H, cyclopropyl-CH₂), 1.11-1.05 (m, 2H, cyclopropyl-CH₂).

KHG24795 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅ n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 71%; melting point: 244° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.79 (s, 1H, HCl), 8.60 (s, 1H, NH), 7.55-7.52 (d, 2H, J=8.1 Hz, ArH), 7.18-7.16 (d, 2H, J=8.4 Hz, ArH), 7.12 (s, 1H, vinyl-H), 4.31-4.26 (m, 2H, CH₂CH₂CH₂CH₃), 3.98 (s, 2H, CH₂), 2.87-2.78 (m, 1H, J=6.9 Hz, isopropyl-C₁), 2.15-1.67 (m, 15H, adamantyl), 1.59-1.47 (m, 2H, CH₂CH₂CH₂CH₃), 1.44-1.22 (m, 2H, CH₂CH₂CH₂CH₃), 0.81-0.76 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24796 [2-(1-adamantylimino)-3-(n-butyl)-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 89%; melting point: 127° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.94 (s, 1H, HCl), 8.56 (s, 1H, NH), 7.68-6.94 (m, 9H, ArH), 7.14 (s, 1H, vinyl-H), 4.34-4.24 (m, 2H, CH₂CH₂CH₂CH₃), 4.00 (s, 2H, CH₂), 2.16-1.68 (m, 15H, adamantyl), 1.58-1.47 (m, 2H, CH₂CH₂CH₂CH₃), 1.35-1.22 (m, 2H, CH₂CH₂CH₂CH₃), 0.82-0.78 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24799 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₂H₅, R₃=R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 75%; melting point: 266° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.66 (s, 1H, HCl), 8.53 (s, 1H, NH), 7.49-7.46 (d, 2H, J=8.4 Hz, ArH), 7.09-7.06 (d, 2H, J=8.7 Hz, ArH), 6.98 (s, 1H, vinyl-H), 3.97 (s, 2H, CH₂), 3.05-2.97 (m, 1H, cyclopropyl-CH), 2.52-2.43 (m, 2H, CH₂CH₃), 2.10-1.62 (m, 15H, adamantyl), 1.24-1.16 (m, 2H, cyclopropyl-CH₂), 1.12-1.06 (m, 3H, CH₂CH₃), 1.02-0.96 (m, 2H, cyclopropyl-CH₂).

KHG24800 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 65%; melting point: 263° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.90 (s, 1H, HCl), 8.61 (s, 1H, NH), 7.39-6.94 (m, 9H, ArH), 7.01 (s, 1H, vinyl-H), 4.05 (s, 2H, CH₂), 3.13-3.05 (m, 1H, cyclopropyl-CH), 2.16-1.68 (m, 15H, adamantyl), 1.32-1.24 (m, 2H, cyclopropyl-CH₂), 1.09-1.02 (m, 2H, cyclopropyl-CH₂).

KHG24801 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 86%; melting point: 261° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.59 (s, 1H, HCl), 8.70 (s, 1H, NH), 7.84-7.26 (m, 3H, ArH), 7.05 (s, 1H, vinyl-H), 4.11 (s, 2H, CH₂), 3.14-3.05 (m, 1H, cyclopropyl-CH), 2.15-1.67 (m, 15H, adamantyl), 1.32-1.23 (m, 2H, cyclopropyl-CH₂), 1.09-1.01 (m, 2H, cyclopropyl-CH₂).

KHG24802 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 77%; melting point: 244° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.55 (s, 1H, HCl), 8.55 (s, 1H, NH), 8.01-7.23 (m, 3H, ArH), 7.05 (s, 1H, vinyl-H), 4.11 (s, 2H, CH₂), 3.09-3.01 (m, 1H, cyclopropyl-CH), 2.16-1.68 (m, 15H, adamantyl), 1.31-1.23 (m, 2H, cyclopropyl-CH₂), 1.08-1.01 (m, 2H, cyclopropyl-CH₂).

KHG24803 [2-(1-adamantylimino)-3-n-butyl-1,3-thiazolidine-4-yl]-N-(3,4-dioxymethylenephenyl)-acetamide hydrochloride [R₁=H, R₂, R₃₂—OCH₂—O(4-), R₄=H, R₅=n-C₄H₉, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 88%; melting point: 220° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.92 (s, 1H, HCl), 8.60 (s, 1H, NH), 7.35-6.83 (m, 3H, ArH), 7.11 (s, 1H, vinyl-H), 5.98 (s, 2H, OCH₂O), 4.35-4.24 (m, 2H, CH₂CH₂CH₂CH₃), 3.98 (s, 2H, CH₂), 2.15-1.66 (m, 15H, adamantyl), 1.58-1.45 (m, 2H, CH₂CH₂CH₂CH₃), 1.34-1.20 (m, 2H, CH₂CH₂CH₂CH₃), 0.82-0.78 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24804 [2-(1-adamantylimino)-3-cyclopropyl-1,3-thiazolidine-4-yl]-N-(3,4-dioxymethylenephenyl)-acetamide hydrochloride [R₁=H, R₂, R₃=2-OCH₂—O(4-), R₄=H, R₅=C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 81%; melting point: 250° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.77 (s, 1H, HCl), 8.57 (s, 1H, NH), 7.35-6.83 (m, 3H, ArH), 7.05 (s, 1H, vinyl-H), 5.98 (s, 2H, benzodioxol-CH₂), 4.01 (s, 2H, CH₂), 3.11-3.01 (m, 1H, cyclopropyl-CH), 2.15-1.67 (m, 15H, adamantyl), 1.30-1.16 (m, 2H, cyclopropyl-CH₂), 1.08-1.00 (m, 2H, cyclopropyl-CH₂).

KHG24805 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(3,5-dichlorophenyl)-acetamide hydrochloride [R₁=H, R₂=3-Cl, R₃=5-Cl, R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 49.4%; melting point: 153° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.40 (s, 1H, HCl), 8.47 (s, 1H, NH), 7.73-7.31 (m, 3H, ArH), 7.15 (s, 1H, vinyl-H), 4.20 (m, 2H, CH₂CH₂), 4.03 (s, 2H, CH₂), 2.16-1.63 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.85 (t, J=7.3 Hz, 3H, CH₃).

KHG24807 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 91.8%; melting point: 155° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.08 (s, 1H, HCl), 8.95 (s, 1H, NH), 7.72-7.01 (m, 4H, ArH), 6.73 (s, 1H, vinyl-H), 4.99 (m, 2H, CH₂CH₂CH₃), 4.18 (s, 2H, CH₂), 2.85 (m, 1H, isopropyl CH), 2.23-1.72 (m, 15H, adamantyl H), 1.66 (m, 2H, CH₂CH₂CH₃), 1.21 (d, J=6.9, 6H, 2

isopropyl CH₃), 0.90 (t, J=7.1 Hz, 3H, CH₃).

KHG24808 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 74.9%; melting point: 213° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.62 (s, 1H, HCl), 8.49 (s, 1H, NH), 7.51-7.11 (m, 4H, ArH), 7.14 (s, 1H, vinyl-H), 4.22 (m, 2H, CH₂CH₂), 3.95 (s, 2H, CH₂), 2.52 (m, 2H, CH₂CH₂CH₂CH₃), 2.16-1.64 (m, 15H, adamantyl H), 1.61 (m, 2H, CH₂CH₂CH₃), 1.51 (m, 2H, CH₂CH₂CH₂CH₃), 1.26 (m, 2H, CH₂CH₂CH₂CH₃), 0.88 (t, 3H, CH₂CH₂CH₃), 0.84 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24809 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 83.7%; melting point: 221° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.24 (s, 1H, HCl), 8.50 (s, 1H, NH), 7.86-7.68 (m, 4H, ArH), 7.15 (s, 1H, vinyl-H), 4.22 (m, 2H, CH₂CH₂), 4.05 (s, 2H, CH₂), 2.16-1.64 (m, 15H, adamantyl H), 1.59 (m, 2H, CH₂CH₂CH₃), 0.84 (t, J=7.3 Hz, 3H, CH₃).

KHG24811 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 96.3%; melting point: 138° C.

¹H NMR (300 MHz, CDCl₃) δ 11.25 (s, 1H, HCl), 8.89 (s, 1H, NH), 7.83-6.93 (m, 4H, ArH), 6.73 (s, 1H, vinyl-H), 4.98 (m, 2H, CH₂CH₂), 4.17 (s, 2H, CH₂), 2.23-1.69 (m, 15H, adamantyl H), 1.66 (m, 2H, CH₂CH₂CH₃), 0.89 (t, J=7.3 Hz, 3H, CH₃).

KHG24812 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-bromophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Br, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 96.4%; melting point: 228° C.

¹H NMR (300 MHz, DMSO-d₆) δ 11.00 (s, 1H, HCl), 8.50 (s, 1H, NH), 7.63-7.49 (m, 4H, ArH), 7.13 (s, 1H, vinyl-H), 4.22 (m, 2H, CH₂CH₂), 4.00 (s, 2H, CH₂), 2.16-1.63 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.84 (t, J=7.3 Hz, 3H, CH₃).

KHG24813 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 94.4%; melting point: 239° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.66 (s, 1H, HCl), 8.51 (s, 1H, NH), 7.51-7.10 (m, 4H, ArH), 7.12 (s, 1H, vinyl-H), 4.23 (m, 2H, CH₂CH₂), 3.96 (s, 2H, CH₂), 2.25 (s, 3H, CH₃), 2.16-1.63 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.84 (t, J=7.3 Hz, 3H, CH₂CH₂CH₃).

KHG24814 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 86.6%; melting point: 240° C.

¹H NMR (300 MHz, CDCl₃) δ 11.09 (s, 1H, HCl), 8.97 (s, 1H, NH), 7.73-7.07 (m, 4H, ArH), 6.71 (s, 1H, vinyl-H), 5.00 (m, 2H, CH₂CH₂CH₃), 4.19 (s, 2H, CH₂), 2.69 (s, 2H, CH₂CH₃), 2.24-1.68 (m, 15H, adamantyl H), 1.67 (m, 2H, CH₂CH₂CH₃), 1.20 (t, J=7.6 Hz, 3H, CH₂CH₃), 0.89 (t, J=7.3 Hz, 3H, CH₂CH₂CH₃).

KHG24815 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-OC₆H₅, R₃=R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 92.1%; melting point: 135° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.86 (s, 1H, HCl), 8.54 (s, 1H, NH), 7.66-6.94 (m, 9H, ArH), 7.13 (s, 1H, vinyl-H), 4.24 (m, 2H, CH₂CH₂), 3.99 (s, 2H, CH₂), 2.16-1.62 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.85 (t, J=7.3 Hz, 3H, CH₃).

KHG24816 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 98.4%; melting point: 131° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.52 (s, 1H, HCl), 8.64 (s, 1H, NH), 7.90-7.27 (m, 3H, ArH), 7.13 (s, 1H, vinyl-H), 4.24 (m, 2H, CH₂CH₂), 4.06 (s, 2H, CH₂), 2.16-1.61 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.86 (t, J=7.3 Hz, 3H, CH₃).

KHG24817 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 93.6%; melting point: 130° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.55 (s, 1H, HCl), 8.57 (s, 1H, NH), 8.04-7.23 (m, 3H, ArH), 7.13 (s, 1H, vinyl-H), 4.22 (m, 2H, CH₂CH₂), 4.07 (s, 2H, CH₂), 2.16-1.64 (m, 15H, adamantyl H), 1.58 (m, 2H, CH₂CH₂CH₃), 0.86 (t, J=7.3 Hz, 3H, CH₃).

KHG24818 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(2-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=2-Cl, R₃=4-CH₃, R₄=H, R₅=n-C₃H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 94.2%; melting point: 201° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.09 (s, 1H, HCl), 8.60 (s, 1H, NH), 7.50-7.12 (m, 3H, ArH), 7.12 (s, 1H, vinyl-H), 4.24 (m, 2H, CH₂CH₂), 4.02 (s, 2H, CH₂), 2.28 (s, 3H, CH₃), 2.23-1.62 (m, 15H, adamantyl H), 1.61 (m, 2H, CH₂CH₂CH₃), 0.88 (t, J=7.3 Hz, 3H, CH₂CH₂CH₃).

KHG24819 [2-(1-adamantylimino)-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃=R₄=H, R₅=C₂H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 97.1%; melting point: 158° C.

¹H NMR (300 MHz, CDCl₃) δ 11.04 (s, 1H, HCl), 8.82 (s, 1H, NH), 7.73-7.10 (m, 4H, ArH), 6.70 (s, 1H, vinyl-H), 5.00 (m, 2H, CH₂CH₃), 4.16 (s, 2H, CH₂), 2.85 (m, 1H, isopropyl CH), 2.23-1.72 (m, 15H, adamantyl H), 1.21 (m, 6H, 2

isopropyl CH₃), 1.20 (m, 3H, CH₃).

KHG24820 [2-(1-adamantylimino)-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=C₂H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 95.3%; melting point: 141° C.

¹H NMR (300 MHz, CDCl₃) δ 11.02 (s, 1H, HCl), 8.80 (s, 1H, NH), 7.72-7.04 (m, 4H, ArH), 6.70 (s, 1H, vinyl-H), 4.99 (m, 2H, CH₂CH₃), 4.16 (s, 2H, CH₂), 2.54 (t, J=7.6 Hz, 2H, CH₂CH₂CH₂CH₃), 2.24-1.72 (m, 15H, adamantyl H), 1.55 (m, 2H, CH₂CH₂CH₂CH₃), 1.34 (m, 2H, CH₂CH₂CH₂CH₃), 1.23 (m, 3H, CH₂CH₃), 0.91 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24821 [2-(1-adamantylimino)-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=C₂H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 83.2%; melting point: 219° C.

¹H NMR (300 MHz, CDCl₃) δ 11.47 (s, 1H, HCl), 8.80 (s, 1H, NH), 7.99-7.50 (m, 4H, ArH), 6.72 (s, 1H, vinyl-H), 5.03 (m, 2H, CH₂CH₃), 4.21 (s, 2H, CH₂), 2.25-1.74 (m, 15H, adamantyl H), 1.22 (t, J=6.9 Hz, 3H, CH₃).

KHG24823 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-chlorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-Cl, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 93.4%; melting point: 236° C.

¹H NMR (300 MHz, CDCl₃) δ 11.66 (s, 1H, HCl), 7.87-7.21 (m, 4H, ArH), 7.20 (s, 1H, vinyl-H), 6.71 (br.s, 1H, NH), 5.56 (m, 1H, isopropyl CH), 4.31 (s, 2H, CH₂), 2.27-1.71 (m, 15H, adamantyl H), 1.64 (d, J=7.0 Hz, 6H, 2

isopropyl CH₃).

KHG24825 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 85.6%; melting point: 178° C.

¹H NMR (300 MHz, CDCl₃) δ 11.34 (s, 1H, HCl), 7.76-7.06 (m, 4H, ArH), 7.17 (s, 1H, vinyl-H), 6.71 (br.s, 1H, NH), 5.63 (m, 1H, isopropyl CH), 4.31 (s, 2H, CH₂), 2.55 (t, J=7.6 Hz, 2H, CH₂CH₂CH₂CH₃), 2.26-1.69 (m, 15H, adamantyl H), 1.63 (d, J=7.0 Hz, 6H, 2

isopropyl CH₃), 1.55 (m, 2H, CH₂CH₂CH₂CH₃), 1.30 (m, 2H, CH₂CH₂CH₂CH₃), 0.91 (t, J=7.3 Hz, 3H, CH₂CH₂CH₂CH₃).

KHG24826 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-trifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CF₃, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 81.8%; melting point: 246° C.

¹H NMR (300 MHz, CDCl₃) δ 11.90 (s, 1H, HCl), 8.04-7.50 (m, 4H, ArH), 7.23 (s, 1H, vinyl-H), 6.68 (br.s, 1H, NH), 5.56 (m, 1H, isopropyl CH), 4.36 (s, 2H, CH₂), 2.28-1.70 (m, 15H, adamantyl H), 1.64 (d, J=7.0 Hz, 6H, 2

isopropyl CH₃).

KHG24828 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(3,5-ditrifluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=3-CF₃, R₃=5-CF_(3, 4)=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 69.6%; melting point: 233° C.

¹H NMR (300 MHz, CDCl₃) δ 12.29 (s, 1H, HCl), 8.43 (s, 2H, ArH), 7.55 (s, 1H, ArH), 7.20 (s, 1H, vinyl-H), 6.80 (br.s, 1H, NH), 5.54 (m, 1H, isopropyl CH), 4.40 (s, 2H, CH₂), 2.28-1.75 (m, 15H, adamantyl H), 1.66 (d, J=7.0 Hz, 6H, 2

isopropyl CH₃).

KHG24829 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-fluoromethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 89.4%; melting point: 227° C.

¹H NMR (300 MHz, CDCl₃) δ 11.57 (s, 1H, HCl), 7.87-6.92 (m, 4H, ArH), 7.19 (s, 1H, vinyl-H), 6.85 (br.s, 1H, NH), 5.59 (m, 1H, isopropyl CH), 4.30 (s, 2H, CH₂), 2.27-1.70 (m, 15H, adamantyl H), 1.64 (d, J=7.0 Hz, 6H, 2

isopropyl CH₃).

KHG24831 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH₃, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 89.9%; melting point: 220° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.64 (s, 1H, HCl), 7.95 (br.s, 1H, NH), 7.51-7.10 (m, 4H, ArH), 7.14 (s, 1H, vinyl-H), 4.98 (m, 1H, isopropyl CH), 4.07 (s, 2H, CH₂), 2.25 (s, 3H, CH₃), 2.16-1.68 (m, 15H, adamantyl H), 1.48 (d, J=6.9 Hz, 6H, 2

isopropyl CH₃).

KHG24832 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 94.7%; melting point: 171° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.65 (s, 1H, HCl), 8.91 (br.s, 1H, NH), 7.53-7.14 (m, 4H, ArH), 7.14 (s, 1H, vinyl-H), 4.97 (m, 1H, isopropyl CH), 4.07 (s, 2H, CH₂), 2.55 (s, 3H, CH₂CH₃), 2.16-1.68 (m, 15H, adamantyl H), 1.48 (d, J=6.9 Hz, 6H, 2

isopropyl CH₃), 1.15 (t, J=7.5 Hz, 3H, CH₂CH₃).

KHG24833 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-phenoxyphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₆H₅, R₃=R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 90.7%; melting point: 164° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.73 (s, 1H, HCl), 7.88 (br.s, 1H, NH), 7.64-6.95 (m, 9H, ArH), 7.15 (s, 1H, vinyl-H), 4.96 (m, 1H, isopropyl CH), 4.08 (s, 2H, CH₂), 2.17-1.68 (m, 15H, adamantyl H), 1.59 (d, J=7.0 Hz, 6H, 2

isopropyl CH₃).

KHG24834 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(4-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-Cl, R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 75.9%; melting point: 228° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.42 (s, 1H, HCl), 7.98 (br.s, 1H, NH), 7.89-7.27 (m, 3H, ArH), 7.14 (s, 1H, vinyl-H), 4.97 (m, 1H, isopropyl CH), 4.15 (s, 2H, CH₂), 2.17-1.68 (m, 15H, adamantyl H), 1.48 (d, J=6.9 Hz, 6H, 2

isopropyl CH₃).

KHG24835 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(5-chloro-2-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=5-Cl, R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 98.1%; melting point: 116° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.48 (s, 1H, HCl), 8.13 (br.s, 1H, NH), 8.03-7.22 (m, 3H, ArH), 7.15 (s, 1H, vinyl-H), 4.96 (m, 1H, isopropyl CH), 4.17 (s, 2H, CH₂), 2.19-1.68 (m, 15H, adamantyl H), 1.48 (d, J=6.9 Hz, 6H, 2

isopropyl CH₃).

KHG24836 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(5-chloro-4-methylphenyl)-acetamide hydrochloride [R₁=H, R₂=5-Cl, R₃=4-CH₃, R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 93.9%; melting point: 231° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.04 (s, 1H, HCl), 8.03 (br.s, 1H, NH), 7.50-7.13 (m, 3H, ArH), 7.15 (s, 1H, vinyl-H), 4.99 (m, 1H, isopropyl CH), 4.13 (s, 2H, CH₂), 2.28 (s, 3H, CH₃), 2.16-1.68 (m, 15H, adamantyl H), 1.48 (d, J=6.9 Hz, 6H, 2

isopropyl CH₃).

KHG24837 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(3,4-dioxymethylenephenyl)-acetamide hydrochloride [R₁=H, R₂, R₃=3-OCH₂—O(4-), R₄=H, R₅=n-C₃H₇, R₆1-adamantyl, n=1, m=0, X=Cl]

yield: 83.8%; melting point: 142° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.76 (s, 1H, HCl), 8.52 (s, 1H, NH), 7.32-6.85 (m, 3H, ArH), 7.11 (s, 1H, vinyl-H), 5.98 (s, 2H, benzodioxol CH₂), 4.22 (m, 2H, CH₂CH₂CH₃), 3.38 (s, 2H, CH₂), 2.16-1.62 (m, 15H, adamantyl H), 1.60 (m, 2H, CH₂CH₂CH₃), 0.84 (t, J=7.2 Hz, 3H, CH₃).

KHG24838 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(3,4-dioxymethylenephenyl)-acetamide hydrochloride [R₁=H, R₂, R₃=3-OCH₂—O(4-), R₄=H, R₅=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 81.4%; melting point: 150° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.70 (s, 1H, HCl), 7.92 (br.s, 1H, NH), 7.32-6.85 (m, 3H, ArH), 7.13 (s, 1H, vinyl-H), 5.98 (s, 2H, benzodioxol CH₂), 4.94 (m, 1H, isopropyl CH), 4.05 (s, 2H, CH₂), 2.16-1.59 (m, 15H, adamantyl H), 1.47 (d, J=6.9 Hz, 6H, 2

isopropyl CH₃).

KHG248039 [2-(1-adamantylimino)-3-n-propyl-1,3-thiazolidine-4-yl]-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁=H, R₂=2-F, R₃=4-NO₂, R₄=H, R₅=n-C₃H₇, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 86.3%; melting point: 145° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.85 (s, 1H, HCl), 8.94-7.58 (m, 3H, ArH), 8.61 (s, 1H, NH), 7.16 (s, 1H, vinyl-H), 4.25 (m, 2H, CH₂CH₂CH₃), 4.13 (s, 2H, CH₂), 2.16-1.62 (m, 15H, adamantyl H), 1.60 (m, 2H, CH₂CH₂CH₃), 0.86 (t, J=7.2 Hz, 3H, CH₃).

KHG24840 [2-(1-adamantylimino)-3-isopropyl-1,3-thiazolidine-4-yl]-N-(2-fluoro-5-nitrophenyl)-acetamide hydrochloride [R₁H, R₂=2-F, R₃=4-NO₂, R₄=H, R₃=CH(CH₃)₂, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 77.9%; melting point: 131° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.80 (s, 1H, HCl), 8.94-7.59 (m, 3H, ArH), 8.08 (br.s, 1H, NH), 7.18 (s, 1H, vinyl-H), 4.97 (m, 1H, isopropyl CH), 4.24 (s, 2H, CH₂), 2.17-1.59 (m, 15H, adamantyl H), 1.48 (d, J=6.8 Hz, 6H, 2

isopropyl CH₃).

KHG24841 [2-(2-adamantylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-n-butylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-n-C₄H₉, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 81%; melting point: 127° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.67 (s, 1H, HCl), 8.87 (s, 1H, NH), 7.53-7.50 (d, 2H, J=8.7 Hz, ArH), 7.13-7.10 (d, 2H, J=8.7 Hz, ArH), 7.05 (s, 1H, vinyl-H), 4.00 (s, 2H, CH₂), 3.70 (s, 3H, CH₃), 3.63-3.53 (m, 1H, admantyl-CH), 2.59-2.53 (m, 2H, CH₂CH₂CH₂CH₃), 2.16-1.46 (m, 14H, adamantyl), 1.62-1.42 (m, 2H, CH₂CH₂CH₂CH₃), 1.34-1.20 (m, 2H, CH₂CH₂CH₂CH₃), 0.90-0.82 (m, 3H, CH₂CH₂CH₂CH₃).

KHG24842 [2-(2-adamantylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-fluorophenyl)-acetamide hydrochloride [R₁=H, R₂=4-F, R₃=R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 56%; melting point: 154° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.91 (s, 1H, HCl), 8.89-8.87 (d, 1H, NH), 7.68-7.13 (m, 4H, ArH), 7.14 (s, 1H, vinyl-H), 4.03 (s, 2H, CH₂), 3.70 (s, 3H, CH₃), 3.63-3.57 (m, 1H, admantyl-CH), 2.17-1.55 (m, 14H, 2-adamantyl).

KHG24844 [2-(2-adamantylimino)-3-methyl-1,3-thiazolidine-4-yl]-N-(4-isopropylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-CH(CH₃)₂, R₃==R₄=H, R₅=CH₃, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 94%; melting point: 245° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.60 (s, 1H, HCl), 8.85-8.84 (d, 1H, NH), 7.53-7.51 (d, 2H, J=8.4 Hz, ArH), 7.20-7.17 (d, 2H, J=8.4 Hz, ArH), 7.13 (s, 1H, vinyl-H), 4.00 (s, 2H, CH₂), 3.69 (s, 3H, CH₃), 3.64-3.57 (m, 1H, admantyl-CH), 2.89-2.77 (m, 1H, isopropyl-CH), 2.18-1.55 (m, 14H, 2-adamantyl), 1.18-1.64 (d, 6H, J=7.2 Hz, isopropyl-CH₃).

KHG24847 [2-(1-adamantylimino)-3-ethyl-1,3-thiazolidine-4-yl]-N-(4-ethylphenyl)-acetamide hydrochloride [R₁=H, R₂=4-C₂H₅, R₃=R₄=H, R₅=C₂H₅, R₆=1-adamantyl, n=1, m=0, X=Cl]

yield: 18.9%; melting point: 144-145° C.

¹H NMR (300 MHz, DMSO-d₆) δ 10.63 (s, 1H, HCl), 8.40 (s, 1H, NH), 7.50 (d, 2H, J=8.4 Hz, ArH), 7.14 (d, 2H, J=8.4 Hz, ArH), 7.11 (s, 1H, vinyl H), 4.32-4.25 (m, 2H, 3-CH₂CH₃), 3.96 (s, 2H, CH₂), 2.55 (m, 2H, CH₂CH₃), 2.49-1.67 (m, 15H, adamantyl), 1.21-1.12 (m, 6H, 2×CH₃).

The novel 2-imino-1,3-thiazoline based compounds according to the present invention have excellent effect of T-type calcium channel inhibition, and thus, it is possible to obtain excellent effect to treat and/or prevent nerve diseases, pain, epilepsy, hypertension, angina pectoris, heart muscle disease, vascular disorder, cancer metastasis, and the like by using the compounds. 

1. A 2-imino-1,3-thiazoline-based compound represented by Chemical Formula I:

wherein R₁ is a hydrogen atom, or a C1-C5 linear or branched alkyl group, R₂, R₃, and R₄ are the same or different from one another, and are independently selected from the group consisting of a hydrogen atom, a halogen atom, a C1-C5 linear or branched alkyl group, a C1-C5 alkyloxy group, a trifluoromethyl group, a trifluoromethoxy group, a phenyloxy group, an amino group, a methanesulfoneamino group, a paratoluenesulfoneamino group, a nitro group, a C1-C5 cyanoalkyl group, a cyano group, a C1-C6 alkoxycarbonyl group, and a C3-C12 cycloalkyl group, R₅ is selected from the group consisting of a C1-C5 linear or branched alkyl group, a C3-C6 cycloalkyl group, and a benzyl group, R₆ is selected from the group consisting of cyclopentyl, cyclohexyl, cycloheptyl, methyl-cyclohexyl, 1-adamantyl, and 2-adamantyl, n and m are independently 0 or 1, HX is present or absent, and when HX is present, X is a halogen atom.
 2. The compound according to claim 1, wherein the R₅ is selected from the group consisting of methyl, ethyl, linear or branched propyl, linear or branched butyl, cyclopropyl, cyclohexyl, and benzyl.
 3. The compound according to claim 1, wherein the R₂, R₃, and R₄ are the same or different from one another, and are independently selected from the group consisting of a hydrogen atom, a halogen atom, methyl, ethyl, linear or branched propyl, linear or branched butyl, methoxy, trifluoromethyl, trifluoromethoxy, phenyloxy, amino, methanesulfoneamino, paratoluenesulfoneamino, nitro, cyanomethyl, cyano, C1-C6 alkoxycarbonyl, and cyclopentyl.
 4. The compound according to claim 1, wherein the R₁ is a hydrogen atom or methyl.
 5. The compound according to claim 1, wherein the compound is one selected from the group consisting of the compounds shown in the following table: Compound salt(O, HBr, code R₁ n m R₂, R₃, R₄ R₆ R₈ HCl) KHG23210 H 1 0 4-F CH3 cy-6 HCl KHG23354 H 1 0 4-Br CH3 cy-6 HCl KHG23355 H 1 0 4-OPh CH3 cy-6 HCl KHG23356 H 1 0 3-Cl, 5-Cl CH3 cy-6 HCl KHG23360 H 1 0 2-F, 5-NO2 CH3 cy-6 HCl KHG23361 H 1 0 2-F, 4-Cl CH3 cy-6 HCl KHG23362 H 1 0 4-Cl CH3 cy-6 HCl KHG23364 H 1 0 4-isoPr CH3 cy-6 HCl KHG23365 H 1 0 4-n-Bu CH3 cy-6 HCl KHG24070 H 1 0 3-Cl, 4-OCH3 CH3 cy-6 HCl KHG24071 H 1 0 2-Cl, 4-CH3, 5-Cl CH3 cy-6 HCl KHG24072 H 1 0 3-Cl, 4-CH3 CH3 cy-6 HCl KHG24073 H 1 0 4-tBu CH3 cy-6 HCl KHG24074 H 1 0 4-CF3 CH3 cy-6 HCl KHG24075 H 1 0 3-CF3, 5-CF3 CH3 cy-6 HCl KHG24076 H 1 0 3-OCH3 CH3 cy-6 HCl KHG24077 H 1 0 4-CH3 CH3 cy-6 HCl KHG24081 H 1 0 2-F, 4-F CH3 cy-6 HCl KHG24082 H 1 1 2-CH3 CH3 cy-6 HCl KHG24083 H 1 1 2-CF3 CH3 cy-6 HCl KHG24084 H 1 1 3-CF3 CH3 cy-6 HCl KHG24085 H 1 0 3-CO2Et CH3 cy-6 HCl KHG24086 H 1 1 3,4-OCH2O CH3 cy-6 HCl KHG24087 H 1 0 2-F, 5-F CH3 cy-6 HCl KHG24088 H 1 0 3-Cl, 4-Cl CH3 cy-6 HCl KHG24090 H 1 0 3-OCH3, 4-OCH3 CH3 cy-6 HCl KHG24091 H 1 0 3-F, 4-CH3 CH3 cy-6 HCl KHG24092 H 1 0 4-C2H5 CH3 cy-5 HCl KHG24093 H 1 0 4-F CH3 cy-5 HCl KHG24095 H 1 0 2-Cl, 4-F CH3 cy-5 HCl KHG24098 H 1 0 4-Br CH3 cy-5 HCl KHG24099 H 1 0 4-OPh CH3 cy-5 HCl KHG24100 H 1 0 3-Cl, 5-Cl CH3 cy-5 HCl KHG24103 H 1 0 2-F, 5-Cl CH3 cy-5 HCl KHG24104 H 1 0 2-F, 5-NO2 CH3 cy-5 HCl KHG24105 H 1 0 2-F, 4-Cl CH3 cy-5 HCl KHG24106 H 1 0 4-Cl CH3 cy-5 HCl KHG24108 H 1 0 3-NO2 CH3 cy-6 HCl KHG24109 H 1 0 3-F CH3 cy-6 HCl KHG24110 H 1 0 4-isoPr CH3 cy-6 HCl KHG24111 H 1 0 3-CH3, 4-Br CH3 cy-6 HCl KHG24112 H 1 1 4-F CH3 cy-6 HCl KHG24113 H 1 1 4-Cl CH3 cy-6 HCl KHG24115 H 1 0 4-isoPr CH3 cy-5 HCl KHG24116 H 1 0 4-n-Bu CH3 cy-5 HCl KHG24117 H 1 0 4-C2H5 CH3 cy-7 HCl KHG24118 H 1 0 4-F CH3 cy-7 HCl KHG24119 H 1 0 4-OCH3 CH3 cy-7 HCl KHG24120 H 1 0 2-Cl, 4-F CH3 cy-7 HCl KHG24121 H 1 0 4-CH2CN CH3 cy-7 HCl KHG24122 H 1 0 4-Br CH3 cy-7 HCl KHG24123 H 1 0 4-OPh CH3 cy-7 HCl KHG24124 H 1 0 2-Cl, 4-CH3 CH3 cy-7 HCl KHG24125 H 1 0 3-Cl, 5-Cl CH3 cy-7 HCl KHG24126 H 1 0 2-F, 4-CH3 CH3 cy-7 HCl KHG24127 H 1 0 2-F, 4-F CH3 cy-7 HCl KHG24128 H 1 0 2-F, 5-Cl CH3 cy-7 HCl KHG24129 H 1 0 2-F, 5-NO2 CH3 cy-7 HCl KHG24130 H 1 0 2-F, 4-Cl CH3 cy-7 HCl KHG24131 H 1 0 4-Cl CH3 cy-7 HCl KHG24132 H 1 0 H CH3 cy-7 HCl KHG24133 H 1 0 4-isoPr CH3 cy-7 HCl KHG24134 H 1 0 4-n-Bu CH3 cy-7 HCl KHG24141 H 1 0 4-OPh CH3 cy-3 HCl KHG24152 H 1 0 4-n-Bu CH3 cy-3 HCl KHG24157 H 1 1 4-Cl CH3 cy-5 HCl KHG24159 H 1 1 4-F CH3 cy-7 HCl KHG24160 H 1 1 4-Cl CH3 cy-7 HCl KHG24161 H 1 1 4-OCH3 CH3 cy-7 HCl KHG24216 H 1 0 3-CF3, 5-CF3 CH3 CH2CH2Ph HCl KHG24218 H 1 0 3-CF3, 5-CF3 CH3 CH2-cy-6 HCl KHG24220 H 1 0 4-isoPr CH3 CH2CH2Ph HCl KHG24222 H 1 0 4-isoPr CH3 CH2-cy-6 HCl KHG24224 H 1 0 4-OPh CH3 CH2CH2Ph HCl KHG24228 H 1 0 4-Cl CH3 CH2CH2Ph HCl KHG24230 H 1 0 4-Cl CH3 CH2-cy-6 HCl KHG24232 H 1 0 2-F, 5-NO2 CH3 CH2CH2Ph HCl KHG24234 H 1 0 2-F, 5-NO2 CH3 CH2-cy-6 HCl KHG24235 H 1 0 4-CH3 CH3 1-Ad HCl KHG24236 H 1 0 4-CH2CH3 CH3 1-Ad HCl KHG24237 H 1 0 4-F CH3 1-Ad HCl KHG24238 H 1 0 4-Cl CH3 1-Ad HCl KHG24239 H 1 0 4-Br CH3 1-Ad HCl KHG24240 H 1 0 4-CF3 CH3 1-Ad HCl KHG24241 H 1 0 3-CF3, 5-CF3 CH3 1-Ad HCl KHG24242 H 1 0 2-F, 5-Cl CH3 1-Ad HCl KHG24243 H 1 0 4-isoPr CH3 1-Ad HCl KHG24244 H 1 0 4-OC6H5 CH3 1-Ad HCl KHG24261 H 1 0 3-CF3, 5-CF3 CH2CH3 cy-6 HCl KHG24262 H 1 0 4-Cl n-Bu cy-6 HCl KHG24263 H 1 0 4-Br n-Bu cy-6 HCl KHG24266 H 1 0 4-Cl cy-6 cy-6 HCl KHG24267 H 1 0 3-CF3, 5-CF3 cy-3 cy-6 HCl KHG24268 H 1 0 4-CF3 cy-3 cy-6 HCl KHG24270 H 1 0 4-n-Bu cy-3 cy-6 HCl KHG24271 H 1 0 2-F, 5-Cl cy-3 cy-6 HCl KHG24272 H 1 0 4-CH2CH3 cy-3 cy-6 HCl KHG24273 H 1 0 4-Br cy-3 cy-6 HCl KHG24276 H 1 0 4-OPh CH2CH3 cy-6 HCl KHG24277 H 1 0 4-n-Bu CH2CH3 cy-6 HCl KHG24278 H 1 0 2-F, 5-NO2 CH2CH3 cy-6 HCl KHG24279 H 1 0 4-CH3 CH2CH3 cy-6 HCl KHG24280 H 1 0 4-CF3 CH2CH3 cy-6 HCl KHG24281 H 1 0 4-OPh n-Bu cy-6 HCl KHG24282 H 1 0 4-n-Bu n-Bu cy-6 HCl KHG24283 H 1 0 4-isoPr n-Bu cy-6 HCl KHG24284 H 1 0 4-F n-Bu cy-6 HCl KHG24285 H 1 0 4-CH3 n-Bu cy-6 HCl KHG24286 H 1 0 4-CH2CH3 n-Bu cy-6 HCl KHG24287 H 1 0 4-Cl n-Pr cy-6 HCl KHG24288 H 1 0 4-Br n-Pr cy-6 HCl KHG24290 H 1 0 4-OPh n-Pr cy-6 HCl KHG24291 H 1 0 4-n-Bu n-Pr cy-6 HCl KHG24292 H 1 1 4-CH3 CH2CH3 cy-6 HCl KHG24293 H 1 1 4-CH3 n-Bu cy-6 HCl KHG24294 H 1 0 4-isoPr n-Pr cy-6 HCl KHG24295 H 1 0 2-F, 5-NO2 n-Pr cy-6 HCl KHG24296 H 1 0 4-F n-Pr cy-6 HCl KHG24297 H 1 0 4-CH3 n-Pr cy-6 HCl KHG24298 H 1 0 4-CH2CH3 n-Pr cy-6 HCl KHG24299 H 1 0 4-Cl benzyl cy-6 HCl KHG24300 H 1 0 4-Br benzyl cy-6 HCl KHG24303 H 1 0 4-isoPr benzyl cy-6 HCl KHG24305 H 1 0 4-F benzyl cy-6 HCl KHG24306 H 1 0 4-CH2CH3 benzyl cy-6 HCl KHG24307 H 1 0 3-CF3, 5-CF3 cy-6 cy-6 HCl KHG24313 H 1 0 4-CH3 cy-6 cy-6 HCl KHG24315 H 1 0 4-OPh cy-3 cy-6 HCl KHG24336 H 0 1 3-Cl CH3 cy-7 HCl KHG24337 H 0 1 4-Cl CH3 cy-7 HCl KHG24338 H 0 1 3-Cl, 4-Cl CH3 cy-7 HCl KHG24339 H 0 1 4-OCH3 CH3 cy-7 HCl KHG24403 H 1 0 4-F CH2CH3 cy-6 HCl KHG24404 H 1 0 4-CF3 n-pr cy-6 HCl KHG24405 H 1 0 3-Cl, 4-CH3 n-pr cy-6 HCl KHG24406 H 1 0 4-n-Bu benzyl cy-6 HCl KHG24407 H 1 0 4-CF3 benzyl cy-6 HCl KHG24408 H 1 0 2-F, 5-Cl benzyl cy-6 HCl KHG24409 H 1 0 4-n-Bu CH3 1-Ad HCl KHG24410 H 1 0 3-Cl, 5-Cl CH3 1-Ad HCl KHG24411 H 1 0 2-F, 4-Cl CH3 1-Ad HCl KHG24412 H 1 0 H CH3 1-Ad HCl KHG24413 H 1 0 2-Cl, 4-CH3 CH3 1-Ad HCl KHG24414 H 1 0 3-Cl, 5-Cl CH2CH3 cy-6 HCl KHG24415 H 1 0 3-Cl, 5-Cl n-pr cy-6 HCl KHG24416 H 1 0 3-Cl, 5-Cl n-Bu cy-6 HCl KHG24417 H 1 0 3-Cl, 5-Cl CH3 1-Ad HCl KHG24418 H 1 0 2-Cl, 4-CH3 CH3 1-Ad HCl KHG24419 H 1 0 4-OCH3 CH3 1-Ad HCl KHG24420 H 1 0 2-Cl, 4-CH3 CH2CH3 cy-6 HCl KHG24421 H 1 0 2-Cl, 4-CH3 n-Bu cy-6 HCl KHG24422 H 1 0 3-Cl, 5-Cl benzyl cy-6 HCl KHG24445 H 1 0 4-NO2 CH3 cy-7 HCl KHG24448 H 1 0 4-NHTs CH3 cy-7 HCl KHG24449 H 1 1 4-NHTs CH3 cy-7 HCl KHG24480 CH3 1 0 4-Cl CH3 cy-6 0 KHG24482 CH3 1 0 4-Br CH3 cy-6 0 KHG24483 CH3 1 0 3-Cl, 5-Cl CH3 cy-6 0 KHG24484 CH3 1 0 2-F, 5-NO2 CH3 cy-6 0 KHG24486 CH3 1 0 4-Br CH3 cy-7 0 KHG24516 CH3 1 0 4-n-Bu CH3 cy-7 HCl KHG24517 CH3 1 0 4-CH2CH3 CH3 cy-7 HCl KHG24518 CH3 1 0 4-F CH3 cy-7 HCl KHG24519 CH3 1 0 4-isoPr CH3 cy-7 HCl KHG24520 CH3 1 0 4-CF3 CH3 cy-7 HCl KHG24521 CH3 1 0 4-t-Bu CH3 cy-7 HCl KHG24522 CH3 1 0 3-CF3, 5-CF3 CH3 cy-6 HCl KHG24523 CH3 1 0 4-CH2CH3 CH3 cy-6 HCl KHG24524 CH3 1 0 4-OCF3 CH3 cy-6 HCl KHG24525 CH3 1 0 4-F CH3 cy-6 HCl KHG24526 CH3 1 0 4-isoPr CH3 cy-6 HCl KHG24527 CH3 1 0 4-CF3 CH3 cy-6 HCl KHG24528 H 1 0 3-isoPr CH3 cy-6 HCl KHG24529 H 1 0 3-CF3, 5-CF3 CH3 cy-6 HCl KHG24530 H 1 0 2-Cl, 3-Cl CH3 cy-6 HCl KHG24531 H 1 0 3-Cl, 4-Cl CH3 cy-6 HCl KHG24532 H 1 0 2-Cl, 5-Cl CH3 cy-6 HCl KHG24533 H 1 0 2-Cl, 4-Cl, 5-Cl CH3 cy-6 HCl KHG24534 H 1 0 3-F, 5-F CH3 cy-6 HCl KHG24535 H 1 0 4-CH3 cy-6 cy-6 HCl KHG24547 H 1 1 2-CF3 cy-6 cy-6 HCl KHG24626 H 0 1 2-F, 5-F CH3 cy-7 HCl KHG24627 H 0 1 3-F, 4-F CH3 cy-7 0 KHG24628 H 0 1 4-CH3 CH3 cy-7 0 KHG24629 H 0 1 4-CH3 CH3 cy-7 HCl KHG24630 H 0 1 3-CF3, 5-CF3 CH3 cy-7 0 KHG24632 H 0 1 3-CF3, 5-CF3 CH3 cy-7 HCl KHG24633 H 0 1 2-Br CH3 cy-7 0 KHG24634 H 0 1 2-Br CH3 cy-7 HCl KHG24636 CH3 1 0 3-F CH3 cy-6 HCl KHG24638 CH3 1 0 H CH3 cy-7 HCl KHG24639 CH3 1 0 4-CH3 CH3 cy-7 HCl KHG24640 CH3 1 0 2-F CH3 cy-7 HCl KHG24641 CH3 1 0 3-F CH3 cy-7 HCl KHG24642 CH3 1 0 4-NO2 CH3 cy-7 HCl KHG24643 CH3 1 0 4-Cl CH3 cy-7 HCl KHG24644 CH3 1 0 3-Cl, 5-Cl CH3 cy-7 HCl KHG24645 CH3 1 0 2-F, 5-NO2 CH3 cy-7 HCl KHG24646 CH3 1 0 3-CF3, 5-CF3 CH3 cy-7 HCl KHG24647 CH3 1 0 4-OCF3 CH3 cy-7 HCl KHG24656 CH3 1 0 4-t-Bu CH3 cy-5 HCl KHG24657 CH3 1 0 4-Cl CH3 cy-5 HCl KHG24666 H 0 1 3-F CH3 cy-7 HCl KHG24667 H 0 1 3-F CH3 cy-7 0 KHG24668 H 0 1 3-Br CH3 cy-7 HBr KHG24669 H 0 1 3-Br CH3 cy-7 0 KHG24670 H 0 1 2-CF3 CH3 cy-7 HBr KHG24671 H 0 1 2-CF3 CH3 cy-7 0 KHG24775 H 1 0 4-Cl n-Bu 1-Ad HCl KHG24776 H 1 0 4-n-Bu n-Bu 1-Ad HCl KHG24777 H 1 0 4-CF3 n-Bu 1-Ad HCl KHG24780 H 1 0 4-F n-Bu 1-Ad HCl KHG24781 H 1 0 4-CH3 n-Bu 1-Ad HCl KHG24782 H 1 0 4-CH2CH3 n-Bu 1-Ad HCl KHG24783 H 1 0 2-F, 4-Cl n-Bu 1-Ad HCl KHG24784 H 1 0 4-Br n-Bu 1-Ad HCl KHG24785 H 1 0 2-F, 5-Cl n-Bu 1-Ad HCl KHG24788 H 1 0 4-isoPr cy-3 1-Ad HCl KHG24789 H 1 0 4-n-Bu cy-3 1-Ad HCl KHG24790 H 1 0 4-CF3 cy-3 1-Ad HCl KHG24792 H 1 0 3-CF3, 5-CF3 cy-3 1-Ad HCl KHG24795 H 1 0 4-isoPr n-Bu 1-Ad HCl KHG24798 H 1 0 4-CH2CH3 cy-3 1-Ad HCl KHG24800 H 1 0 4-OPh cy-3 1-Ad HCl KHG24801 H 1 0 2-F, 4-Cl cy-3 1-Ad HCl KHG24802 H 1 0 2-F, 5-Cl cy-3 1-Ad HCl KHG24803 H 1 0 3-OCH2O-4 n-Bu 1-Ad HCl KHG24804 H 1 0 3-OCH2O-4 cy-3 1-Ad HCl KHG24805 H 1 0 3-Cl, 5-Cl n-Pr 1-Ad HCl KHG24807 H 1 0 4-isoPr n-Pr 1-Ad HCl KHG24808 H 1 0 4-n-Bu n-Pr 1-Ad HCl KHG24809 H 1 0 4-CF3 n-Pr 1-Ad HCl KHG24811 H 1 0 4-F n-Pr 1-Ad HCl KHG24812 H 1 0 4-Br n-Pr 1-Ad HCl KHG24813 H 1 0 4-CH3 n-Pr 1-Ad HCl KHG24814 H 1 0 4-CH2CH3 n-Pr 1-Ad HCl KHG24815 H 1 0 4-OPh n-Pr 1-Ad HCl KHG24816 H 1 0 2-F, 4-Cl n-Pr 1-Ad HCl KHG24817 H 1 0 2-F, 5-Cl n-Pr 1-Ad HCl KHG24818 H 1 0 2-Cl, 4-CH3 n-Pr 1-Ad HCl KHG24819 H 1 0 4-isoPr CH2CH3 1-Ad HCl KHG24820 H 1 0 4-n-Bu CH2CH3 1-Ad HCl KHG24821 H 1 0 4-CF3 CH2CH3 1-Ad HCl KHG24823 H 1 0 4-Cl isoPr 1-Ad HCl KHG24826 H 1 0 4-CF3 isoPr 1-Ad HCl KHG24828 H 1 0 3-CF3, 5-CF3 isoPr 1-Ad HCl KHG24829 H 1 0 4-F isoPr 1-Ad HCl KHG24831 H 1 0 4-CH3 isoPr 1-Ad HCl KHG24832 H 1 0 4-CH2CH3 isoPr 1-Ad HCl KHG24833 H 1 0 4-OPh isoPr 1-Ad HCl KHG24834 H 1 0 2-F, 4-Cl isoPr 1-Ad HCl KHG24835 H 1 0 2-F, 5-Cl isoPr 1-Ad HCl KHG24836 H 1 0 2-Cl, 4-CH3 isoPr 1-Ad HCl KHG24837 H 1 0 3-OCH2O-4 n-Pr 1-Ad HCl KHG24838 H 1 0 3-OCH2O-4 isoPr 1-Ad HCl KHG24839 H 1 0 2-F, 5-NO2 n-Pr 1-Ad HCl KHG24840 H 1 0 2-F, 5-NO2 isoPr 1-Ad HCl KHG24842 H 1 0 4-F CH3 2-Ad HCl KHG24847 H 1 0 4-CH2CH3 CH2CH3 1-Ad HCl

wherein, cy-5 indicates cyclopentyl, cy-6 indicates cyclohexyl, cy-7 indicates cycloheptyl, Pr indicates propyl, Bu indicates butyl, Ph indicates phenyl, 1-Ad indicates 1-adamantyl, 2-Ad indicates 2-adamantyl, and wherein R2, R3, and R4 represent substituents at the phenyl group, and when the substituent is hydrogen, it is not indicated.
 6. A composition for inhibiting T-type calcium channel activity containing the compound of claim 1 as an active ingredient.
 7. A composition for treating a disease or symptom selected from the group consisting of pain, epilepsy, hypertension, and angina pectoris, which contains the compound of claim 1 as an active ingredient, wherein the disease or symptom is triggered by over-expression of T-type calcium channel.
 8. A composition for food or food additives containing the compound of claim
 1. 9. A method of preparing the compound represented by Chemical Formula I, comprising the steps of: heating/reflowing the compounds represented by Chemical Formulas II and III in a solution of a C1 to C5 alcohol for 5 to 20 hours at 20to 130° C., to prepare the compound represented by Chemical Formula IV; adding a basic aqueous solution, heating/reflowing for 30 minutes to 5 hours at 20 to 120° C., and then adjusting the pH to 1 to 4 by adding a hydrogen halide, to prepare the compound represented by Chemical Formula V; and adding the compound represented by Chemical Formula VI and an amide condensation binder to the obtained compound represented by Chemical Formula V, and allowing them to react, to prepare the compound represented by Chemical Formula I:

wherein R₁ is a hydrogen atom, or a C1-C5 linear or branched alkyl group, R₂, R₃, and R₄ are the same or different from one another, and are independently selected from the group consisting of a hydrogen atom, a halogen atom, a C1C5 linear or branched alkyl group, a C1-C5 alkyloxy group, a trifluoromethyl group, a trifluoromethoxy group, a phenyloxy group, an amino group, a methanesulfoneamino group, a paratoluenesulfoneamino group, a nitro group, a C1-C5 cyanoalkyl group, a cyano group, a C1-C6 alkoxycarbonyl group, and a C3-C12 cycloalkyl group, R₅ is selected from the group consisting of a C1-C5 linear or branched alkyl group, a C3-C6 cycloalkyl group, and a benzyl group, R₆ is selected from the group consisting of cyclopentyl, cyclohexyl, cycloheptyl, methyl-cyclohexyl, 1-adamantyl, and 2-adamantyl, n and m may be independently 0 or 1, X and Y are the same or different from each other and are independently selected from the group consisting of fluorine, chlorine, bromine, and iodine, and HX is present or absent.
 10. A method of preparing the compound represented by Chemical Formula I comprising the step of heating/reflowing the compounds represented by Chemical Formulas VII and VIII in a solution of a C1 to C5 alcohol for 5 to 25 hours at 20 to 130° C., and allowing them to directly react, to prepare the compound represented by Chemical Formula I:

wherein R₁ is a hydrogen atom, or a C1-C5 linear or branched alkyl group, R₂, R₃, and R₄ are the same or different from one another, and are independently selected from the group consisting of a hydrogen atom, a halogen atom, a C1-C5 linear or branched alkyl group, a C1-C5 alkyloxy group, a trifluoromethyl group, a trifluoromethoxy group, a phenyloxy group, an amino group, a methanesulfoneamino group, a paratoluenesulfoneamino group, a nitro group, a C1-C5 cyanoalkyl group, a cyano group, a C1-C6 alkoxycarbonyl group, and a C3-C12 cycloalkyl group, R₅ is selected from the group consisting of a C1-C5 linear or branched alkyl group, a C3-C6 cycloalkyl group, and a benzyl group, R₆ is selected from the group consisting of cyclopentyl, cyclohexyl, cycloheptyl, methyl-cyclohexyl, 1-adamantyl, and 2-adamantyl, n and m are independently 0 or 1, HX is present or absent, and when HX is present, X is a halogen atom. 